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Abstract
This thesis describes studies into the synthesis of the batzelladine alkaloids including a 
detailed study into the synthesis of alkylidenepyrrolidines.
Chapter 1 is a brief introduction to the batzelladine alkaloids highlighting all significant 
work carried out since their isolation in the mid 1990’s.
Chapter 2 looks at the viability of Lewis acid promoted Friedel-Crafts reactions for the 
formation of quinolones, and the usefulness of this reaction to the synthesis of 
batzelladine alkaloids.
Chapter 3 includes a detailed methodology study into the formation of 
alkylidenepyrrolidines, and the reasons why a new synthesis is required.
Chapter 4 investigates the Kishi three-component coupling reaction, including a 
mechanistic study and a synthetic study.
Chapter 5 describes our work into the synthesis of batzelladine C and incorporates the 
work carried out and detailed in Chapters 2 and 3.
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Abbreviations
Ac Acetyl
AIBN 2,2’-Azobisisobutyronitrile
AIDS Acquired Immune Deficiency Syndrome
All Allyl
APCI Atmospheric Pressure Chemical Ionisation
Bn Benzyl
Boc f-Butoxycarbonyl
Cbz Benzyloxycarbonyl
CDI Carbonyldiimidazole
COSY Correlation spectroscopy
DCM Dichloromethane
de Diastereomeric excess
DIOP 4,5-bis(diphenylphosphino-methyl)-2,2-dimethyl-dioxolane
DMAP 4-Dimethylaminopyridine
DME Ethyleneglycol dimethylether
DMF V,V-Dimethylformamide
DMP Dess-Martin periodate
DMSO Dimethylsulphoxide
ee Enantiomeric excess
Et ethyl
g-NOSEY gradient Nuclear Overhauser Enhancement Spectroscopy 
HIV Human Immunodeficiency Virus
HMPA Hexamethylphosphoramide
IPA Isopropyl alcohol
IR Infra Red
KHMDS Potassium bis(trimethylsilyl)amide
LDA Lithium diisopropylamide
m-CPBA meta Chloroperbenzoic acid
Me methyl
MEM 2-Methoxyethoxymethyl
MPM para-methoxybenzyl
Moc Methoxycarbonyl
Ms Methanesulphonyl
NMR Nuclear Magnetic Resonance
nOe Nuclear Overhauser Effect
NOESY Nuclear Overhauser Enhancement Spectroscopy
Nu Nucleophile
Ph Phenyl
PPA polyphosphoric acid
psi pounds per square inch
p-Tol para- Tolyl
PTSA para-T oluenesulphonic acid
RT Room Temprature
SET Single Electron Transfer
TBAF Tetrabutylammonium fluoride
TBS r-Butyldimethylsilyl
Tf Trifluoromethanesulphonyl
TFA Trifluoroacetic acid
TFAA Trifluoroacetic anhydride
THF Tetrahydrofuran
Ts 4-Toluenesulphonyl
Chapter 1
Introduction to the Batzelladine 
Alkaloids
1
Introduction to the Batzelladine alkaloids
During the 1990’s scientists at SmithKline Beecham were investigating potential new 
treatments for HIV. Specifically, they had been investigating the binding of the gpl20 
glycoprotein to the CD4 receptor of the human T-lymphocyte cells. This binding is vital 
to the replication of the virus as it controls the entry of the virus into the human cells. 
Without access to the biochemical environment within the cell the virus is unable to 
replicate. Any compound capable of interrupting or inhibiting this interaction would 
potentially be a treatment for HIV. Over 5000 biologically active natural product 
extracts were tested for their ability to disrupt the gpl20-CD4 binding. Of all the extracts 
tested, only one displayed activity in the absence of light, the methanolic extract of the 
bright red Caribbean Sponge Batzella sp. Bioassay-directed fractionation, followed by 
chromatography led to the isolation of 21 compounds, of which five were novel 
alkaloids of similar nature named collectively as the Batzelladines, and subcategorised 
by letters. The initially proposed structures of batzelladine A -  E are shown in Figure 1, 
although some of these structures have been revised (vide infra).
The structures of these compounds were elucidated using an array of NMR techniques 
combined with mass spectrometric information and degradation products. Results from 
some showed similarities to the compound crambescin A (1). Unfortunately they were 
unable to acquire X-ray data so that the absolute configuration of the stereogenic centres 
could not be fully determined.1
NH
Crambescin A (1)
2
NH
H
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' 9n 19
NH
NH
H
N
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N
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Figure 1 Initially proposed structures o f batzelladines A - E
Two years later, the same group isolated four more batzelladine alkaloids (Figure 2). 
These compounds were shown to be active in the dissociation of protein tyrosine kinase 
from the CD4 receptor on T-lymphocyte cells. It is believed that this binding is critical 
in the initiation of antigenic responses. If this was the case these compounds could
3
provide treatment for autoimmune disorders like murine lupus and allergic 
encephalomyelitis.2
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Figure 2 Initially proposed structures o f batzelladines F - 1
In early 2005 Gallimore et al. were investigating new lead compounds and extracted the 
Caribbean Sponge Monanchora unguifera. Among already known guanidine compounds 
was the new alkaloid batzelladine J ( l l ) .3
4
Batzelladine J (11)
Since 1995 the batzelladine alkaloids have been the subject of a great deal of research by 
groups across the world. However, to date there have been relatively few 
enantioselective total syntheses published and a number of the alkaloids are still to be 
synthesised.
The earliest reported investigations into the batzelladine alkaloids is by Rao et al. in 
1995 when they reported the synthesis of the tricyclic guanidine core of batzelladine A 
(Scheme l).4 Their synthesis is based around the pyrrole intermediate 13, which, in turn, 
was synthesised from the commercially available azetidinone 12 in 18 steps. This has all 
the necessary stereogenic centres in place for the final guanidine. Deprotection and 
reaction with carbonyl diimidazole yielded the urea 14, which was O-methylated, and, 
following reduction of the azide, cyclised to the tricyclic guanidine 15.
5
O TBS
>OAc
NH
12
18  S tep s
HoC C9 H1 9
>TBDE&
15
CoH9n 19
1) Me2 S 0 4, PhH, 
reflux, 16 h.
2 ) H2, P d -B a S 0 4  
MeOH, 12 h.
69%
65% 1) TFA, DCM,
0 aC - rt, 30  min.
2) CDI, THF, 0 = 0 .
TBD
14
9 n 19
Scheme 1
During the early 1990’s, Snider and co-workers had been studying the marine natural 
product ptilomycalin A, which contains a similar tricyclic guanidine 16 to that found in 
the batzelladine alkaloid family. Already they had a synthesis in place for the formation 
of the tricyclic core of ptilomycalin A (Scheme 2) that with slight modification could be 
used for the formation of the batzelladine alkaloids.5
Me
O TBS TBSO-
Et
Me
16
Scheme 2
6
Over a period of two years Snider and his group synthesised the tricyclic cores of 
batzelladines A, B and D6 and achieved the total synthesis of batzelladine E by using 
modifications of their original synthesis. Scheme 3 shows their key precursor 17 for the 
formation of batzelladine E. Notably this was a simpler intermediate to make than for 
previous substrates and contained all the desired side chains for the final compound. A 
double conjugate addition reaction with O-methylisourea gave compound 18 as the 
major isomer, which underwent amination and further cyclisation to give compound 19. 
This was then converted into structure 6, the proposed structure of batzelladine E.7
O-Methylisourea, 
Hunig's B ase, 
DMSO  
55 8 C, 4  h.
C.H4n 9
64%
42%
C4 H9
1) NH4 OAc, NH3, 
f-BuOH, 60 eC.
2) NaCNBH3, NaH 2 P 0 4  
MeOH, rt.
C5 H1 1  N N 
H
c 4H9
r -
Scheme 3
On comparison of the *H NMR spectrum of this compound with that of natural 
batzelladine E, Snider observed differences. This prompted the synthesis of the 
cw-double bond isomer 18 using an identical process for the cyclisation reaction to that 
previously shown. The spectroscopic data obtained for this compound were identical to 
those of the natural product, resulting in the revision of the structure of batzelladine E to 
compound 20.
7
NH
Revised structure of Batzelladine E (20)
In related work,6 the original stereochemistry of the tricyclic portions of batzelladine A 
and D were shown to be incorrect. Compound 22 was prepared from the minor trans 
isomer 21 (Scheme 4) isolated from a similar reaction to that shown in Scheme 3.
E t0 2C
9 '  '19
1) NaBH4, IPA, rt.
2) NH4 OAc, NH3, 
MeOH, 60 BC, 4 8  h.
C9H19
22
1) NaCNBH3, 
NaH 2 P 0 4, rt,
16  h, 6 5  BC ,18 h.
2) NaOH, MeOH  
rt,18 h.
H3C N ^ H O  CgH-j 9 
NH2
E t0 2C
H ,C  N N
DMP, DCM, rt, 
MeOH, rt, 12  h.
r c 9H19
H OM e
Scheme 4
The data for the acid 22 was identical to that derived from the degradation of 
batzelladine A. From this work, Snider was able to revise the structures of batzelladines 
A (23) and D (24).
8
NH Revised structure of Batzelladine A (23)
H
N
NH
Revised structure of Batzelladine D (24)
During this time, Murphy et al. were also working on the ptilomycalin A systems, and 
had developed a similar bis-enone double Michael acceptor 25. The key difference was 
the use of guanidine itself as the nucleophile followed by cyclisation of the spirocyclic 
units (Scheme 5).8
O TBS
T BSO
25
1) Guanidine-DM F, 3 h.
2 ) MeOH, HCI, 0  SC.
3) HBF4, HgO.
2 0 % BF,
Scheme 5
Again, transfer of this system to that required for the batzelladine alkaloids involved a 
significantly less complex intermediate 26. With an added reduction step, the tricyclic 
guanidine 27 was produced as a single diastereoisomer (Scheme 6).9
9
1) Guanidine-DM F, 3 h.
2) NaBH4, THF.
3) MeOH, HCI, 0 SC.
4) HBF4, H2 0 .
H3C O O C9H19
31 %
26
Scheme 6
This system produced only the cis isomer, the incorrect isomer for tricyclic portions of 
batzelladine A and D from Snider's revised models. However, on comparison with the 
left-hand tricyclic portion of batzelladine F, similarities were observed. Independent 
work by Murphy and Snider led to the revised structure of batzelladine F (28).10
Me
Revised structure of Batzelladine F (28)
In the early 1990’s Overman’s group had been developing a tethered Biginelli 
condensation directed towards the total synthesis of ptilomycalin A. Condensation of 
urea 29 with /J-ketoester 30 formed the bicyclic urea 31 with good stereocontrol 
(Scheme 7).11 As this method uses chiral non-racemic starting materials, the formation 
of a single enantiomer of the target compound is possible.
10
HO N 
H2N ^ O
TIPSO
Morpholine, H C 0 2 H, 
EtOH, N agSO ^ 70 °C.
29
61 %
TIPSO
R 0 2C
S te p s
Ptilomycalin A
Scheme 7
A similar approach was then applied to the batzelladine alkaloids;12 the logical starting 
point was batzelladine B, which requires a cis relationship of protons straddling the 
pyrrolidine nitrogen. To keep conditions of the tethered Biginelli consistent with those 
previously used, the cyclic guanidine 32 was synthesised. Upon hydrolysis of the acetal, 
spontaneous cyclisation was observed to give the bicyclic guanidine 33, which could 
then be condensed under normal conditions to give the tricyclic guanidine 34 in a high 
yield and good stereoselectivity (90 %, 80 % de) (Scheme 8).13
11
MeO
)Me
C7H’5 Zn, H“  N
H N ^ N H  Ac0H-H20. © © I
T  --------------- ~ Cl H2N^ N'
NHTroc 1 0 0 %  M
C7H7n 15
3 2 33
9 4  %, 80  % de
Morpholinium acetate, 
N a 2 S 0 4, C F 3 CH 2 OH, 90 °C ,  
M ethylacetoacetate.
H3C N 0 N
34
Scheme 8
Attention turned then to batzelladine D. The significant difference here is that a trans 
arrangement of protons is seen around the pyrrolidine nitrogen. To achieve this Overman 
used the acyclic guanidine 35 instead of the cyclic guanidine 32 shown above as the 
Biginelli precursor. This allowed good control (6.1 : 1) over the stereochemical outcome 
of the reaction, after hydrolysis and Biginelli reactions the bicyclic guanidine 37 was 
obtained with trans stereochemistry. Formation of the tricyclic system was achieved by 
activation of the hydroxyl group and displacement by the guanidine NH2. The only 
significant downside to this route was the hydrogenation of the double bond, which 
proceeded with a yield of only 23 %, with the majority of the product being an undesired 
diastereoisomer (Scheme 9).14
12
>Me
MeO
CbHu
H2 N ^ N H  OH 
II 100
NH
35
1 ) AcOH-H2 0 ,  rt.
2) 36 , Morpholinium 
a ceta te , NaH 2 P 0 4
5 5 %
RO'
H ©H
Rh-Al2 0 3) H2, 
50  psi, MeOH, 
EtOAc.
2 3 %
R 0 2C
37
C qH9n 19
6 0 %
1) MsCI, NEt3> 
0 °C  to rt.
2 ) NEt3, CHCI3  
reflux.
R 0 2C
H3C N © N  c 9 h 1 9  
3  H Cl H 9  1 9
36 R = (CH2)4NHCbz
Scheme 9
Overman’s most impressive achievement in the batzelladine campaign was the total 
synthesis of batzelladine F.15 Within this synthesis a linear approach was utilised which 
saw the Biginelli reaction developed for batzelladine B used to form the left-hand 
tricyclic core 38 (Scheme 10).
13
NHCbzx
HN NH
1) 50 psi H2  10% Pd-C, 
AcOH, MeOH.
2) AcOH, H2 O.
9 8 %
■N ‘° H
^  X ®  ®
Me N NH2  A cO
H z
8 2 %
39 , Morpholine, AcOH, 
N a 2 S 0 4, C F 3 CH2 OH, 
60 QC.
AII02C
O T B D PS
C 0 2AII 0 T B D p s
Me'
AcO
38
Scheme 10
The protecting group was removed and the side chain manipulated to generate the 
/^-ketoester 40 necessary for the second tethered Biginelli reaction. This was carried out 
using the methodology developed for batzelladine D, and with a further hydrogenation 
completed the enantioselective total synthesis of batzelladine F (42) (Scheme 11).
14
TBS'
0
HO
AcO
3 equivalen ts 41 , Morpholine, 
AcOH, NaH 2 P 0 4,
CF 3 CH3 OH.5 9 %
HO
S tep s
Revised structure for Batzelladine F (42)
Scheme 11
It is important to note that this structure differs from that originally proposed by Patil. 
The revision of the structure of batzelladine F was made on the basis of the synthesis of 
this compound and various stereoisomers, along with the synthesis of stereoisomers of 
the originally proposed structure. Using this same method a number of batzelladine F 
analogues were synthesised and tested for biological activity.16
Having completed the total synthesis of batzelladines D and F, attention was turned to 
dehydrobatzelladine C. The major difference between the tricyclic moieties is in the
15
oxidation state with dehydrobatzelladine C containing a tetrahydro-5,6,6a- 
triazaacenaphthalene ring system. The tricyclic compound 43 was synthesised using the 
method described previously, and was then oxidised using eerie ammonium nitrate to the 
necessary oxidation state 44 (Scheme 12).17
C 0 2 (CH2)4NHBoc
9 3 %
Scheme 12
In the late 1990’s Nagasawa et al. were investigating ways of controlling protein-protein 
interactions with small molecules; their chosen target was batzelladine D (22).
In their approach the key transformations are two 1,3-dipolar cycloadditions. The first is 
between the nitrone 45 and 1-undecene to give isoxazolidine 46, which is then 
oxidatively cleaved to regenerate the nitrone functionality. The second cycloaddition is 
between this newly regenerated nitrone 47 and methyl crotonate, which gives compound 
48 with the desired trans configuration of protons around the pyrrolidine nitrogen 
required for batzelladine D. The guanidine moiety is added in a single step from addition 
of the activated thiourea 49 to the pyrrolidine nitrogen to give the guanidine 50, which is 
set up for two Mitsunobu reactions to complete the tricyclic system (Scheme 13).18 A 
similar approach was used to confirm the stereochemistry of the left-hand tricyclic 
portion of batzelladine F.19
16
100%
T BSO  '''•
H3C O H T B SO
1) LiAIH4, Et2 0 ,  0 °C
2) TBSCI, Imidazole,
DCM, rt.
3 ) H2, Pd-C, EtOH, rt. vNH
i________________  Me02C '< ./^  ^
Methyl crotonate, 
T oluene,
H,C
'CgH 19
49
C b z N ^  NCbz 
H
HgCI2 i NEt3i DMF.
NHCbzC bzN
Scheme 13
Modifications to the synthesis allowed the use of a chiral nitrone (51) as the starting 
material, opening up an enantioselective route; this method was then used to form 
compound 52 corresponding to the bicyclic portion of batzelladine A (Scheme 14).20
MPM
PhCH3, 90 fiC 
4 0 %
51
P T IP S
OMPM
C 0 2Me
S te p s
----------- ^ N v ^ N B o cT
N Boc
52
Scheme 14
Chronologically, the first to turn their attention to the bicyclic portions of batzelladines 
A and B were the Gin group who developed a stepwise synthesis of the bicyclic 
guanidine 53 from the bromolactone 54, which gave the urea 55 after an Eschenmoser 
sulphide contraction and condensation with bis(4-nitrophenyl)carbonate 56. 
Methanolysis of the urea 55 followed by 0-methylation of the urea gave the robust 
isourea 57, which with further manipulation was converted into the hydrolysis product 
of batzelladine A 53 (Scheme 15).21
Br"«.
CbzN  
H 5 4
1) Pyrrolidine-2- 
thione, 90  SC.
2) P P h 3> NEt3> CHCI3
51 %
H
C bzN . 56 , N aH .T H F ,
71 %
'N N Cbz 
>H
J J H 2+ 0 2CH S tep s  
'N NH  -------—
OH
C 0 2Me u n  
53
N N
70 % 2  step s
1 )A c 2 0 ,N E t3> 
DMAP, DCM.
2) MeOTf, DCM.
V -O A c  88 °/o 2 Steps 
C 0 2Me
57
1 ) H2  Pd-C, 
EtOAc.
2 ) N aOM e, 
MeOH.
N NH
C 0 2M e
Scheme 15
During this time the Elliott group had been investigating the synthesis of the bicyclic 
and tricyclic cores needed for batzelladine A. The strategy employed differed from other 
groups, by utilising the same reaction pathways for both cyclic guanidines. Initial work 
was based on their annulation of azolines (Scheme 16).22
18
PhHN ^  kl™-
2 equivalents PhNCO
Et
48  h, rt, 
5 8 % Et
Scheme 16
It is clear to see the similarities between these products and the cyclic cores of the 
batzelladine alkaloids. Conceptually, the bicyclic core of batzelladines A and B could be 
prepared by reaction of an alkenylpyrroline with an isothiocyanate followed by acylation 
with a chloroformate (Scheme 17).23
Scheme 17
Unfortunately, this sequence of steps proved not to be viable, and a modified route was 
devised. This utilised a three-component coupling reaction of alkylidenepyrrolidine 58, 
an aldehyde and silicon tetraisothiocyanate (Scheme 18).
C IC 02R
Me Me
S i(N C S)4, MeCHO
b en zen e , 3 h 
81%OTBS OTBS OTBS
5 8 59 60
2
Scheme 18
With variation of the side chain in the 5-position this route could also be applied to the 
tricyclic cores of the batzelladine alkaloids as shown in Scheme 19.24
Me
•C 02Et NH
Si(NCS)4, MeCHO
NH
NHBocHBoc
EtOzC
Scheme 19
To date there has been extensive work carried out on the total synthesis of the 
batzelladine alkaloids, although there have been relatively few enantioselective routes 
reported. A number of the family are still to be synthesised.
20
Chapter 2
Synthesis of Quinolin-2-ones
21
2.1 Introduction
Early investigations, by the Elliott group, into the annulation reactions of 
alkenyloxazolines (Scheme 20) had identified a well-defined transition state in which 
the stereogenic centre induces a helical twist. Therefore, only one face of the alkene is 
available for ring-closure (Figure 3).
V -J
Et
PhNCO,
Heat.
Me
HY ^ N P h
°u 7 A °
Et
Me
PhN 
-  H
NPh
/
Et
Scheme 20
Figure 3 3 dimensional representation of the oxazoline
Following on from these interesting reactions it was postulated that if an acyclic system 
was used, it should be possible to influence the conformation with a Lewis acid (Scheme 
21).
22
RR
Scheme 21
Previous work, highlighted below, has shown that these reactions can be promoted with 
the use of Bronsted and Lewis acids, although to date a very limited range of Lewis 
acids have been used. Asymmetric synthesis has not as yet been attempted by using an 
acid promotion approach. So far the most notable attempts for asymmetric reactions of 
this type have been achieved through photocyclisation in the solid state (Scheme 22). In 
this case exactly the type of ‘chiral twist’ proposed above was observed in the solid state
Of*leading to high asymmetric induction.
C(OH )Ph2
C (O H )Ph 2
Co-crystal
Scheme 22
2.2 -  Background to Quinolin-2-one Synthesis
Quinolin-2-ones have found many applications in synthetic and medicinal chemistry; 
these include non-steroidal hormone interactions for the treatment of breast cancers and 
potential contraceptive properties.27 They have also been shown to be good platelet 
aggregation inhibitors.28
23
Early synthetic methods utilised a strong acid to cyclise aromatic amides. In 1945, 
Kaslow et al. reported the amide cyclisation with sulphuric acid to give the
OQcorresponding quinoline (Scheme 23).
a / 1
Me 
59
Scheme 23
A similar cyclisation used polyphosphoric acid at 120 °C to cyclise amide 61 (Scheme 
24).30
Ph
O l,X
H 
61
Scheme 24
Over the years free-radical chemistry has been shown to be a versatile way of 
constructing carbon-carbon bonds; this system is no exception lending itself to a number 
of different radical cyclisations. Jones et al. were investigating 6 exo-trig radical 
cyclisation reactions using the unsaturated aromatic amide 63, where the aryl radical 
generated then cyclises onto the double bond (Scheme 25).31
H2 S 0 4
75  fiC 
8 3 %
Me
Me
6 0
24
M e
rjj o
H
63
Bu3 SnCI, NaBH 3 CN,
BuOH
64%
isl O 
H
Scheme 25
As a nice modification to the reaction, both the initial radical and the radical acceptor 
can be on the aromatic side chains. This led to a greater regioselectivity of the 6-exo 
reactions and a higher yielding reaction. Ikeda et al. achieved yields in the region of 90 
% using a chloroamide 64 and tributyltin hydride (Scheme 26).32
Scheme 26
Alternatively the radical can be generated to react with the aromatic ring system. 
Scheme 27 shows the aromatic amide with a sulphonyl group on the side chain 65, this 
sulphonyl group can be removed to generate the radical to form exclusively the six-
Me
CIH2C O 
64
membered product. In this example the tosyl radical is used as the radical source.33
Me
N O
Me
65
C^^ Et
^ S 0 2Allyl TsN a, Cu(OAc ) 2  Me
isi o
Me
C 0 2Et
5 3 %
Scheme 27
25
An interesting way of synthesising a highly substituted quinoline was reported by 
Torroba et al. in which they used an Ugi four-component coupling reaction where amine 
66 is treated with an isocyanide, aldehyde, and a carboxylic acid. This product is then 
nicely set up for an intramolecular Knoevenagel reaction. This method allowed the
Scheme 28
To date only a small amount of the literature has referred to the asymmetric synthesis of 
quinolin-2-ones and those there have been have only achieved moderate yields. Alper et 
al. reported the homogeneous palladium-catalysed cyclisation of amine 67 in a high 
pressure atmosphere of carbon monoxide with the chiral ligand 2-(-)-DIOP to give the 
quinoline 68 in good yield and a 33 % ee (Scheme 29).35
addition of considerable functionality in a single step (Scheme 28).34
p-CH 3 C 6 H4 CHO,
'O c-CgHuNC, NCCH2C 0 2H,
M eOH, rt, 48  h 
7 2 %
O
Me
26
NH2  CO (500 psi),
H2  (1 0 0  psi) 
DCM, 100 °C, 4 8  h
Pd(OAc)2, 2-(-)-DIOP,
'N O 
H 
6867
91 % yield 
33 % e e
Scheme 29
2.3 New Synthetic Methods
As mentioned at the start of this chapter, it was hoped that the conformation of the 
aromatic amide could be controlled by the use of a Lewis acid. If this was successful, the 
use of a chiral Lewis acid may be able to influence the stereochemical outcome of the 
reaction.
The use of a Lewis acid to promote this reaction had been previously reported, where the 
amide 69 and 6 equivalents of aluminium chloride had been reported to give the desired 
transformation to the quinoline 70 (Scheme 30).36
Me
N O 
H
6  equ iva len ts AICI3  < 4 ?
PhCI, 120 9C 
9 3 % H
69 70
Scheme 30
Our initial studies were carried out on the similar amide 61 synthesised from aniline and 
cinnamoyl chloride (Scheme 31).
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Cinnamoyl chloride 
Et3 N, DMAP,
Scheme 31
Initially the cyclisation reaction of compound 61 was carried out using polyphosphoric 
acid. This gave compound 62 cleanly and in good yield (Scheme 32).
PPA, 120 fiC, 10 min
79 %
Scheme 32
The cyclisation was repeated using amide 61 and a similar method to that reported by 
Tzeng et al. (Scheme 33). Slight variations included the use of 5 equivalents of Lewis 
acid and the temperature was reduced to 90 °C. Although the expected product was 
isolated in 25 % yield, it was clear from the *11 NMR spectrum of the crude reaction 
mixture that a number of side reactions had taken place. It was also noted that the 
aluminium chloride used for this reaction was quite old, and possibly not of good 
quality.
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Scheme 33
The reaction was repeated using fresh aluminium chloride (Scheme 34). On this 
occasion a single product was produced in good yield, however, it was not the desired 
quinoline 62; instead it was the dearylated compound 71.
5 equivalents AICI3,
PhCI, 9 0  BC, 6  h
H
H
61 71
Scheme 34
It was concluded that the original supply of aluminium chloride used was of poor quality 
and the actual amount of Lewis acid added for the first iteration of the reaction was 
unknown. To investigate the effect of variation in concentration of the Lewis acid, a 
range of concentrations were evaluated.
When one equivalent was used (Scheme 35) no reaction was observed and starting 
material was recovered.
1 equivalent AICI3,
H
61
Scheme 35
However when three or more equivalents of aluminium chloride were used the 
dearylated compound 71 was predominant in good yield (Scheme 36).
3 equivalents AICI3,
PhCI, 90  SC, 2  h 
6 0 %
H
61 71
Scheme 36
When two equivalents were used, a range of products were obtained, the majority of 
which was the dearylated quinoline 71 with small amounts of the desired product 62 and 
trace amounts of as yet unidentified side products (Scheme 37).
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2  equ ivalents AICI3,
Scheme 37
Two further reactions were carried out using either one and a half or one and 
three-quarter equivalents. When one and a half equivalents were used, only starting 
materials were recovered. However, when one and three-quarters were used the reaction 
proceeded to give a range of products some of which on comparison with the *H NMR 
of the products from 2 equivalents showed similar coupling and chemical shifts. These 
included the desired quinoline 62. It was also clear that only a very small amount of the 
dearylated product 71 was produced (Scheme 38).
1.75 equivalents AICI3,
+
H
H H
Ph
Ni
61 62 71
H
73
Scheme 38
It was pleasing to see that only a small amount of dearylation had occurred giving 
credence to the method as a way of making the desired compounds. The range of other 
compounds produced was surprising. Tzeng et a l had reported that when benzene was 
used as a solvent, conjugate addition of the solvent was the major product, but when 
chlorobenzene was used no solvent inclusion was observed.37
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As solvent incorporation had been previously reported, compound 73 was not wholly 
unexpected.
On a separate occasion it was also noted that two other compounds where formed during 
the reaction. These compounds 72 and 74 (identified by isotopic ratio patterns in the 
mass spectra) seem to suggest that a degree of reversibility within the reaction must be 
present (Scheme 39). Unfortunately separation of individual compounds was not 
achieved, so full characterisation was not possible.
Ni
H
73
H
75
Scheme 39
Further evidence for reversibility in this type of reaction was published by Olah et a /.,38 
in which he observed a range of products during the superacid-mediated addition of 
benzene to compound 71, and reasoned that the reaction pathway must involve an
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number of steps in equilibrium as shown in Scheme 40. In particular, the loss of benzene 
from compound 62 was demonstrated.
Ph, -H+
N 0 +HN O H
N + OH
Ph, -H+
N+ OHN+ O H N OH
Ph, -H+
N OH
Scheme 40
Tzeng et al. had reported significant differences in the reaction products when 
substituted aromatic rings were used. They did not, however, investigate substitution on 
the nitrogen. We were keen to investigate the scope of the reaction and to see if 
substitution on the nitrogen would affect the reaction in any way. Three other amides 
were synthesised from their respective TV-substituted anilines and cinnamoyl chloride 
(Scheme 41).
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NHi
R
Cinnamoyl chloride 
Et3 N, DMAP,
DCM, rt, 18  h
a R = Me, 83 % 
b R = Ph, 8 5  % 
c R = Bn, 7 8  %
Scheme 41
It was decided initially to try the cyclisation reactions using polyphosphoric acid to 
ascertain whether all the substrates behaved in a similar way to amide 61. This was 
really only a concern for the benzyl derivative 76c where there was a small chance of 
cyclisation though the benzyl group (Scheme 42).
PPA, 120 eC, 10 min
a R = M e, 81 % 
b  R = Ph, 8 5  % 
c R = Bn, 74  %
Scheme 42
It was pleasing to see that all the chosen amides cyclised to give the desired products in 
good yields.
For the cyclisations using aluminium chloride, one and three-quarter equivalents were 
used, as it had given the best results to date; the solvent temperature and length of 
reaction were kept in line with those used before (Scheme 43).
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1.75 equivalents AICI3, 
PhCI, 9 0  °C, 2  h
a  R = Me, 81 % 
b R = Ph, 78  % 
c R = Bn, 41 %
Scheme 43
It was immediately clear that these substrates were behaving differently to amide 61. 
The most notable difference was the amount of solvent incorporation. A slight trace of 
solvent incorporation was detected on the !H NMR spectrum of the crude reaction 
mixture when amide 76a was cyclised. For the others, no solvent incorporation was 
detected. The reaction of 76c was clean with no obviously identifiable side products; 
however, the isolated yield was low.
The use of acids has so far been limited to very strong acids like triflic acid, 
polyphosphoric acid and the Lewis acids aluminium chloride and aluminium bromide. 
We were interested to see whether these reactions could be promoted using a weaker 
Lewis acid. To this end bismuth chloride was examined as a potential alternative. It was 
decided to test just one and a half and two equivalents, as this would provide the 
necessary information to determine whether the two Lewis acids were performing in the 
same manner (Scheme 44).
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61
X equivalents BiCI3
PhCI, 90 2 C, 4  d ays
X = 1 .5 ,7 9  % 
X = 2 , 7 2  % 70
Scheme 44
It was evidently clear that the Lewis acids were performing differently. When the 
reaction was evaluated after two hours, no reaction had taken place, and it took four days 
for the reaction to reach completion. The pleasing result was that only the desired 
compound had been formed and neither solvent incorporation nor dearylation was 
observed. It is plausible that the softer nature of the cation formed with bismuth chloride 
may reduce the likelihood of reaction with chlorobenzene.
Cyclisation reactions were carried out on the amides 76a, 76b and 76c. In these cases 
two equivalents of Lewis acid were used (Scheme 45).
76
2  equ ivalents BiCI3,
PhCI, 9 0  <€, 4  d a y s
a  R = Me, 8 5  % 
b R = Ph, 5 9 %  
c  R = Bn, 31 %
77
Scheme 45
Reactions proceeded well with no incorporation of solvent. However, for R = Bn the 
yield was again low. On this occasion it was possible to identify some of the side 
products (Scheme 46).
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N '^ O  PhC1, 90 4 days
2  equ iva len ts BiCI3,
rsl O 
Bn
fsl O 
HBn 31 %
76c 77c 62 61
Scheme 46
The loss of the benzyl could occur directly, or the reaction could proceed by loss of 
phenyl followed by hydrolysis of the resulting iminium ion.
Our original intention had been to investigate conformational control of the Friedel-Craft 
acylation with the catalytic use of a chiral Lewis acid, although this now looked 
implausible due to the amount of Lewis acid required for the reaction. Conformation of 
the amide may still be playing a role on the outcome of the reaction. The favourable 
conformation for the reaction would be 78 and could easily switch if R = a small group 
e.g. ‘H’ to the less favourable conformation 79. When R = a bulky group e.g. Bn or Ph 
then the most favourable conformation would be the desired 78 (Scheme 47).
78 79
Scheme 47
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If this was the only effect then the rates of reaction should be R = Ph being the fastest as 
only one conformation is available, followed by R =Bn, R = Me and finally R = H. 
However, this is not what was observed in the reactions when bismuth chloride was 
used, they followed the pattern R = Me then R = Ph, R = H and finally R = Bn. One 
possible explanation for this is the accessibility of the carbonyl oxygen, for 
complexation with the Lewis acid. When R = a bulky group the oxygen is being 
sterically hindered, only when R = Me is there a chance of a favourable conformation 
that allows free access to the carbonyl oxygen. A three-dimensional representation of the 
amides (76a) and (76b) (Figure 4) shows the most likely conformations. It can clearly 
be seen that for amide (76a) that the oxygen is less hindered.
76 a  7 6 b
Figure 4 3 dimensional representation of compounds 76a and 76b (MM2 energy 
minermised).
The use of microwave radiation to initiate reactions as an alternative to conventional 
heating has recently received a lot of attention. It was decided to see if this reaction 
could be improved, with the shortening of reaction times and reduction of side reactions 
by the use of microwave radiation.
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Due to solubility and safety issues only aluminium chloride in chlorobenzene was 
investigated. The conditions used were 15 minutes at 100 watts (Scheme 48).
2 equivalents AICI3,
PhCI, 15  min, 100 W
a R = Me, 53%  
b R = Ph, 60%  
c  R = Bn, 33 %
7 7
Scheme 48
For this part of the investigation we wanted to observe quantities converted and product 
distributions; to do this the ]H NMR spectra of the crude reaction mixtures were used. It 
was decided not to try the reaction for amide 61 due to the complex mixture of products 
obtained.
One of the advantages of the microwave equipment used39 is the ability to keep the 
reaction at a constant temperature under continuous microwave irradiation. This means 
that the reaction is as much as possible being promoted by the microwave influence and 
it is not just an alternative heating source.
Rates of conversion were R = Ph = R = Me > R = Bn. One possible reason for the 
similar rates of reaction of R = Ph and R = Me could be that the microwave radiation is 
speeding up interconversion of the two conformations effectively reducing the steric 
hindrance observed under conventional methods. When R = Bn there is still a high level 
of steric hindrance which would still produce a relatively slower reaction time.
The use of microwave radiation did indeed reduce the reaction time, though not by as 
much as had been hoped for. Products from the reactions were almost identical to those 
observed when conventional heating was employed.
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In conclusion to this work, it is our belief that the use of bismuth chloride is the best for 
this kind of reaction, although reaction times are a lot longer the reactions are cleaner 
and less sensitive to small variations in the concentration of Lewis acid used.
Although this work is not directly relevant to the synthesis of the Batzelladine alkaloids, 
and the ultimate goal of achieving an asymmetric synthesis of 3,4-dihydroquinolin-2- 
ones was not explored, it has provided an insight into the mechanism of the cyclisation 
of cinnamamides under various conditions, leading to an improved synthesis of 
3,4-dihydroquinolin-2-ones.
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Chapter 3
Synthesis of Alkylidenepyrrolidines
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3.1 Introduction
The previous approach used by the Elliott group for the synthesis of the batzelladine 
alkaloids utilises an alkylidenepyrrolidine as the key starting material.24 This can be 
transformed into the cyclic guanidine seen in all known batzelladine alkaloids (Scheme 
49). For example, compound 80 would undergo three-component coupling to give 
compound 81, which would then be transformed into the tricyclic target 82. Compound 
83 would give compound 84, which would require removal of the hydroxymethyl group 
to give the bicyclic target 85.
C9H19
/ x S i(N C S ) 4
/" M.epHq,E102C ,N
NA 9H« C° 2E' PhH H3CAnAs 
80 H
^OTBS
VlH
R3SiO  
Si(N C S)4, PhH
C 0 2Et
83
81
N3 Et02C//. |J> C ~ l 'H
S tep s  X
H3C N N C 9 H 19 
H
Tricyclic Target 
82
N NH S tep s
NHX
/  N NH
OSiR;
84
C 0 2Et
Bicyclic Target 
85
O SiR 3
Scheme 49
The synthesis of the alkylidenepyrrolidines is key, both to the overall yield and 
versatility of this approach. Scheme 50 highlights the synthesis of the 
alkylidenepyrrolidine 83, from glutamic acid 86, required for the bicyclic guanidine 
found in batzelladine A. Six steps are required, with an overall yield of 18%.
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HOOC'
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2  SOCI2, EtOH 
COOH
reflux, 1 h 
8 0 % 87
L aw esson 's R eagen t
PhCH3, reflux, 
'C 02Et 1 h, 8 8  %
Ethyl 2-brom oacetoacetate, 
N aH C 03, DCM, reflux, 16 h 
71 %
CC^Et
Me Me
TBSCI, im idazole,
NH
THF, RT, 16  h 
65 %
T BSO HO
N aBH4, THF
H2 0 ,  reflux, 2 h 
9 4 %
E t0 2C
C 0 2Et
NaOEt, EtOH, 
reflux, 2  h 
6 0 %
Scheme 50
A partial synthesis of a precursor to the tricyclic guanidine core of the natural products 
was also achieved.24 An 11 step synthesis was required to reach compound 88, while 
modifications would be required to form the desired target 89 (Scheme 51).
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Both of the syntheses detailed above are long with low overall yields, which would 
result in slow progress to the desired targets. A significantly improved approach to both 
sides of Batzelladine A was required, and it was decided to develop an improved 
synthesis of alkylidenepyrrolidines.
3.2 Background to Alkylidenepyrrolidine Synthesis
Alkylidenepyrrolidines have been shown to be useful and versatile building blocks for 
heterocyclic and natural product chemistry. Over the years a varied range of syntheses 
and use of these compounds has been documented. The most widely used synthesis to 
date is the Eschenmoser sulphide contraction.40 Knott first reported the reaction in 
1955 41 However, it was not until it was used in the synthesis of Vitamin B12 that the true 
potential was realised 42
BrCH2 COCH 3
C 0 2Et C 0 2Et
90 91
/V-methylpiperidine
b e n z e n e
reflux
69%
C 0 2Et C 0 2Et
93 92
Scheme 52
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The general reaction shown above (Scheme 52) indicates the chemical pathway that is 
followed for this reaction. It starts with the alkylation of the thiolactam 90 with a 
or-halocarbonyl. This intermediate 91, in the presence of a base such as 
A-methylpiperidine forms the thiirane 92, which, in the presence of a thiophile, typically 
triphenylphosphine, gives the alkylidenepyrrolidine 93.
The a-halocarbonyl compounds are most commonly used as the alkylating agent in 
these types of reactions. However, other leaving groups have been used. In the synthesis 
of carbapenems, Koskinen et al. utilised the triflate leaving group 94 (Scheme 53).43
Scheme 53
A further modification to the reaction by Michael et al. showed that the alkylating agent 
does not need a leaving group adjacent to the carbonyl. In this example the
T f0C H 2 C 0 2Me
Ph3P, Et3 N, 
C 0 2Me DCM, 6 6  %
methanethiolate is displaced in a Knoevenagel-type reaction (Scheme S4).44
D M e
2. 95, Et3 N, CHgClz 
56  %
Me
^ ^ ^ C O z X - B u SM e
O
95
Scheme 54
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This method was also used in the synthesis of the azinomycin natural products, in which
Scheme 55
Throughout all the examples illustrated above, a thiophile has been used either within 
the compound or a phosphorus reagent like triphenylphosphine has been added. It has 
been shown that in certain cases the reaction can progress in good yield without a 
thiophile of any sort (Scheme 56).46
Scheme 56
In all of the Eschenmoser sulphide contractions shown, the double bond geometry is 
controlled by the substituents on nitrogen. If unsubstituted, the (Z) isomer is generally 
formed, while any other substituent will favour the (E) isomer. For example, the 
thiolactam 98 gives exclusively the (E) isomer 99 (Scheme 57).47
the complex thiolactam 96 was reacted with an azalactone 97 (Scheme 55).'
toluene, pyridine
O T B D PS
TESO O TBDPS
BrC H (C 0 2 Et)
CH2 CI2, 25  *0 , 1 2  h 
O TBD PS then K H C03, 4  h O T B D PS9 7 %
47
BrCHjCOEt, PPh 3
MeQ
Me
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M eQ
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Scheme 57
Useful starting materials for these types of reactions are the pyroglutamic acid 
derivatives.48 They provide a ready source of chiral starting materials, in which the 
chiral ester group is not particularly prone to racemisation under either acid or basic 
conditions. Although the carbonyl is relatively unreactive, it can be made more reactive 
in a number of ways. The use of Lawesson’s reagent to convert it into the thiolactam set 
the stage for the examples shown above. An alternative method is to make an iminoether 
such as the conversion of lactam 100 to 101 as shown in Scheme 58 49
© 0  
(Et3 0 )B F 4, DCM
NH -------------------------- *
rt, 4 0  h
C 0 2Et
100
COoEt
Scheme 58
The amidoester 102 can then be reacted with a 1,3-dicarbonyl nucleophile e.g. 
Meldrum’s acid 103 with further elaboration to the alkylidenepyrrolidine 104 (Scheme 
59).50
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C02Me
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Scheme 59
The range of conditions available for this type of reaction makes it compatible with 
sensitive functional groups. Scheme 60 shows the reaction of an acid sensitive ketal 105 
with the iminoether 106 to the corresponding alkylidenepyrrolidine 107 in good yield.51
O
EtOzCvJL^CHg
♦ B 0.O L C H , 2-hydroXyPyridin% 1  0*PeMe
M eO OMe 9 0  ”tt,’, 1£ d a y s  V_/NH/o
106 105 107
Scheme 60
Modifications to this process have allowed the reaction to progress with substitution on 
the nitrogen atom. It is possible to make the iminium ion 108 from the lactam 109. This 
undergoes reaction with enolates as above (Scheme 61).52
49
o +
Et2 0 ,  95%
Et30  BF4
109 108
■C02Me
LDA, THF, 91 %
M e 0 2C >
Scheme 61
The final method in this category is to make a diether derivative. This is formed by 
reaction of the lactam 110 with dimethyl sulphate, followed by a sodium ethoxide work 
up to give the intermediate 111. This is then heated in 4-chloroacetophenone over 8 
hours to give alkylidenepyrrolidine 112 (Scheme 62).53
(M e0 ) 2 S 0 2  
80 °C, 1 2  h
then NaOEt, EtOH
110 111
4-CIC 6 H4 COCH 3  
80 °C, 8  h 
5 5 %
112
Scheme 62
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An alternative electrophilic source of the pyrrolidine ring is to use a nitrone. This was 
demonstrated well with the reaction of nitrone 113 with phosphonate 114 to give the 
alkylidenepyrrolidine as a 1:1 mixture of double bond isomers 115 and 116 (Scheme
63).54 This reaction proved to be a good way of producing nitrile derivatives in good 
yield. However, limitations include side-reactions when esters are used.
1 1 4
(EtO)2 ( 0 ) P \ / C N
NaOEt, EtOH
1 1 3  115 116
Scheme 63
All of the above methods started from similar pyrrole derivatives. An alternative is to 
form the ring system during the reaction. A good example is the formation of the 
alkylidenepyrrolidine 117, where the azide 118 through an aldol condensation with the 
p-keto ester 119 to form the intermediate 120. This intermediate 120 then undergoes a 
tandem Staudinger-aza-Wittig reaction to give the alkylidenepyrrolidine 117 (Scheme
64).55
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Scheme 64
Alternatively, similar reactions have been carried out under hydrogenation conditions 
although the overall yield is slightly lower (Scheme 65).56
NHCbz
CbzHN
T B SO
Scheme 65
The nitrogen source can simply be a substituted amine. In the formation of 
alkylidenepyrrolidine 121, aniline is used as the nitrogen source, which reacts with the 
ketone carbonyl of the /?-keto ester 122 to give the enamine intermediate 123, which can 
then cyclise to give compound 121 (Scheme 66).57
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Scheme 66
C 0 2Et
E t0 2C
NHPh
NPh
123 121
This method is convenient due to the availability of starting materials which can be 
synthesised from commercially available lactones by a Reformatsky reaction (Scheme 
67).58
c x BrCH2 C 0 2 f-Bu
Zn/Cu, THF 
then MsCI 
58%
M sO
PhCH 2 NH 2
CH 2 CI2
5 7 %
C w c o *'-Bu
N
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Scheme 67
Propiolic esters provide alternative electrophilic species for the formation of 
alkylidenepyrrolidines. An addition of an amine nucleophile will give rise to an 
enamine, which can then cyclise as in the example below (Scheme 68).59
53
c o 2Me
N al, N a 2 C 0 3  
THF, reflux 
85 %
C 0 2Me
Scheme 68
3.3 New Studies in Alkylidenepyrrolidine Synthesis
It is well known that carbamates derived from lactams can be selectively attacked at the 
lactam carbonyl by a range of nucleophiles. These have included Grignard,60 and other 
organometallic reagents.61 As well as these, hetero-nucleophiles62 and stabilised anions 
have also been extensively reported.63"64 In a number of instances these products have 
been cyclised to form pyrrolines and pyrrolidines (Scheme 69).65"66
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However to date there has been only one such example for the formation of an 
alkylidenepyrrolidine by this method (Scheme 70).67
PhS02CH3
yNB0C BuLi, THF Ph° 2 S > ^  ^ ^ / N H B o c  
96 %
124 125
TFA, DCM  
6 7 %
v
126
Scheme 70
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This type of approach would provide an extremely convenient synthesis of 
alkylidenepyrrolidines, using simple reactions, and only three steps from the lactam. We 
have therefore conducted a study into the scope and usefulness of this simple 
transformation for the formation of alkylidenepyrrolidines. Lactams 127, 87 and 129 
were chosen for the study. It was essential that any methods used can be scaled up to 
multi-gram quantities (Schemes 71, 72 and 73). These reactions have been carried out 
on a 5 g scale with no significant drop in yields.
( B o c l A  DMAP
u
ANEt3, DCM \  N Boc
87%
127 124
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Scheme 73
Initial studies into the viability of the reaction were carried out on the achiral lactam 
124. For the purposes of the synthesis of the batzelladine alkaloids, an ester was required 
as the electron withdrawing group, so ethyl acetate was chosen for optimisation of the 
reaction (Scheme 74).
CH3 C 0 2Et
N Boc ---------------------► _  ^ N H B oc
LDA, THF E1°
18 h
1 2 4  83%  1 3 2
Scheme 74
Initial results from this stage were promising, with good yields achieved with little or no 
purification required. Early reactions were carried out using a 10% excess of lithium 
diisopropylamide. When this was reduced to a stoichiometric amount there was no 
noticeable drop in yield. However, the crude product was then essentially pure (as 
determined by and 13C NMR spectroscopy).
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Two more acetates were chosen to test the concept. These were the synthetically useful 
menthyl acetate and benzyl acetate. Both acetates have been shown to have potentially 
useful properties for the synthesis of the batzelladine alkaloids. Menthyl acetate could be 
used as a directing group for asymmetric induction during the three-component coupling 
reaction, which is described in detail in Chapter 4 (Scheme 75). The ease with which the 
benzyl group can be removed through hydrogenation makes it a useful functional group 
(Scheme 76). In both cases the same conditions were used. Although, purification was a 
necessity in both cases, good yields were obtained.
(-)-Menthyl acetate
NHBoc
18 h 
80%124 133
Scheme 75
Benzyl aceta te
N H Boc
N Boc
124 68 % 134
Scheme 76
The scope of the reaction was widened to incorporate other nucleophiles. As mentioned 
above, sulphones had already been used. These reactions were repeated, with the yields 
obtained in line with those reported in the literature (Scheme 77).
NBoc LDA, THF
' 18  h
O
Ph's ' NHBoc
O
124 64% 127
Scheme 77
Next, ketones were used as the source of the nucleophile. Two were chosen: acetone and 
acetophenone. From the outset these reactions proved to be inferior to those of the 
esters. When carried out under the same conditions as the esters, crude yields were 
found to be lower and the reaction produced both the enol and keto tautomers (Scheme
Scheme 78
After purification by flash chromatography R = Ph gave exclusively the enol tautomer, 
when R = Me a 5 : 1 ratio in favour of the enol tautomer was observed.
With any asymmetric synthesis it is important to reduce the chances of racemisation. 
One potential problem can be the use of a strong acid during the ring-closing step. The 
original synthesis of the sulphonyl alkylidenepyrrolidine 126 used a large excess of 
trifluoroacetic acid. It was not known whether this would cause racemisation of 
pyroglutamic ester derivatives, but it was considered prudent to investigate whether 
milder conditions could be utilised.
78).
N H Boc NHBocNBoc
18 h
124 13 5  R = Me 74  %
13 6  R = Ph 7 5  %
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First attempts to cyclise the P-ketoester 132 to the corresponding alkylidenepyrrolidine 
were successful using either a 10% solution of trifluoroacetic acid or p-toluenesulphonic 
acid in dichloromethane (Scheme 79). No significant difference in the yield was 
observed between either acid
E t0 2C
10 % TFA In DCM
NBoc^  v  v  NHBoc EtO 2  h
89%
132
Scheme 79
The obvious drawback to this result is that the Boc protecting group had not been 
removed as was hoped. In fact compound 132 undergoes the same cyclisation reaction in 
chloroform with no added acid, over a period of three days.
However, it was necessary for the protecting group to be removed; of the acids used 
above trifluoroacetic acid was chosen as any excess could be removed in vacuo instead 
of by aqueous work-up. The reaction was repeated using different amounts of acid. Less 
than two equivalents gave the protected product, whereas two or more equivalents gave 
the deprotected alkylidenepyrrolidine 138 (Scheme 80).
C 0 2Et
2  equivalents TFA
^  ./NHBoc “ 7 7
EtO v  v  ^  rt, 2 h
8 2 %
132 138
Scheme 80
Although this was a larger excess than hoped for, it had the added advantage that solvent 
could be omitted when the reaction was carried out on a large scale (>1 g). Due to the
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trifluoroacetic acid being removed in vacuo, the amount of water used in the work-up 
was reduced giving very high yields in the region of 85 % with excellent purity.
This same method was used on the other purified ring-opened compounds 133, 134,135 
and 136 (Scheme 81) and although yields were not as high as for compound 142, they 
were still good with excellent purity.
Scheme 81
Due to the simplicity of the cyclisation step, it was decided to try the reaction as a ‘one 
pot’ method, where the acid is added directly to the reaction mixture after the ring 
opening. Enough acid was added to quench the reaction plus two equivalents. The 
reaction was successful (Scheme 82). However, although the yield was close to that 
observed when the reaction was carried out over two steps, it was necessary to purify the 
compound by flash chromatography.
R N H Boc
2 equivalents TFA
139 R = C 0 2 -Menthyl, 80  %
140 R = C 0 2 Bn, 8 6  %
141 R = CO M e, 8 5 %
142 R = COPh, 7 4 %
128 R = P h S 0 2  6 7 %
3.1 equivalents [|
N B oc NHBoc
126 132 63 % overall 138
Scheme 82
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Once the method had been confirmed the lactam was changed to the chiral 
pyroglutamate derivative 128. The reactions were carried out using the above methods. 
In general yields were similar to those for lactam 126. When ethyl acetate was used as 
the source of the nucleophile, the reactions were consistently high in purity with higher 
yields than any other nucleophilic source tested. In both examples using ketones, only 
the enol tautomer was isolated after flash chromatography (Scheme 83).
CH3COR ft  ft  
  ----------   NHBoc
LDA, THF i.
18 h C 0 2Et
C 0 2 Et
14 3  R = OEt, 78 %
1 2 8  1 4 4 R  = OBn, 6 7 %
1 4 5  R = CH3, 7 2 %
1 4 6  R = Ph, 74  %
Scheme 83
N B oc
Although every effort had been made to find mild conditions for the ring-closing step, 
racemisation was still a potential concern. In order to establish whether any racemisation 
was occurring the lactam 128 was subjected to the ring-opening/ring-closing protocol 
with optically pure 0 -(-)-menthyl acetate and with racemic menthyl acetate (Scheme 
84).
 ^ N Boc
C 0 2Et 
1 2 8
CH 3 COR
LDA, THF 
18 h
RO
NHBoc 
C 0 2Et
1 4 7  R = 0-(-)-M enthyl, 71 %
1 4 8  R = 0-(±)-M enthyl, 73  %
2  equivalents  
TFA, rt, 2 h
C 0 2R
C 0 2Et
149  R = 0-(-)-M enthyl, 71 %
150  R = 0-(±)-M enthyl, 69 %
Scheme 84
11The C NMR spectrum from the ring-closure reaction derived from racemic menthyl 
acetate showed clear doubling of peaks. Figure 5 shows the region from 50 ppm -  30 
ppm of the 13C NMR spectra of products 149 and 150. It can clearly be seen from the
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peaks at 47.2, 41.5 and 31.4 that for compound 149 no epimerisation has occurred, as 
the same peaks for compound 150 are doubled. There is no reason why compound 147 
should behave differently to the other alkylidenepyrrolidines synthesised, so we are 
confident that no racemisation is occurring with any of the compounds synthesised.
Expanded portion o f the 13 C NMR spectrum for compound 149.
35.0 32.5
Expanded portion o f the 13C NMR spectrum for compound 150.
47.5 45.050.0 
ppm  (ft)
42.5 40.0 37.5 35.0 32.5 30.0
Figure 5
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Using the same conditions all other products from the ring-opening step 143, 144, 145 
and 146 were cyclised using 2 equivalents of trifluoroacetic acid. Both other acetates 
proceeded with yields and purity in line with that previously observed. Unfortunately 
cyclisation of compounds 145 and 146 proceeded with lower yields than expected, 
although the purity was as high as previously seen (Scheme 85).
2 equivalents TFA
NHBoc -------------------------- ■*
rt, 2 h 
C 0 2Et
3 S 5 " n l n  1 5 1  R « O E t , 82 %
3 2 2  5  = S Bn' 15 2  R = OBn, 72  %
l 4 6 R = P h ’ I 5 3  R -  Me, 55%1 4 6  R = Pn, 1 5 4  R = Ph, 4 4 %
C 0 2Et
Scheme 85
The final series of reactions investigated used the TBS protected lactam 131. As results 
had been consistent throughout all examples, ethyl acetate was again chosen for the first 
reaction (Scheme 86). As shown below this reaction progressed as expected, although 
the yields were slightly lower than compared to previous reactions.
N Boc LDAj JH F E1°
CH3 C 0 2Et
NHBoc
18 h ^OTBS
7 5 %
155
Scheme 86
When compound 155 was reacted under the same cyclisation conditions as above, both 
the Boc and the TBS groups were removed to give the deprotected alkylidenepyrrolidine 
156 (Scheme 87).
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2 equivalents
NHBoc
E t 0  i  TFA, rt, 2 h
T B S O ^  6 4  %
1 5 5  156
C 0 2Et
Scheme 87
It was then possible to reprotect the hydroxyl group to give the alkylidenepyrrolidine 83 
(Scheme 88), that had previously been synthesised through the alternative Eschenmoser 
sulphide contraction method (Scheme 50).
C 0 2Et
TBSCI, Et3N
DMAP, DCM 
0 H  rt, 18 h
COoEt
156 7 3  % 8 3
Scheme 88
Over the course of the investigation there were instances in which the ring-opening step 
failed to produce products of sufficient purity or yields to make them a viable substrate. 
These included the highly stabilised anions derived from nitromethane and 
methyldiphenylphosphine oxide.
As described in the introduction to this chapter, when a substituent is present on 
nitrogen, the (E) isomer will generally be formed for steric reasons. However, if there is 
no substitution on the nitrogen, the (Z) isomer is favoured, as in this configuration 
hydrogen bonding can take place between the carbonyl and the NH. This trend was 
supported by spectroscopic information gained during the course of these investigations. 
The NH peak in the *H NMR spectra of alkylidenepyrrolidines is broad and in the region 
of 8 ppm, both of which are indicative of hydrogen bonding. Also the IR spectra show a 
broad peak around 3370 cm'1, again indicating hydrogen bonding of the NH.
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Unfortunately it is not possible to determine the double-bond geometry using nOe 
studies, since a mutual enhancement of the alkene CH  and the NH peaks can be 
attributed to exchange of these protons. It is expected that the iV-protected compound 
137 was isolated as the (E) isomer and upon deprotection isomerised to the (Z) isomer.
With all these factors taken into account, the method provides a useful synthesis of 
chiral alkylidenepyrrolidines, in overall yields of around 50 % compared with the 
previously reported yields in the range of 20 %, from commercially available starting 
materials, successfully carried out on scales of up to 5 g with little or no need for 
chromatography.
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Chapter 4
Investigations into the Three-Component 
Coupling Reaction
67
4.1 Introduction
The retrosynthetic Scheme 89 below shows a convenient short way of converting an 
alkylidenepyrrolidine into a bicyclic guanidine.
C5H11
NH
NH
NH
Scheme 89
This method would allow access to both the left and right-hand sides of batzelladine A, 
and with small adjustments it is easy to envisage being able to form all of the bicyclic 
and tricyclic guanidines from the batzelladine alkaloid family.
Previous studies within the group were directed to the formation of the left-hand side of 
batzelladine A (23). Shown in Scheme 90 is the formation of the guanidine precursors 
59 and 60 from alkylidenepyrrolidine 58. It is important to note that the reaction 
proceeded cleanly and the diastereoisomers were easily separated; however, at this point 
there was still some uncertainty about the relative stereochemistry of the products.
Si(N C S)4, MeCHO
b en zen e , 3 h 
81%
58 59 60
2 1
Scheme 90
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Kishi et al. first reported this type of three-component coupling in 1977 during their 
synthesis of Saxitoxin. In this transformation, alkylidenepyrrolidine 157 was converted 
into the bicyclic urea 158 by reaction with isocyanic acid and acetaldehyde (Scheme 
91).68
C 0 2Me Me
CH3 CHO, HNCO
Et2 0 ,  rt 
7 2 %
157
NH
158
Scheme 91
This was later modified to use silicon tetraisothiocyanate to produce the thiourea 159 as 
shown in Scheme 92.69
C 0 2Me
PhCH 2 CHO, S i(N C S ) 4
b en zen e , rt 
7 5 %
HoPh
M e0 2C
NH
159
Scheme 92
In his final modification to the reaction, the chiral aldehyde 160 was used to influence 
the stereoselectivity of the reaction of alkylidenepyrrolidine 161 to the thiourea 162 and 
its diastereo isomer 163. The selectivity achieved was 9:1 in favour of the opposite 
stereochemistry to the natural product. Using the other enantiomer of the aldehyde 
would produce the correct natural product stereochemistry (Scheme 93).70
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COpMe
0
H
160
Si(N C S)4, b en zen e , rt 
8 0 %
161
NH
162
+
NH
163
Scheme 93
For the purposes of our batzelladine alkaloid synthesis the diastereoselectivity of this 
three component coupling is disappointing. A detailed understanding of the reaction 
mechanism would be useful in guiding further studies
To date, two mechanisms have been postulated for the formation of the bicyclic 
thiourea. The first was proposed by Kishi et al. The first step of the reaction would be an 
A-acylation with the isothiocyanate to give the thiourea 164. This thiourea would then 
condense with the aldehyde to form the imine 165. The imine could then cyclise with the 
enamine to form the cyclic thiourea 166 (Scheme 94).
C 0 2 Mg
Si(N C S ) 4
ri
Me02C v ^ k ©
< N S
166
M e 0 2C HN.S i(N C S ) 3  M e° 2 c  
RCHO
n
Me02C' Y ^ 'NH- I A
\ N
165
Scheme 94
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If a chiral aldehyde is used then stereocontrol of the cyclisation of 165 to 166 would be 
expected. This is best rationalised by the Felkin-Anh model,70*5 using a Newman 
projection for the intermediate 165 it can clearly be seen that one conformation allows 
for an unhindered approach along the Burgi-Dunitz angle.
Angle of attack
Figure 6 Felkin-Anh model o f compound 165 showing the Burgi-Dunitz angle.
A  related reaction shows an alternative mechanism, suggested by the Elliott group22 
showed a similar reaction pathway to the formal aza-Diels-Alder reaction observed 
when an oxazoline 167 is reacted with an isocyanate (Scheme 95).25 In examples of this 
type, total stereocontrol is achieved.
PhNCO
\—y
Et
167
Q' ©N n 0\_ y
Et
168
Scheme 95
For the case of the three component coupling, there are two possible pathways to form 
the intermediate 169 which is similar to the intermediate 168 shown in Scheme 95. Ring 
closure could then proceed via the same mechanism giving the desired thiourea 170 
(Scheme 96).
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M e 0 2C
RCHO
Si(N C S ) 4
'C02Me
'NH ---------*
'CH2OTBS
Si(N C S ) 4
CH2OTBS
M e0 2 C N  HN^Si(NC S ) 3
N^ S 
c h 2o t b s
RCHO
Me02C v ^  N^Si(NCS)3
c h 2o t b s
169
NH
-CH2O TBS
170
Scheme 96
Based on previous results, we would expect the cyclisation of intermediate 169 to form 
170 to proceed with complete stereocontrol. As the stereoselectivity is only moderate, 
this mechanism would appear unlikely, although if both double bond isomers of 169 
were formed, selectivity of the product would be affected and potentially lowered.
Unfortunately neither of these proposed mechanisms has been backed up by any 
rigorous experimental data. It is our hope that the mechanism of the reaction can be fully 
determined and the stereochemical outcome controlled.
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First of all we need to consider the reactivity of alkylidenepyrrolidines on carbon or 
nitrogen and which the most likely site for reaction is.
4.2 Alkylations and Acylations of Alkylidenepyrrolidines
Over the years, alkylidenepyrrolidines have been finding more and more applications in 
synthetic chemistry. A great deal of work with alkylidenepyrrolidines centres on their 
ambident nucleophilicity and which site is the more reactive under certain conditions. 
Figure 7 shows the two nucleophilic sites on the simple alkylidenepyrrolidine 157. 
From here, reactions at either site will be referred to as either reaction on nitrogen or 
carbon.
There are thought to be three main factors that dictate the regioselectivity of 
electrophilic attack: first, the nature of the electrophile, how reactive it is and how stable 
the products are; second are the conditions of the reaction, i.e. whether a base is used 
and how strong that base is also at what temperature the reaction is carried out at; third is 
the double bond geometry of the alkylidenepyrrolidine, although there is not enough 
published material to make any firm conclusions about this particular point.
The simplest of these reactions is shown in Scheme 97 where an alkylidenepyrrolidine 
138 containing a single electron-withdrawing group is alkylated with iodomethane.71 
Under these conditions, reaction takes place on carbon.
N u c le o p h ilic /-> p o 2Me
carbon ( j T j
Nucleophilic nitrogen
157
Figure 7
73
C02Et
NaH, toluene
then CH3I 
7 4%
H3 C X / C 0 2Et
Scheme 97
It is possible to get a second alkylation on the same position by heating the sodium salt
72of the alkylidenepyrrolidine with an alkyl halide at high temperatures (Scheme 98).
'COoEt /7-C3H7V_^COoEt
NaH, toluene, reflux, 1 h 3H7 I
‘NH then n-C3 H7 l, reflux, 12 h
74 % \ _/
138
Scheme 98
For alkylation on nitrogen, it is necessary to change the electrophile; in this case the 
electrophiles of choice are sulphates and sulphonates which give good yields of the 
A-alkylated compound (Scheme 99).73
Ph
£
MeH
1 , KOf-Bu, DMF, 25  8C
2, M e 0 S 0 2 C 6 H4 CH3, 41 % 
or (M e0 ) 2 S 0 2  8 8  %
yr  NMe
Men
Me Me
Scheme 99
Acylations of alkylidenepyrrolidines are more sensitive to reaction conditions and steric 
effects than alkylations. An example of this is the reaction of alkylidenepyrrolidine 138
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with acetyl chloride where the reaction takes place on nitrogen to produce a good yield 
of compound 170 (Scheme 100).74
■C02Et CH 3 COCI E t0 2C
toluene, pyridine
NH reflux, 3 h, 71 % C H 3
138 170
Scheme 100
When the similar reaction was carried out on the slightly more hindered
Scheme 101
Using these basic principles, a range of additional functionalities can be added to the 
initial alkylidenepyrrolidine to produce both structurally interesting compounds and 
natural products. Scheme 102 shows reaction of alkylidenepyrrolidine 172 with the 
anhydride 173 in the preparation of angiotensin-converting enzyme inhibitor
alkylidenepyrrolidine 171 the reaction was solely on carbon (Scheme 101).75
CH3COCI, toluene
C 0 2Me
C 0 2Me
171
A58365A.76
75
C 0 2Bn 0  0  0  Bn02CX X H C 0 2H
173
i b en zen e , reflux
9 5  %
CO2M6 'C 0 2Me
1 7 2
step s
HC C 0 2H
c o 2h
A 58365A
Scheme 102
It is also possible to get reaction to occur at the 3-position of the pyrrolidine ring, 
although this is not generally observed for A-unsubstituted alkylidenepyrrolidines. 
Alkylidenepyrrolidine 174 in the presence of a strong base, e.g. lithium 
diisopropylamide, and a good electrophile underwent reaction to form the new 
alkylidenepyrrolidine 175 (Scheme 103).77
174 175
Scheme 103
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The three-component coupling reaction used for the batzelladine synthesis features an 
acylation-type reaction using an isothiocyanate. If we assume that the initial reaction is 
between the alkylidenepyrrolidine and the isothiocyanate, then this must be an 
Af-acylation. This seemed likely according to the work of Tronche. In their, work a range 
of isocyanates were reported to react predominantly on nitrogen (70 : 30 
regioselectivity) (Scheme 104).78
C 0 2Et
138
Ph
HN
EtOoC
PhNCO, b en zen e, HN
reflux, 1 2  h NH
307 0
Scheme 104
However when this was repeated within the group, the results differed significantly with 
those reported. Results showed the majority of isocyanates reacting preferentially on 
carbon in all but two instances (Table 1 entries 5 and 6) where a 1 : 1 and 1 : 2 ratio of 
products was formed, Table 1 shows a summary of results obtained from these studies.79
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Entry Heterocumulene Conditions Ratio CiN 
acylation
1 PhNCO CHCI3 , 25 °C, 18 h 2 . 1 : 1
2 PhNCO CHCI3 , reflux, 2 h 3.4:1
3 PhNCO benzene, reflux, 2  h 5.2:1
4 PhNCO THF, reflux, 2 h 7:1
5 BnNCO CHCI3 , 25 °C, 18 h 1 : 2
6 BnNCO CHCI3 , reflux, 20 h 1 : 1
7 n-BuNCO Pyridine, 100 °C, 65 h 2.3:1
8 4 -MeC6 H4 NCO CHCI3 , reflux, 2 h 2.3:1
9 TsNCO CHCI3 , 25 °C, 2 h 1 : 0
1 0 CI3CCONCO CHCI3 , 25 °C, 18 h 1 : 0
1 1 PhNCS CHCI3 , reflux, 18 h 1 : 0
1 2 PHNCS CHCI3 , 25 °C, 48 h. 0 : 0
13 BnNCS CHCI3 , reflux, 18 h 1 : 0
14 n-BuNCS Pyridine, 100 °C, 46 h 1 : 0
Table 1
For the purpose of our investigations the important results shown are those of the 
isothiocyanates (Table 1 entries 11 -  14). In none of these cases was evidence of 
reaction on nitrogen observed. It is unlikely that either C or N acylation is occurring in 
the much milder conditions used for the three-component coupling reaction.
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4.3 The Three-Component Coupling Reaction
4.3.1 Mechanistic Studies on the Three-Component Coupling Reaction
Based on the results described above, it seemed likely that annulation occurs by initial 
attack on carbon. This would suggest that both mechanisms described at the start of the 
chapter are in fact incorrect, and a better understanding of the reaction is needed.
In the mechanisms described above, an intermediate is formed either by reaction of the 
isothiocyanate and the lactam (Scheme 105), or from the lactam and the aldehyde 
(Scheme 106).
-CC^Et M602C-
Si(N C S ) 4  ^  HN
NH S
Si(N C S ) 3
138
Scheme 105
■?
RCHO M e 0 2 C \ ^
6 1
Scheme 106
It was hoped that if either of these reactions occurs, we would be able to monitor their 
progress by carrying out the reactions in an NMR tube and recording spectra at regular 
intervals.
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As already mentioned it was thought the most likely site for initial reaction would be on 
carbon. *H and 13C NMR spectra were obtained every ten minutes; however, no changes 
were observed when either silicon tetraisothiocyanate or the aldehyde was mixed with 
the lactam. If the third reactant was added to either of the mixtures, reaction proceeded 
to the bicyclic product within the time taken to acquire the spectrum.
Under reaction conditions reported by Kishi, the isothiocyanate is stirred with the 
aldehyde for a period of 30 minutes. It is possible that this produces a reactive 
intermediate (Scheme 109). This reaction was repeated in an NMR tube using 
benzaldehyde and silicon tetraisothiocyanate 176 in deuterated benzene. {H and 13C 
NMR spectra were obtained every 10 minutes for 1 hour. Over this time a broadening of 
the aldehyde CH peak was observed in the !H NMR spectrum but no change was 
observed in the 13C NMR spectrum. When the experiment was repeated using deuterated 
chloroform as the solvent, no changes were observed in any of the spectra obtained. 
Unfortunately the isothiocyanate C was not observable on the spectrum.
S i(N C S ) 4  + j f
H R
176
Scheme 107
Although these results proved inconclusive, the mechanism shown in Scheme 107 still 
appeared to be the most likely. The product 177 would be a good electrophile and should 
be able to react with the alkylidenepyrrolidine, presumably on the carbon. This 
mechanism would still be consistent with the results reported by Kishi using the chiral 
aldehyde 158. Since addition of the alkylidenepyrrolidine to the chiral intermediate 178 
would give the same stereochemistry as that reported by way of the same Felkin-Anh 
transition state.
RV H
n
S
177
80
Me O"' y
r©
H
n
S
178
We therefore feel that the most likely pathway for the three-component coupling 
reaction is shown in Scheme 108. This would explain why when a chiral aldehyde is 
used the selectivity would be higher than when the chirality is induced from the chiral 
side chain shown on the alkylidenepyrrolidine 151.
Scheme 108
4.3.2 Synthetic Studies on the Three-Component Coupling Reaction
Although the three-component coupling reaction is reliable, purification is not 
straightforward. The low levels of diastereocontrol are also far from ideal. Finally, while 
benzene had been shown to be a good solvent for the reaction, its toxicity and 
hygroscopy are undesirable.
We therefore sought to optimise the reaction conditions and purification method 
initially, with the intention of optimising the levels of stereocontrol by investigation of a 
range of alkylidenepyrrolidine substrates as prepared in Chapter 3.
151 179
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When flash chromatography was carried out on crude reaction mixtures, yields were 
irreproducible from one reaction to the next. It was also noted that a dark purple band 
formed on the silica gel during chromatography, indicating that a reaction was 
occurring. When this band was isolated it showed some peaks from the *H NMR 
spectrum consistent with the desired product but was not the desired bicyclic thiourea.
Therefore, initial optimisation reactions were carried out by assessment of the crude 
reaction mixtures. At this point the achiral substrate 138 was used to optimise the 
conditions. A number of solvents were evaluated, in the hope that benzene could be 
replaced in this reaction (Scheme 109).
Ph
COoEt
2  S i(N C S)4, PhCHO
NH
NH
138 180
Solvent Crude Yield of 
compound 180
Benzene 78 %
Toluene 76%
THF 100%
Dichloromethane 79%
Chloroform 76%
Scheme 109
Various common solvents were used for the evaluation. These included toluene, 
tetrahydrofuran, chloroform and dichloromethane. In general there was little or no 
change with the varying solvents that could not be attributed to experimental error. Only 
with tetrahydrofuran was the purity of the crude product significantly lower. Overall the 
solvent of choice is dichloromethane, due to its low toxicity, low boiling point, and ease 
of drying and low freezing point.
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When the reaction is carried out, a silicon by-product is formed that is insoluble in all of 
the tested solvents listed above. It was postulated that some product might be lost by the 
formation of this unknown product. It was known that silicon tetraisothiocyanate 
degrades on contact with moisture; this degradation product is also insoluble in water. 
However when mixed with a dilute aqueous base, it degrades to water-soluble 
compounds. A simple test showed that the bicyclic urea was unaffected by washing with 
a 0.5 M sodium hydroxide solution.
As a pleasing side-effect, after the crude product was washed with sodium hydroxide the 
brightly coloured band was not observed when flash chromatography on silica gel was 
carried out. At this point, the isolated purified yields were reproducible.
Silicon tetraisothiocyanate is only sparingly soluble in dichloromethane. We therefore 
considered alternative reagents, the most obvious of which is trimethylsilyl 
isothiocyanate. The use of this reagent would allow us to determine whether more than 
one isothiocyanate is required for the reaction. The first reaction was carried out using a 
one-to-one molar ratio of all reactants. It was pleasing to see that the yield and purity of 
the reaction was as good as any achieved using silicon tetraisothiocyanate. From a 
mechanistic point this shows that only one isothiocyanate group is required. Two other 
aldehydes where tested using this method to asses the versatility of the reaction (Scheme 
110). Trimethylsilyl isothiocyanate has the additional advantage of being commercially 
available.
R
Me3 SiN C S, RCHO 
DCM, rt, 30  min
138
181 R = Me, 7 4 %  
18 0  R = Ph, 70 %
182  R = C sH n 75%
Scheme 110
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To date, all diastereoselective coupling reactions carried out within our group had the 
directing group on the 5-position of the pyrrolidine ring. If a chiral alkylidenepyrrolidine 
such as 139 where the chiral group distant from the ring was used, it might be able to 
influence the stereocontrol of the new stereogenic centre formed in the trimolecular 
annulation (Scheme 111). However, it was clear from the 13C NMR spectrum of the 
crude reaction mixture, which showed equal intensity of the doubled peaks, that little or 
no stereoselectivity had been achieved. As the yield of the reaction is still high, it could 
still be a viable way of making the left-hand side bicyclic portions, as with work the 
diastereoisomers could be separated.
M e3 SiN C S, MeCHO,
'0 °
H
139
DCM, 3 h 
6 7 %
Me
NH
183
Scheme 111
As mentioned earlier, it is necessary to have a chiral side chain on the 
alkylidenepyrrolidine for the formation of the tricyclic portions of the batzelladine 
alkaloids (Figure 8). The most accessible chiral alkylidenepyrrolidine synthesised (151) 
was used to investigate further alterations to the annulation.
Tricyclic Target 
82
Figure 8
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It was already known that some selectivity was observed in the trimolecular annulation 
using the similar alkylidenepyrrolidine 58 (Scheme 114).
Me
OEt
S i(N C S )4, CH3 CHO EtO NH
NH
b e n z e n e  3 h
OTBS
TBSO
58 5 9
5 4 %
Me
NHEtO
6 0
2 7 %
Scheme 112
This reaction was repeated changing only the alkylidenepyrrolidine to 151 (Scheme 
113). The stereochemisty shown is based on assignments as discussed in section 5.4.
MeMe
EtO NHOEt Si(N C S)4, CH3 CHO, EtO NH
SNH b en zen e , 3 h
✓
C 0 2Et7 0 %
151
1.3 :1 1 8 4 a : 184b
184a 184b
Scheme 113
Two important things were concluded from this reaction. The first was that the 
stereoselectivity was slightly lower than seen in Scheme 114. Again this was determined 
from !H and 13C NMR spectra of the crude reaction mixtures. Secondly, the 
diastereoisomers formed could not be easily separated by flash chromatography on silica 
gel. However, this substrate was used for further studies, as any change in 
stereoselectivity would still be identifiable.
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The first change was to switch the solvent to dichloromethane, (Scheme 114). The 
reaction proceeded as expected with a very similar diastereoselectivity and yield to that 
when benzene was used.
OEt S i(N C S)4, CH3 CHO,
DCM, 3 h
"p o  p i 76  %
T 1 .3  :1 184a:184b
EtO NHEtO NH
C 0 2Et
151 184a 184b
Scheme 114
As the reaction was being carried out over 3 hours it was hoped that by cooling the 
reaction, the stereoselectivity could be improved. By using dichloromethane as the 
solvent it was possible to cool the reaction to -78 °C (Scheme 115). This was done for 
the entire duration of the reaction including the aqueous quench. However, once again 
no difference was observed from the standard. This did indicate that the reaction was 
most probably occurring a lot quicker than the 3 hours originally used.
151
0 E t S i(N C S)4, MeCHO, 
DCM, 3 h, -78 aC
C 0 2Et 7 0  o/c
1 .3  :1 184a :184b
Me
EtO NHNH
C 0 2Et
184a 184b
Scheme 115
Thirdly the switch to the alternative isothiocyanate, trimethylsilyl isothiocyanate was 
made (Scheme 116). Again yields and stereoselectivity were within experimental errors 
of previous reactions.
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“OEt TM SNCS, CH3 CHO, EtO
D C M ,3 h
C 0 2Et 79 %
1.3 :1 184a :184b
C 0 2Et C 0 2Et
151 184a 1 8 4 b
Scheme 116
Now that an improved synthetic method had been finalised, the versatility of the reaction 
was investigated. To date, all three-component coupling reactions had been carried out 
with an ester group as the electron-withdrawing group on the alkylidenepyrrolidine. As 
alkylidenepyrrolidines 153 and 154 had already been synthesised, they became obvious 
candidates for the three-component coupling reaction (Scheme 117).
Scheme 117
The yields were again in line with previous experiments and as expected the 
stereoselectivity was unaffected.
As well as the different alkylidenepyrrolidines a number of aldehydes had been used and 
no difference had been seen in the selectivity though yields were all consistent (Scheme 
118).
MeaSiNCS, CgHnCHO
C 0 2Et
153  R = Me,
1 5 4  R = Ph,
1 8 7  R = M e, 6 8 %
1 8 8  R = Ph, 7 3 %
CQ 2Et
87
OEt M e3 SiN C S, RCHO,
DCM, 3 0  min
C 0 2Et
151
EtO' NH
/
C 0 2Et 
18 4  R = Me, 7 0  % 
1 8 9 R = C 5H11) 78%  
190  R = Ph, 7 4 %
Scheme 118
The reaction with acetaldehyde proceeded in line as that for hexanal. When 
benzaldehyde was used differences in the !H NMR spectra were observed. When the 
alkyl aldehydes were used the peak (identified as a double doublet) corresponding to the 
proton on the 5-position of the major isomer was consistently downfield of the minor 
isomer (identified as a doublet). In the case of benzaldehyde the peak for the major 
isomer (identified as a doublet) was upfield of the minor (identified as a double doublet). 
It is uncertain whether this is due to a switch in selectivity or just an effect of the aryl 
group. It is possible that the aryl group could be interacting during the initial annulation 
reaction, but no evidence is available at present to support or disprove this theory. Until 
a method to determine the absolute stereochemistry of the products becomes available it 
is impossible to tell which isomer is indeed being favoured from these reactions.
Although this work has not led to a full understanding of the mechanism of the 
trimolecular annulation reaction, it has shown a versatile and useful way of forming 
bicyclic thioureas, from a range of chiral and non-chiral alkylidenepyrrolidines without 
racemisation and with a good degree of stereocontrol.
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Chapter 5
Synthesis of the Tricyclic Guanidine core 
of Batzelladine C
89
5.1 Introduction
As mentioned in Chapter 1, the batzelladine alkaloids have proven challenging targets 
for the past decade and to date a number are still to be synthesised, batzelladine C (4) is 
one of the family that has to date not been synthesised. It contains a single tricyclic 
guanidine unit with three side chains. In the original isolation and structural elucidation 
the stereochemistry of the heptyl carbon chain was confirmed but the authors were not 
able to identify the relative configuration of the pentyl chain. Total synthesis is essential 
to finally determine the relative and absolute stereochemistry of this alkaloid. This 
chapter details our investigations into the total synthesis of batzelladine C.
H
h2n ^ /N .T
NH N C7H15
Batzelladine C (4)
By utilising the methodology detailed in chapters 3 and 4 it was hoped that a short 
asymmetric synthesis of this challenging natural product could be accomplished. 
Scheme 119 shows a retrosynthetic pathway from the natural product to a simple 
alkylidenepyrrolidine.
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Hy n
NH
RO
,H
RORORO
NH
192 191193
TM SNCS,
CgHnCHO
RO
194 195
Scheme 119
There are two key steps to this reaction sequence where the new stereogenic centres are 
formed. The first is the trimolecular annulation reaction to form 193, which has been 
covered in the previous chapter. The second is the iodocyclisation step from the bicyclic 
guanidine 192 to the bicyclic guanidine 191.
91
5.2 New Synthetic Strategies
From the methodology already carried out on alkylidenepyrrolidines and the 
trimolecular annulation, it was known that we could make the central aspect of the 
guanidine core, and that this could be achieved from a range of pyrrolidinones.
The obvious starting material for this sequence would be 5-allylpyrrolidin-2-one 195. 
Two literature methods for the formation of this compound were evaluated. Both 
methods start from the inexpensive and commercially-available succinimide 196.
The first method by Speckamp et a/.80 starts with the reduction of succinimide to lactam 
197, which is then coupled with an organozinc reagent to give the desired product 195 
(Scheme 120).81
J — \  NaBH„,EtOH J ~ \  f ' - '  Zn, . ,
*’ " 0 ----------   XH rt, 18 h H THF, rt, 18 h
196 197
Scheme 120
The first step of the reaction proceeded according to the literature; however, in our hands 
the organozinc coupling step was unsuccessful.
The second method, by Hiemstra’s group, again starts with succinimide 196. Addition of 
a Grignard reagent was immediately followed by reduction to give lactam 195 (Scheme 
121).82
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H196
2. NaCNBH3, HCI 
8 6 %
O
195
Scheme 121
This reaction worked well, and provided the desired compound 195 in excellent yield in 
multi-gram quantities (up to 9 g).
Using the methodology developed in Chapter 3, the lactam 195 was A-protected as the 
Boc carbamate providing the activated lactam 198 ready for alkylidenepyrrolidine 
synthesis (Scheme 122).
A number of different acetates could have been used for the formation of the 
alkylidenepyrrolidine. Potentially the most useful for the synthetic target is the 
phthalimide protected acetate 199, synthesised from 4-bromobutyl acetate 200 and 
potassium phthalimide 201 (Scheme 123).
(BocfcO, Et3N
DMAP, DCM, 
rt, 18 h
195 198
8 3 %
Scheme 122
Again it was pleasing to see that this reaction could be carried out on a large scale (up to
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1
Me O
200
N' Ka+
201
O
DMF, 100 8 C, 6 h 
4 2 %
Me O'
v p
' NY
o
199
Scheme 123
The acetate 199 was reacted under the standard conditions detailed in Chapter 3 for the 
ring-opening step (Scheme 124).
O' N 
Boc
198
199, LDA, THF,
-78  8 C, 18 h 
1 0  % (crude)
NHBoc
202
Scheme 124
Unfortunately, yields for this step were very low, and combined with the yields for the 
formation of the acetate it was decided that this method was not feasible to produce the 
required amounts of starting alkylidenepyrrolidine required for this investigation.
The highest yielding acetate used to date was ethyl acetate, although this would require 
further manipulation later on in the synthesis it was considered to be a viable alternative. 
Using the standard method the alkylidenepyrrolidine 204 was synthesised in good yield 
(Scheme 125).
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O'
CH3 C 0 2 Et, LDA.THF
N 
Boc
198
EtO
NHBoc
203
TFA, DCM, 
rt, 2  h
E t02C
N 
H
204
72%  
( 2  step s)
Scheme 125
The three-component coupling reaction, to form the bicyclic thioureas 205a and 205b, 
was carried out using the revised method of trimethylsilyl isothiocyanate and hexanal for 
a period of 30 minutes, then quenched with aqueous dilute sodium hydroxide, followed 
by a flush through a plug of silica gel (Scheme 126).
E t02C
1 . M e 3 SiN C S, j? /— v
CH 3 (CH2)4CHO E t O " \ ^
204
2. dil NaOHaq
74 %
2.4:1 205a205b
J  N
5H11
205a
EtO
+
205b
Scheme 126
Again the reaction proceeded with a good yield and purity. It was also pleasing to see 
that the diastereomeric ratio was in the region of 2.4 : 1. The assignment of the relative 
stereochemistry of these compounds is discussed in section 5.4. It was decided at this 
point to carry the mixture of diastereoisomers through the rest of the sequence. This was
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primarily due to problems encountered with flash chromatography on previous 
thioureas.
The bicyclic guanidine 206 was then formed with the conditions used previously within 
the Elliott group. This method does not involve isolating the S-methylated compound 
produced by the reaction of methyl iodide and the thiourea (Scheme 127).
EtO
205 (42 % d.e.)
1 . Mel, reflux
2. NH3, NH4 OAc
3. Chromatography
EtO 
C5H"  nA „
8 6 %
H NH2  H C 0 2  
20 6
Scheme 127
The reaction proceeded as expected with a high yield obtained. Purification of 
compound 206 was achieved by flash chromatography using a mobile phase of 
dichloromethane / methanol / water / formic acid. This results in isolation of the formate 
salt of the guanidine. However, there was no separation of diastereoi somers by 
chromatography. Due to this, full characterisation was not obtained on this compound.
The iodocyclisation to form the tricyclic guanidine 207 was carried out using a large 
excess of iodine in the presence of potassium carbonate for a period of 18 hours, 
(Scheme 128).
1 j C \ h
A  A  A h ,
C 5 H „ n  nH
2 0 7  
Scheme 128
EtO
C51h i i n  A
H NH 2 H C 0 2  
2 0 6
6  equ ivalents l2,
K2 C 0 3 ,MeCN, 
rt, 18 h
46%
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After chromatography on silica gel, a single diastereoisomer was obtained in 46 % yield. 
No other product was isolated with sufficient purity for identification. In view of the 
yield, it is safe to conclude that this product is derived from the major isomer of the 
three-component coupling reaction which had a selectivity of 2.4 : 1. A series of NMR 
experiments were carried out to determine the structure and stereochemistry of the 
product. These included standard !H and 13C NMR spectra, and gradient NOESY and 
gradient COSY 2-dimensional spectra.
Initial structural determination was carried out by comparison of NMR spectrum of 
207 with that of batzelladine C.1 These spectra are shown in Figure 9 with proton 
assignments according to the natural product numbering. The methine proton HI 1, is not 
distinct in compound 207 since it overlaps with the CH2O of the ethyl ester; similarly 
H9|3 overlaps with the protons of the CH2I functionality. These protons appear as a pair 
of doubled doublets at around 3.40 ppm. The assignment of these protons is supported 
by the correlation data.
H NMR spectrum of Batzelladine C
NH
Batzelladine C (4)
'  >\ .A------ 10a 12a
7!o- T -2.37? I2.0T rPM
Figure 9a
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*H NMR spectrum of compound 207
207
5 & 11
9a 10a
12a
T i— i— r
ppm (f1)
Figure 9b
COSY NMR spectra of 207 and of batzelladine C are shown in Figure 10. 
Assignments of cross-peaks are shown on the spectra.
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Figure 10b
The stereochemistry of the right-hand pyrimidine ring in the natural product was drawn 
as shown in the original report. However, the basis for this assignment was not 
discussed. While the close similarity between the !H NMR data for compound 207 and 
the natural product (in particular, H9p does not show coupling to HI Op) would lead us 
to suggest that compound 207 has identical stereochemistry to the natural product, we 
sought verification of the relative configuration using NMR methods.
The g-NOESY NMR spectrum of compound 207 is shown in Figure 11. Proton HI3 
shows a distinct cross-peak to H12p (although H10P and H12p are overlapping, a 
correlation between H I3 and H10P is extremely unlikely irrespective of the
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stereochemistry) and to the CH2I group. Proton H ll shows cross-peaks to HI0(3 and/or 
H12p. Proton H9|3 shows a cross-peak to HI Op. Based on this, we can conclude that 
protons H9p, H1O0, Hl l ,  H12J3 and HI 3 are all on the same face of the tricyclic system. 
Proton HI5 did not show any diagnostic cross-peaks, so that we are unable to assign the 
stereochemistry at this centre. Three-dimensional representations (MM2 minimised) of 
the two possible stereoisomers of the compound 207 are shown in Figure 12. The 
g-NOESY data are consistent with either structure. In particular, HI2a is not expected 
to show cross-peaks to either of H ll or H13. All other cross-peaks, including those of 
the impurity mentioned above, are assigned on the spectrum.
g-NOESY NMR spectrum o f compound 207
ppm
-  -0.5
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Figure 11
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taa/is-configuration of 207 cw-configuration of 207
Figure 12
These results confirm the stereochemistry of the right-hand pyrimidine ring, which is the 
same as that found in the natural product. Therefore, the iodocyclisation reaction 
produces the correct stereochemistry required for the natural product synthesis. 
Unfortunately, we were unable to determine the stereochemistry of the pentyl chain on 
the left-hand pyrimidine ring.
The next step involved the displacement of the iodine with an alkyl chain. This was 
attempted by reaction with hexyllithium in the presence of a copper catalyst (Scheme
Scheme 129
Unfortunately this reaction did not proceed as desired and no useful product was 
obtained.
At this point we had achieved what had originally been highlighted as the key steps for 
the synthesis. However, there were still a number of areas to be investigated.
129).
DCM, 18 Hrs
X
2 0 7
102
5.3 Further Investigations
Although the key steps had been addressed and achieved, there were still areas that 
needed to be investigated and areas where improvements could be made. It was decided 
to carry out this next section of our research using model compounds that were more 
accessible than the intermediates for the synthetic route toward the natural product 
resulting from the multi-step synthesis described above.
Our attention had been drawn to the stereochemical outcome of the trimolecular 
annulation of the alkylidenepyrrolidine 204; to date this had produced the highest level 
of selectivity seen within the Elliott group. Separation of diastereoisomers was still not 
possible due to degradation during chromatography, although the reasons for the 
degradation were not apparent. It was decided to make the ^-methylated isothiourea and 
test that compound to exposure to silica gel. Initially these investigation were carried out 
on the achiral thiourea 181. The method used previously involved a 1 hour reflux with 
methyl iodide, a quench with triethylamine, and a flush through silica gel was added to 
isolate the isothiourea 208 (Scheme 130).
EtO NH
181
Mel, DCM, 
reflux, 1 h
EtO'
SM e
208
Scheme 130
The results from this were unexpected; it transpired that in the 1 hour reflux, very little 
of the desired methylated compound is formed. It does in-fact complete within 12 hours 
at reflux in dichloromethane (Scheme 131).
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EtO NH
181
1. Mel, DCM, reflux, 12 h
2. Et3N
91 %
EtO'
SM e
20 8
Scheme 131
The bicyclic methylated compound 208 was then purified by flash chromatography on 
silica gel. It was pleasing to see that the yields obtained on multiple repeats of the 
reaction were consistent, and that when the same compound was purified repeatedly no 
significant loss of yield was noted.
This method was then repeated with the synthetic intermediate bicyclic thiourea 205 
(Scheme 132).
EX0^ r Q - ' \
c5Hh
H s  
205 (42 % d.e.)
1. Mel, DCM, reflux, 12 h EtO
2 -E t3N C 5 H u
64 %
Single d iastereoisom er
11
2 0 9
Scheme 132
This produced a high yield of the mixture of diastereoisomers, from which the major 
isomer 209 was easily isolated; however, the minor isomer was never isolated pure 
enough for characterisation purposes.
An alternative ester to ethyl acetate for the formation of the alkylidenepyrrolidine would 
be benzyl acetate. The benzyl ester has the major advantage over ethyl acetate, in that it 
can be cleaved under mild hydrogenation conditions.
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The formation of the alkylidenepyrrolidine 211 was carried out under identical 
conditions to those used previously (Scheme 133).
NBocBoc Benzyl acetate, LDA,
/  BnO
\ ___   THF, -78  aC
NHBoc
195 210
TFA, DCM, 
rt, 2  h
5 7 %
( 2  s tep s)
B n 0 2C
211
Scheme 133
The yields were slightly lower than those that we had come to expect from ethyl acetate 
but were in line with those observed when benzyl acetate had been used before (see 
Chapter 3).
The three-component coupling reaction was carried out to form the bicyclic thiourea 212 
using the standard conditions and produced good crude yields with high degree of purity 
(Scheme 134).
1. Me3 SiNCS, 
CH3 (CH2)4CHO I
0
B n 02G 2. dil NaOH(aq)
63 %
2.2 : 1211 212a 212b
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Scheme 134
Although the overall yields were lower than had been seen for the ethyl acetate 
derivative it was possible to separate out the diastereoisomers of compound 213 at this 
stage. Both the major and the minor isomers were separated and fully characterised.
The bicyclic thiourea 212 as a mixture of its diastereoisomers was 5-methylated by a 12 
hour reflux in methyl iodide and dichloromethane (Scheme 135).
Scheme 135
Again it was possible to separate out the major diastereoisomer and obtain full 
characterisation, although the minor isomer was not isolated in sufficient purity for 
characterisation purposes.
We now had two possible routes to the bicyclic urea which, depending on the final route 
chosen for the synthesis, could be used.
Around this time Gin, and co-workers published their work on the synthesis of 
Batzelladine D. In this synthesis, a similar iodocyclisation was used to form the tricyclic 
guanidine (Scheme 136).83 This was carried out using a cis double bond on the precursor 
214. In light of this it was decided to investigate the viability of adding a cw-double 
bond in our side chain.
1. Mel, DCM, 
reflux, 1 2  h
2 .2  :1 213a:213b
212 (45 % d .e.) 213a 213b
N Boc
BocHN
NHPMBMe'
2 1 4
1) I2, K2CO3, 
DME
2) 10 % Pd/C, 
Et3N,
3) TFA 
51 %
XH
N
H
Me'
Batzelladine D
9n 19
Scheme 136
A good starting point for this investigation were the chiral glutamic ester derivatives. 
We had previously reduced the pyroglutamate ester 87 to the alcohol 129. This was then 
tosylated (Scheme 137).
NaBH4, EtOH, TsCI, Et3N,
NH ---------------------- -
3 h \— ( DMAP, DCM
— OH rt, 18 h
8 1 %  1 2 9  78 % 215
Scheme 137
The simplest way of adding the required functionality at this stage would be to displace 
the tosylate with an alkyne (Scheme 138), this could then be reduced to the alkene using 
Lindlar reduction which would give us the desired cis double-bond isomer.
/>BuLi, THF, - 78 QC 
6 h
Scheme 138
O
^JvJBoc
v"-"O T s
215
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Unfortunately only starting materials were recovered. One possible modification was to 
replace the tosyl group with a halogen. This was done by stirring the lactam 215 in 
acetone with Nal under reflux, which gave a clean yield of the halogenated analogue 216 
(Scheme 139).
Scheme 139
Displacement of the iodine with an acetylide was attempted under the same conditions 
as for the tosylate. However, again no successful reaction was achieved, although most 
of the starting material was recovered.
An alternative way of adding a cis double bond would be through a Wittig reaction using 
an unstabilised ylid. Using the oxidative cleavage reaction developed in the early 1950’s 
by Johnson et a/.84 and later modified by Jin et a lP  on the allyl lactam 195 could 
produce the desired aldehyde for the Wittig reaction (Scheme 140). Unfortunately this 
reaction was unsuccessful and no identifiable products were recovered.
r \ o
Nal, A cetone,
NBocN Boc
O Ts 6 2 %
215 216
K2 0 s 0 4, 2H 2 0 ,  N a l0 4
2 ,6 -lutidine, d ioxane 
rt, 18 h.
X
195
Scheme 140
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When carried out on the protected lactam 198 the reaction gave a good yield with 
excellent purity of the aldehyde 217 (Scheme 141).
K 2 0 s 0 4 .2H 20, N a l0 4
NBocIBoc
2 ,6 -lutidine, dioxane, 18 h
9 5 % 217198
Scheme 141
It was hoped that a Wittig reaction could be carried out with an unstabilised ylid to give
Q /r
the cis double bond. The phosphonium salt 218 was prepared by literature methods, 
and reacted under standard conditions with aldehyde 198 (Scheme 142). Once again, the 
reaction did not proceed as expected and no recoverable products were isolated.
NBoc
KHMDS
Scheme 142
One possible reason for the reactions not producing the desired products could be from 
the activating effect of the Boc carbamate. If this is the case the lactam carbonyl would 
become a viable position for reaction. A further possibility would come from steric 
hindrance of the aldehyde side chain from the Boc group which would further reduce the 
chances of reaction occurring at the desired site.
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5.4 Determination of the Relative Stereochemical Outcome of the 
Three-Component Coupling Reaction
The final area of research carried out was to determine the relative stereochemistry of 
the three-component coupling reactions. To do this a combination of Kishi’s chiral 
aldehyde method was combined with our own version using a chiral 
alkylidenepyrrolidine. In Kishi’s enantioselective total synthesis of 
(-)-decarbamoylsaxitoxin, a modified three-component coupling reaction was reported 
using the (/?)-aldehyde 160 to give the (^-configuration at the new stereogenic centre 
(Scheme 143).
CC^Me
Si(N C S)4, b en zen e , rt 
8 0 %
Scheme 143
Since the chiral influence of the aldehyde is greater than that of the ester group in our 
alkylidenepyrrolidine 151 then the major product from the reaction with the aldehyde 
160 will also have the same (S) configuration at the new stereogenic centre. If we then 
use both enantiomers of the alkylidenepyrrolidine 151 we will be able to determine the 
relative relationship between the two chiral centres.
Alkylidenepyrrolidine 219, the enantiomer of compound 151, was synthesised from the 
corresponding amino acid (Scheme 144).
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A. ^ N Boc
C 0 2Et
1. CH3 C 0 2 Et, LDA.THF, 
-78  gC, 18 h_____________
2. TFA, DCM, 2 h
71 % (2 step s) C 0 2Et
Scheme 144
The three-component coupling reaction was carried out using the single enantiomer 
alkylidenepyrrolidine 219, the aldehyde 160 and trimethylsilyl isothiocyanate in 
dichloromethane for 30 minutes (Scheme 145).
TM SNCS, DCM, 30 min
Scheme 145
Figure 13 shows the region of the !H NMR spectrum that corresponds to the proton at 
the pyrrolidine 5-position. It can clearly be seen that the peak corresponding to the major 
isomer is a doubled doublet, were as the peak corresponding to the minor isomer is 
upfield and is a doublet.
I ll
CH( C02Et)N 
of major isomer
C//(C02Et)N 
of minor isomer
5.0505.100 5.075 5.0255.225 5.175 5.150 5.1255.250 
ppm (11)
5.200
Figure 13
The reaction of the alkylidenepyrrolidine 151 was carried out under identical conditions 
to those above (Scheme 146).
COoEt
151
P-
° V ^ o
H
160
TM SNCS, DCM, 30 min
C0 2Et
222
2
NH
C0 2Et
223
1
Scheme 146
The JH NMR spectrum shown in Figure 14 clearly shows the same arrangement of 
peaks this time the doublet is the major isomer and the minor isomer is observed as a 
double doublet.
112
CH(C 0 2Et)N 
of major isomer
CH( C 02Et)N 
of minor isomer
5.0255.250 5.175 5.125 5.100 5.075 5.0505.225 5.150
ppm (11)
Figure 14
In neither of the reactions was the selectivity as high as reported originally by Kishi, it is 
assumed that the presence of the dithiane group on the alkylidenepyrrolidine 161 is 
enhancing the selectivity observed but that it does not affect the configuration of the 
major product.
With this taken into account we can assume, based on the levels of stereoselectivity 
observed, that when the alkylidenepyrrolidine 219 (with R configuration) is used the 
stereoselectivity is reinforced, as a higher selectivity is observed than when its 
enantiomer 151 is used.
If we assume that the major product in both the above cases has (S) stereochemistry at 
the new stereogenic centre then the major compound from the reaction of the (S) 
alkylidenepyrrolidine 151 will give a trans configuration between the new dioxolanyl 
group and the ester group on the 5-position. When the (R) alkylidenepyrrolidine 219 is 
used the major isomer configuration is cis.
This would indicate based on the relative positions of the peaks in the !H NMR that the 
major isomer observed in all cases when the alkylidenepyrrolidine 151 has been used is
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the cis isomer. Figure 15 shows the region in question from the !H NMR spectrum of 
the products from the reaction of alkylidenepyrrolidine 151 and hexanal.
s I
C//(C02Et)N 
C//(C02Et)N of minor isomer
of major isomer
g  s
1— 1— '— -I— '— I— 1— 1 1— ' I '— 1 '— 1 I 1 1 1 1 I '— T 1 1 
5.20 5.10 5.00 4.90
ppm (11)
Figure 15
It can be seen that the coupling patterns are repeated in this example where a double 
doublet assigned to the cis configuration is downfield of the doublet assigned to the 
trans configuration.
The original three-component coupling reaction carried out within the Elliott group 
using alkylidenepyrrolidine 58 appeared to produce the opposite major isomer. The 
reaction was repeated using the same alkylidenepyrrolidine but with octanal as the 
aldehyde (Scheme 147).
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NHSi(N C S)4, C7 H15CHO
DCM, 3 h, RT
O TBS
OTBS85 % crude yield5 8
224a
2.2
NH
+
OTBS
224b
Scheme 147
The results confirmed the originally reported data; Figure 16 shows the *H NMR data 
from the reaction showing the same protons as those in Figure 13.
C//(CH2OTBS)N 
of major isomer
4.204.50 4.40 4.304.70 4.50
ppm (11)
Figure 16
Although the multiplicity within this example is not as clear as those of the previous 
example, the relative positions of the peaks would indicate that the major product 
formed from this reaction has a trans configuration.
Recently a mixture of isomers of the thiourea 189 has been reduced using sodium 
borohydride.87 The results from this work showed that only the major diastereoisomer
(assigned to be cis as described above) was reduced, and that the new position of the 
proton of the 5-postion of the pyrrolidine ring was coincidental with the minor isomer 
from the reaction using alkylidenepyrrolidine 58 as shown in Figure 16. Therefore, it is 
clear that these two different directing groups do produce opposite stereochemical 
outcomes.
When the allyl alkylidenepyrrolidine 204 is used the relative positions of the peaks of 
the thiourea match with those from the reaction of alkylidenepyrrolidine 58. This would 
indicate that the major product most likely has the trans configuration.
From this information we can assign the structure shown in Figure 17 to our tricyclic 
guanidine 207.
Figure 17
Although batzelladine C was never fully synthesised during the time of this project each 
of the key steps were successfully investigated, resulting in an excellent synthesis of 
bicyclic thioureas and guanidines, and tricyclic guanidines.
5.5 Future Work
With time for the project running out, the final piece of work to be investigated was the 
hydrolysis of the ester. Primarily it was important to discover how stable the resulting 
carboxylic acid was. To this end the achiral isothiourea 208 was hydrolysed using 
sodium hydroxide in methanol (Scheme 148).
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SM e
2 0 8
10 % NaOH in MeOH 
 »
sea led  tube, 100 fiC, 
18 h.
84 % crude yield
HO'
SM e
22 5
Scheme 148
With evidence that the carboxylic acid 225 is stable the final few steps to add the second 
guanidine moiety can be carried out according to literature procedures, which will only 
leave the addition of the alkyl side chain to be investigated (Scheme 149).
EtO
C5H11 NH 51 *11
2 0 7
CyH7n 15
Scheme 149
Batzelladine D
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Chapter 6
Experimental Section
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6.1. General Experimental Points
Melting points were determined on a Gallenkamp melting point apparatus and are 
uncorrected. Infrared spectra were recorded on a Perkin Elmer 1600 FTIR 
spectrophotometer. Mass spectra were recorded on a Fisons VG Platform II 
spectrometer and on a Micromass Q-TOF Micro spectrometer. NMR spectra were 
recorded on a Bruker DPX 400 spectrometer operating at 400 MHz for *H and at 100 
MHz for 13C at 25 °C, or on a Bruker Avance 500 spectrometer operating at 500 
MHz for *H and 125 MHz for 13C at 25 °C. All chemical shifts are reported in ppm 
downfield from TMS. Coupling constants (/) are reported in Hz. Multiplicity in *H 
NMR is reported as singlet (s), doublet (d), double doublet (dd), double double 
doublet (ddd), double double double doublet (dddd), double triplet (dt), double 
quartet (dq), triplet (t), and multiplet (m). Multiplicity in 13C NMR was obtained 
using the DEPT pulse sequence. Flash chromatography was performed using Matrex 
silica 60 35-70 micron.
Compounds 195,197 and 215 were kindly made by M. Loveday.
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6.2 Experimental Data for Chapter 2 
(£)-iV-Phenylcinnamamide (61).88
Cinnamoyl chloride (3.33 g, 20 mmol) was added to a solution of aniline (3.64 mL 
40 mmol), and DMAP (10 mg) in dichloromethane 60 mL and the solution stirred at 
room temperature for 1 hour. Saturated aqueous ammonium chloride (100 mL) was 
added and the solution extracted with dichloromethane (3 x 100 mL). The combined 
organic layers were washed with brine (2 x 100 mL), dried over magnesium sulphate 
and the solvent was removed in vacuo to give a crystalline solid which was 
recrystallised from diethyl ether / hexane to give the title compound (3.77 g, 84 %) as 
a white crystalline solid.
Mp: 152 -  152.5 °C (lit: 152 -  153 °C).
*H NMR (400 MHz; CDC13): 8 = 7.71 (d, J  = 15.5, 1 H, alkene CH), 7.57 (broad d, J 
= 7.0, 2 H, 2 x aromatic CH), 7.49 -  7.45 (m, 2 H, 2 x aromatic CH), 7.35 -  7.28 (m, 
5 H, 5 x aromatic CH), 7.07 (t, J = 7.2, 1 H, aromatic CH), 6.49 (d, J  = 15.5, 1 H, 
alkene CH).
13C NMR (100 MHz; CDC13): 8 =142.5 (alkene CH), 138.0 (aromatic Q , 134.6 
(aromatic C), 130.0 (aromatic CH), 129.1 (aromatic CH), 128.9 (aromatic CH), 127.9 
(aromatic CH), 119.9 (CH=CH).
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3,4-Dihydro-4-phenylquinolin-2(li/)-one (62).29
Reaction of 61 with polyphosphoric acid.
6261
(£)-N-Phenylcinnamamide (1.00 g, 4.5 mmol) was added to polyphosphoric acid (10 
g). The resulting mixture was stirred at 120 °C for 10 minutes. The reaction mixture 
was poured into cold water (250 mL) and extracted with ether (2 x 100 mL). The 
combined ether extracts were concentrated in vacuo to give a yellow crystalline solid 
which was recrystallised from ethanol to give the title compound (710 mg, 72 %) as a 
white crystalline solid.
Mp: 176 -  177.5 °C (lit: 177 -  178 °C).
lH NMR (400 MHz; CDC13): 6 7.26 -  6.96 (m 10 H, 9 x aromatic CH and NH), 4.51 
(t, J  = 7.7, 1 H, CH), 2.98 (dd, J  = 17.8 and 7.7, 1 H, one of CH2), 2.94 (dd, J  = 17.8 
and 7.7, 1 H, one of CH2).
I3C NMR (100 MHz; CDCb): 8 = 171.2 (C=0), 143.5 (aromatic C), 137.1 (aromatic 
C), 128.9 (aromatic CH), 128.4 (aromatic CH), 127.9 (aromatic CH), 127.3 (aromatic 
CH), 126.7 (aromatic C), 123.4 (aromatic CH), 115.8 (aromatic CH), 42.0 (CHCH2),
38.4 (CHCH2).
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3,4-Dihydro-4-phenylquinolin-2(l//)-one (62)
Reaction of compound 61 with 5 equivalents of poor quality aluminium chloride
6261
(£)-Af-Phenylcinnamamide (120 mg, 0.5 mmol) was added to a solution of 
aluminium chloride (333 mg, 2.5 mmol) in chlorobenzene (15 mL) and the solution 
was stirred at 90 °C for 2 hours. The resulting mixture was quenched with 
hydrochloric acid (2 M, 100 mL) and extracted into diethyl ether (2 x 50 mL). The 
combined ether extracts were concentrated in vacuo to give an oily solid which was 
recrystallised from methanol : diethyl ether to give the title compound (32 mg, 28 
%).
Data as previously reported.
3,4-Dihydro-4-phenylquinolin-2(l/7)-one (62)
Reaction o f compound 61 with 1.5 equivalents o f bismuth chloride.
61 62
(F)-7V-Phenylcinnamamide (60 mg, 0.25 mmol) was added to a solution of bismuth 
chloride (118 mg 0.38 mmol) in chlorobenzene (10 mL) and the resulting solution 
stirred at 90 °C for 4 days. The reaction mixture was quenched with hydrochloric 
acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The combined ether 
layers were dried over magnesium sulphate and the solvent was removed in vacuo to
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give an oily solid which was recrystallised from methanol to give the title compound 
(47 mg, 79%) as a white crystalline solid.
Data as previously reported.
3,4-Dihydro-4-phenylquinolin-2(l//)-one (62).
Reaction o f compound 61 with 2 equivalents of bismuth chloride.
N O 
H
N O 
H
6261
(£)—TV-Phenylcinnamamide (60 mg, 0.25 mmol) was added to a solution of bismuth 
chloride (158 mg 0.5 mmol) in chlorobenzene (10 mL) and the resulting solution 
stirred at 90 °C for 4 days. The reaction mixture was quenched with hydrochloric 
acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The combined ether 
layers were dried over magnesium sulphate The solvent was removed in vacuo to 
give a oily solid which was recrystallised from methanol to give title compound (43 
mg, 72%) as a white crystalline solid.
Data as previously reported.
Reaction of compound 61 with 5 equivalents o f good quality aluminium chloride.
(£)-iV-Phenylcinnamamide (120 mg, 0.5 mmol) was added to a solution of 
aluminium chloride (333 mg, 2.5 mmol) in chlorobenzene (15 mL) and the solution
Quinolin-2(m)-one (71).89
H
61 71
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stirred at 90 °C for 2 hours. The resulting mixture was quenched with hydrochloric 
acid (2 M, 100 mL) and extracted with diethyl ether (2 x 50 mL). The combined 
ether layers were concentrated in vacuo to give an oily solid which was recrystallised 
from methanol to give the title compound (75 mg, 66 %) as a white crystalline solid. 
Mp. 199 -  199.5 °C (lit: 196 -  197 °C).
*H NMR (400 MHz; CDC13): 6 = 7.74 (d, J  = 9.5, alkene CH), 7.52 -  6.99 (m, 5H, 
aromatic- CH and NH), 6.63 (d, J  = 9.5, alkene CH).
13C NMR (100 MHz; CDC13): 6 = 174.5 (C=0), 141.6 (CH), 137.3 (aromatic C) 
129.1 (aromatic CH), 129.0 (aromatic CH) 128.0 (aromatic C), 120.1 (CH)
Quinolin-2(l//)-one (71).
Reaction o f compound 61 with 3 equivalents o f aluminium chloride.
(£)-/V-Phenylcinnamamide (60 mg, 0.25 mmol) was added to a solution of 
aluminium chloride (99 mg, 0.75 mmol) in chlorobenzene (10 mL) and the solution 
stirred at 90 °C for 2 hours. The resulting mixture was quenched with hydrochloric 
acid (2 M, 50 mL) and extracted into diethyl ether (2 x 25 mL). The combined ether 
layers were concentrated in vacuo to give an oily solid which was recrystallised from 
methanol to give the title compound (30 mg, 50 %) as a white crystalline solid.
Data as previously reported.
H
H
61 71
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Quinolin-2(li/)-one (71).
Reaction o f compound 61 with 2 equivalents aluminium chloride.
rsi o
H
61 71 62
(£)-iV-Phenylcinnamamide (60 mg, 0.25 mmol) was added to a solution of 
aluminium chloride (66 mg, 0.5 mmol) in chlorobenzene (10 mL) and the solution 
stirred at 90 °C for 2 hours. The resulting mixture was quenched with hydrochloric 
acid (2 M, 50 mL) and extracted into diethyl ether (2 x 25 mL). The combined ether 
layers were concentrated in vacuo to give an off white solid which was recrystallised 
from methanol to give a mixture of compounds predominantly the title compound, 
(40 mg, 72 %) contaminated with with traces of 3,4-dihydro-4-phenylquinolin- 
2(l//)-one (62) as an off-white crystalline solid.
Data as previously reported.
3,4-Dihydro-4-phenylquinolin-2(l//)-one (62) and 3-(4-chlorophenyl)-iV,3- 
diphenylpropanamide (73).
Reaction o f compound 61 with 1.75 equivalents o f aluminium chloride.
H
Ph
61 62
H
73
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(Ej-N-Pheny lcinnamamide (60 mg, 0.25) was added to a solution of aluminium 
chloride (57 mg, 43 mmol) in chlorobenzene (10 mL) and the resulting solution 
stirred at 90 °C for 2 hours. The resulting solution was quenched with hydrochloric 
acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The solvent was 
removed in vacuo to give a crystalline solid recrystallised from methanol to give the 
title compounds (1:1 mixture, 55 mg) as a white crystalline solid.
*H NMR (400 MHz; CDC13): 8 = 7.26 -  6.96 (m 10 H, 9 x aromatic CH and NH), 
4.51 (t, J = 7.7, 1 H, CH), 3.04 -  2.90 (m, 2 H, CH2CO)
MS-ES: mJz (%) 106 (100) 336 (90) 252 (30), 338 (30).
(E')-iV-Methyl-iV-phenylcinnamaimde (76a).90
Cinnamoyl chloride (6.22 g, 37 mmol) was added to a solution of N-methylaniline 
(4.04 mL, 37 m m ol), triethylamine (5 mL) and DMAP in dichloromethane (60 mL) 
and the solution stirred at room temperature for 18 hours. The reaction was quenched 
ammonium chloride (100 mL) and extracted into dichloromethane (3 x 100 mL). The 
combined dichloromethane layers were washed with brine (2 x 100 mL), dried over 
magnesium sulphate and the solvent removed in vacuo to give a crystalline solid 
recrystallised from diethyl ether / hexane to give the title compound (7.34 g, 83 %) as 
a white crystalline solid.
Mp: 61 -  61.5 °C (lit: 62 -  63 °C).
*H NMR (500 MHz; CDC13): 8 = 7.59 (d, J  = 15.5, 1 H, alkene CH), 7.36 (apparent
H, aromatic CH), 7.14 (d, J  = 7.3, 2 H, aromatic CH), 6.29 (d, J  = 15.5, 1 H, alkene 
CH) 3.33 (s, 3 H, NCH3).
13C NMR (125 MHz; CDCI3): 8 = 166.2 (C=0), 143.7 (aromatic C), 141.7 (alkene 
CH), 135.2 (aromatic C), 129.7 (2 x aromatic CH), 129.5 (2 x aromatic CH), 128.7
Me
Me
76a
t, J  = 7.6, 2 H, aromatic CH), 7.28 (t, J  = 7.4, 1 H, aromatic CH), 7.25 -  7.15 (m, 5
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(aromatic CH), 127.9 (aromatic CH), 127.6 (2 x aromatic CH), 127.4 (2 x aromatic 
CH), 118.8 (alkene CH), 37.6 (CH3).
(£)-AVV-Diphenylcinnamamide (76b).91
Cinnamoyl chloride (4.92 g, 30 mmol) was added to a solution of N,N-diphenyl 
amine (5.00 g, 30 mmol), triethylamine (3 mL) and DMAP (10 mg) in 
dichloromethane (60 mL) and the resulting solution stirred at room temperature for 
18 hours. The reaction was quenched with saturated aqueous ammonium chloride 
(100 mL) and extracted into dichloromethane (3 x 100 mL). The combined 
dichloromethane layers were washed with brine (2 x 100 mL), and dried over 
magnesium sulphate. The solvent was removed in vacuo to give a crystalline solid 
which was recrystallised from methanol to give the title compound (7.62 g, 85 %) as 
an off-white crystalline solid.
Mp:101 -  101.5 °C (lit: 102 -  102.5 °C).
JH NMR (500 MHz; CDC13); 8 = 7.70 (d, J  = 15.5, 1 H, alkene CH), 7.36 -  7.16 (m, 
15 H, aromatic CH), 6.41 (d, J  = 15.5, 1 H, alkene CH).
13C NMR (125 MHz; CDCI3): 5 = 166.2 (C=0), 142.8 (aromatic C), 142.7 (alkene 
CH), 135.1 (aromatic C), 129.8 (aromatic CH), 128.8 (aromatic CH), 128.0 (aromatic 
CH).
Ph
Ph
76b
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(I£)-iV-Beiizyl-iV-pheiiylcinnamamide (76c).
NHi
Bn N Oi
Bn
76c
Cinnamoyl chloride (5.6 g, 33 mmol) was added to a solution of N-benzylaniline (6.2 
g, 33 mmol), triethylamine (3.1 mL) and DMAP in dichloromethane (60 mL) and the 
resulting solution stirred at room temperature for 18 hours. The resulting solution 
was quenched with saturated aqueous ammonium chloride (100 mL) and extracted 
into dichloromethane (3 x 100 mL). The combined dichloromethane layers were 
washed with brine (2 x 100 mL), dried over magnesium sulphate and the solvent 
removed in vacuo to give a crystalline solid which was recrystallised from methanol 
to give the title compound (8.06 g, 78 %) as a light brown crystalline solid.
Mp: 88 -  89 °C.
‘H NMR (500 MHz; CDC13): 8 = 7.68 (d, J = 15.5, 1 H, alkene CH), 7.32 -  7.14 (m
alkene CH) 4.93 (s, 2 H, CH2).
13C NMR (125 MHz; CDCI3): 8 = 166.0 (C=0), 142.3 (alkene CH), 142.0 (aromatic 
C), 137.5 (aromatic C), 135.2 (aromatic C), 129.6 (aromatic CH), 129.5 (aromatic 
CH), 128.7 (aromatic CH), 128.4 (aromatic CH), 128.4 (aromatic CH), 127.9 
(aromatic CH), 127.8 (aromatic CH), 127.4 (aromatic CH), 118.8 (alkene CH), 53.2 
(CH2).
IR (Thin film): 3028, 2927, 1654, 1617, 1384, 699 cm 1.
MS-ES: mJz (%) 314 (MH+, 100)
HRMS-ES: m/z [M + K]+ calcd for C22Hi9NOK: 352.1104; found: 352.1102.
13 H, aromatic CH), 7.00 (d, J  = 8.0, 2 H, aromatic CH), 6.30 (d, J  = 15.5, 1 H,
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3,4-Dihydro-1 -methyl-4-phenylquinolin-2(lH)-one
Reaction o f compound 76a with polyphosphoric acid.
76a
(£)-7V-Methyl-N-phenylcinnamamide (500 mg, 2.1 mmol) was added to 
polyphosphoric acid (5 g) and the resulting solution stirred at 120 °C for 10 minutes. 
The reaction mixture was poured into cold water (125 mL) and extracted with 
dichloromethane (2 x 50 mL). The combined dichloromethane layers were dried over 
magnesium sulphate and the solvent was removed in vacuo to give a yellow 
crystalline solid which was recrystallised from ethanol to give the title compound 
(710 mg, 72 %) as an off-white crystalline solid.
Mp: 122-122.5 °C
m  (DCM): 3434, 1672, 1598, 754, 700 cm 1.
NMR (500 MHz; CDC13): 6 = 7.25 (apparent t, J  = 7.6, 2 H, aromatic CH), 7.19 
(apparent q, J = 7.6, 2 H, aromatic CH), 7.08 (d, J  = 7.3, 2 H, aromatic CH), 6.98 (d, 
J  = 8.1, 1 H, aromatic CH), 6.91 (t, J  = 7.5, 1 H, aromatic CH), 6.84 (d, J  =7.4, 1 H, 
aromatic CH), 4.15 (apparent t, J  = 7.4, 1 H, CH), 3.31 (s 3 H CH3), 2.91 (dd, J = 
15.8 and 8.5, 1 H, one of CH2), 2.86 (dd, J  = 15.8 and 6.4, 1 H, one of CH2).
13C NMR (125 MHz; CDCI3): 8 = 169.4 (C=0), 141.1 (aromatic C), 140.4 (aromatic 
C), 129.2 (aromatic C), 128.9 (aromatic CH), 128.1 (aromatic CH), 127.9 (aromatic 
CH), 127.8 (aromatic CH), 127.2 (aromatic CH), 123.1 (aromatic CH), 114.9 
(aromatic CH), 41.5 (CH), 38.9 (CH2), 29.6 (CH3).
MS-ES: m/z (%) 238 (MH+, 100).
HRMS-ES: m/z [M + Na]+ calcd for C^HisNONa: 260.1051; found: 260.1049.
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3,4-Dihydro-l-methyl-4-phenylqumolin-2(lf/)-one (77a)
Reaction of compound 76a with 1.75 equivalents of aluminium chloride.
77a
(£)-7V-Methyl-N-phenylcinnamamide (130 mg, 0.55 mmol) was added to a solution 
of aluminium chloride (128 mg, 0.96 mmol) in chlorobenzene (10 mL) and the 
resulting solution stirred at 90 °C for 2 hours. The reaction mixture was quenched 
with hydrochloric acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). 
The combined ether layers were dried over magnesium sulphate and the solvent was 
removed in vacuo to give a oily solid. Purification by flash column chromatography 
(eluent; dichloromethane : methanol 100:1) gave the title compound (121 mg, 81%) 
as an off-white crystalline solid.
Data as previously reported
3,4-Dihydro-l-methyl-4-phenylquinolin-2(l//)-one (77a)
Reaction o f compound 76a with 2 equivalents o f bismuth chloride.
76a 77a
(£)-W-Methyl-Af-phenylcinnamamide (360 mg, 1.5 mmol) was added to a solution of 
bismuth chloride (956 mg 3.0 mmol) in chlorobenzene (10 mL) and the resulting 
solution stirred at 90 °C for 4 days. The resulting solution was quenched with
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hydrochloric acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The 
solvent was removed in vacuo to give a oily solid. Purification by flash column 
chromatography (eluent; dichloromethane : methanol 100:1) gave the title compound 
(306 mg, 85 %) as a off-white crystalline solid.
Data as previously reported.
3,4-Dihydro-l -methyl-4-phenylquinolin-2(lf/)-one (77a)
Reaction o f compound 76a with 2 equivalents o f aluminium chloride under 
microwave conditions.
MeMe
76a 77a
(fs)-Af-Methyl-Af-phenylcinnamamide (119 mg, 0.5 mmol) was added to a solution of 
aluminium chloride (133 mg, 1.0 mmol) in chlorobenzene (5 mL) and the resulting 
solution stirred under microwave conditions 100 W at 90 °C with cooling for 15 
minutes. The resulting mixture was quenched with hydrochloric acid (2 M, 50 mL) 
and extracted with diethyl ether (2 x 25 mL). The combined ether layers were dried 
over magnesium sulphate and the solvent was removed in vacuo to give a oily solid 
identified as the title compound and starting material (53 % conversion from starting 
material).
Data as previously reported.
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3,4-Dihydro-1,4-diphenylquinolin-2(l//)-one (77b)
Reaction o f compound 76b with polyphosphoric acid.
76b 77b
(E)-N,N-Diphenylcinnamamide (250 mg, 0.8 mmol) was added to polyphosphoric 
acid (5 g) and the resulting solution stirred at 120 °C for 10 minutes. The reaction 
mixture was poured into cold water (125 mL) and extracted with dichloromethane (2 
x 50 mL). The combined dichloromethane layers were dried over magnesium 
sulphate and the solvent was removed in vacuo to give a yellow crystalline solid 
which was recrystallised from ethanol to give the title compound (212 mg, 85 %) as 
an off-white crystalline solid.
Mp: 110-111 °C.
JR (DCM): 3061, 1685, 1599, 753, 735, 696 cm 1.
JH NMR (500 MHz; CDCI3): 6 = 7.44 (apparent t, J = 7.7, 2 H, 2 x aromatic CH), 
7.36 (d, J  = 7.5, 1 H, aromatic CH), 7.30 (apparent t, J  = 7.4, 2 H, 2 x aromatic CH), 
7.25 -  7.12 (m, 6 H, 6 x aromatic CH), 7.04 -  6.98 (m, 1 H, aromatic CH), 6.37 (d, J 
= 8.1, 1 H, aromatic CH), 4.33 (apparent t, J  = 6.9, 1 H, CH), 3.10 -  3.02 (m, 2 H, 
CH2).
13C NMR (125 MHz; CDCI3): 8 = 169.1 (C=0), 141.4 (aromatic C), 141.1 (aromatic 
C), 138.3 (aromatic C), 129.9 (aromatic CH), 129.4 (aromatic CH), 129.0 (aromatic 
CH), 128.9 (aromatic CH), 128.6 (aromatic C), 128.3 (aromatic CH), 128.2 (aromatic 
CH), 127.8 (aromatic CH), 127.6 (aromatic CH), 127.3 (aromatic CH), 123.3 
(aromatic CH), 117.8 (aromatic CH), 117.4 (aromatic CH), 41.7 (CH), 39.4 (CH2). 
MS-ES: m/z (%) 338 (MH+, 100).
HRMS-ES: m/z [M + K]+ calcd for C2iHi7K: 338.0944; found: 338.0944.
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3,4-Dihydro-l,4-diphenylquinolin-2(l//)-one (76b)
Reaction o f compound 76b with 1.75 equivalents of aluminium chloride.
76b 77b
(F)-N,7V-Diphenylcinnamamide (150 mg, 0.5 mmol ) was added to a solution of 
aluminium chloride (116 mg, 0.88 mmol) in chlorobenzene (10 mL) and the resulting 
solution stirred at 90 °C for 2 hours. The reaction mixture was quenched with 
hydrochloric acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The 
combined ether layers were dried over magnesium sulphate and the solvent was 
removed in vacuo to give a oily solid. Purification by flash column chromatography 
(eluent 100 : 1 dichloromethane : methanol) gave the title compound (117 mg, 78%) 
as an off-white crystalline solid.
Data as previously reported.
3,4-Dihydro-l,4-diphenylquinolin-2(l/7)-one (76b)
Reaction o f compound 76b with 2 equivalents o f bismuth chloride.
Ph Ph
76b 77b
(£)-Af-7V-Diphenylcinnamamide (400 mg, 1.3 mmol) was added to a solution of 
bismuth chloride (836 mg 2.6 mmol) in chlorobenzene (10 mL) and the resulting 
solution stirred at 90 °C for 4 days. The reaction mixture was quenched with 
hydrochloric acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The
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combined ether layers were dried over magnesium sulphate and the solvent was 
removed in vacuo to give a oily solid. Purification by flash column chromatography 
(eluent 100 : 1 dichloromethane : methanol) gave the title compound (236 mg, 59 %) 
as an off-white crystalline solid.
3,4-Dihydro- l,4-diphenylqmnolin-2(117)-one (76b)
Reaction o f compound 76b with 2 equivalents of aluminium chloride under 
microwave conditions.
PhPh
76b 77b
(£)-7V,//-Phenylcinnamamide (150 mg, 0.5 mmol) was added to a solution of 
aluminium chloride (133 mg 1.0 mmol) in chlorobenzene (5 mL) and the resulting 
solution stirred under microwave conditions 100 W at 90 °C with cooling for 15 
minutes. The resulting mixture was quenched with hydrochloric acid (2 M, 50 mL) 
and extracted with diethyl ether (2 x 25 mL). The combined ether layers were dried 
over magnesium sulphate and the solvent was removed in vacuo to give a oily solid 
identified as the title compound and starting material (60 % conversion from starting 
material).
Data as previously reported.
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1-Benzyl-3,4-dihydro-4-phenylqumolin-2(l//)-one (77c) 
Reaction o f compound 76c with polyphosphoric acid.
76c 77c
(£>yV-Benzyl-./V-phenylcinnamamide (250 mg, 0.8 mmol) was added to 
polyphosphoric acid (5 g) and the resulting solution stirred at 120 °C for 10 minutes. 
The reaction mixture was poured onto cold water (125 mL) and extracted with 
dichloromethane (2 x 50 mL). The combined dichloromethane layers were dried over 
magnesium sulphate and the solvent was removed in vacuo to give a brown oil. 
Purification by flash column chromatography (eluent 100 : 1 dichloromethane : 
methanol) gave the title compound (170 mg, 68 %) as a light brown oil.
*H NMR (400 MHz; CDCI3): d = 7.32 -  7.11 (m, 11 H, aromatic CH), 7.08 -  6.85 
(m, 3 H, aromatic CH), 5.23 (d, J = 16.1, 1 H, one of benzyl CH2), 4.99 (d, J  = 16.1, 
1 H, one of benzyl CH2), 4.26 (apparent t, J = 6.9, 1 H, CH), 3.65 (dd, J = 15.8 and 
7.9, 1 H, one of CH2), 3.02 (dd, J  = 15.8 and 6.0, 1 H, one of CH2).
13C NMR (100 MHz; CDC13): d = 170.7 (C=0), 140.9 (aromatic C), 139.9 (aromatic 
C), 136.8 (aromatic C), 128.8 (aromatic CH), 128.7 (aromatic CH), 128.3 (aromatic 
CH), 127.9 (aromatic CH), 127.8 (aromatic CH), 127.1 (aromatic CH), 126.7 
(aromatic C), 126.6 (aromatic CH), 123.2 (aromatic CH), 115.6 (aromatic CH), 45.9 
(benzyl CH2), 42.0 (CH), 38.4 (CH2).
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1-Benzyl-3,4-dihydro-4-phenylquinoIin-2(li/)-one (77c)
Reaction o f compound 76c with 1.75 equivalents o f aluminium chloride.
76c 77c
(E)-N-B enzyl-N-pheny lcinnamamide (150 mg, 0.47 mmol) was added to a solution 
of aluminium chloride (112 mg, 0.83 mmol) in chlorobenzene (10 mL) and the 
resulting solution stirred at 90 °C for 2 hours. The combined ether The resulting 
solution was quenched with hydrochloric acid (2 M, 50 mL) and extracted with 
diethyl ether (2 x 25 mL). The combined ether layers were dried over magnesium 
sulphate and the solvent was removed in vacuo to give a brown. Purification by flash 
column chromatography (eluent; dichloromethane : methanol 100 : 1) gave the title 
compound (62 mg, 41%) as a light brown oil.
Data as previously reported.
l-Benzyl-3,4-dihydro-4-phenylquinolin-2(l/7)-one (77c)
Reaction o f compound 76c with 2 equivalents o f bismuth chloride.
Bn Bn
76c 77c
(£)-Af-Benzyl-Af-phenylcinnamamide (312 mg, 1.0 mmol) was added to a solution of 
bismuth chloride (630 mg 2.0 mmol) in chlorobenzene (5 mL) and the resulting 
solution stirred at 90 °C for 4 days. The reaction mixture was quenched with 
hydrochloric acid (2 M, 50 mL) and extracted with diethyl ether (2 x 25 mL). The
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combined ether layers were dried over magnesium sulphate and the solvent was 
removed in vacuo to give a oily solid. Purification by flash column chromatography 
(eluent 100 : 1 dichloromethane : methanol) gave the title compound (96 mg, 32 %) 
as a light brown oil.
Data as previously reported.
1-Benzyl-3,4-dihydro-4-phenylquinolin-2(li[/)-one (77c)
Reaction o f compound 76c with 2 equivalents o f aluminium chloride under 
microwave conditions.
BnBn
76c 77c
(£)-A^-Benzyl-7V-diphenylcinnamamide (78 mg, 0.25 mmol) was added to a solution 
of aluminium chloride (64 mg, 0.5 mmol) in chlorobenzene (5 mL) and the resulting 
solution stirred under microwave conditions 100 W at 90 °C with cooling for 15 
minutes. The resulting mixture was quenched with hydrochloric acid (2 M, 50 mL) 
and extracted with diethyl ether (2 x 25 mL). The combined ether layers were dried 
over magnesium sulphate and the solvent was removed in vacuo to give a oily solid 
identified as the title compound and starting material (47 % conversion from starting 
material).
Data as previously reported.
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6.3 Experimental Data for Chapter 3
tert-Butyl 2-oxopyrrolidine-l-carboxylate (124).
h -  -
127
To a solution of pyrrolidinone (4.0 g, 47 mmol), DMAP (10 mg) and triethylamine (5 
mL) in dichloromethane (100 mL) was added di-terf-butyl dicarbonate (10.25 g, 47 
mmol) in dichloromethane (25 mL) over 10 minutes at 0 °C. The resulting solution 
was warmed to 25 °C and stirred for 18 hours. The reaction was quenched with 
saturated aqueous ammonium chloride solution (100 mL) and extracted into 
dichloromethane (3 x 100 mL). The combined dichloromethane layers were washed 
with brine (2 x 150 mL) and dried over magnesium sulphate. The solvent was 
removed in vacuo, to give a dark brown oil. Purification by flash column 
chromatography on silica gel (eluent hexane:ethyl acetate 4:1) gave the title 
compound (7.58 g, 87 %) as a pale yellow oil.
lH NMR (400 MHz; CDC13): 8 = 3.65 (t, J = 7.2, 2 H, CH2N), 2.42 (t, 7 = 8.1, 2 H, 
CH2CO), 1.90 (apparent quintet, J  = 7.6, 2 H, CH2CH2), 1.43 (s, 9 H, (CH3)3C).
13C NMR (125 MHz; CDC13): 8 = 174.4 (ester C=0), 150.3 (carbamate C=0), 82.8 
((CH3)3CO), 46.5 (CH2N), 33.0 (CH2CO), 28.1 ((CH3)3C), 17.4 (CH2CH2).
O
^ N B o c
124
138
(S)-Ethyl 5-oxopyrrolidine-2-carboxylate (87) .93
O
/ ■ „ „
H O O C ^  " '
C 0 2Et
86 8 7
Thionyl chloride (64.6 g, 0.54 mol) was added to a suspenstion of L-glutamic acid 
(40.0 g, 0.27 mol) in ethanol (250 mL) dropwise at 0 °C. The resulting solution was 
slowly brought to reflux for 1 hour. The solvent was removed in vacuo to give 
off-white crystals which, after heating at 145 °C at 1 mm Hg for 8 hours gave the 
title compound (34.4 g, 81 %) as a waxy solid.
Mp: 4 9 -5 0  °C (lit: 5 0 -5 1  °C).
*H NMR (400 MHz; CDC13): 6 = 7.12 (s, 1 H, NH), 4.20 (dd, J  = 8.2 and 5.1, 1 H, 
CHN), 4.15 (q, J  = 7.1, 2 H, CH2CH3), 2.45 -  2.25 (m, 3 H, CH20  and one of 
CH2CH2), 2.18 -  2.09 (m, 1 H, one of CH2CH2), 1.22 (t, J  = 7.1, 3 H, CH3).
13C NMR (125 MHz; CDC13): 6 = 178.2 (ester C=0), 172.1 (amide C=0), 61.6 
(CH20), 55.5 (CHN), 29.3(CH2CO), 24.8 (CH2CH2), 14.1 (CH3).
tert-Butyl 4-oxo-5-(phenylsulphonyl)pentylcarbamate (125).67
NHBoc
A solution of n-butyllithium (2 mL, 2.5 M in hexanes, 5 mmol) in THF (10 mL) was 
cooled to -78 °C. Methyl phenyl sulphone (0.77 g, 5 mmol) in THF (3 mL) was 
added over 30 minutes, after which the solution was stirred for a further 30 minutes 
at -78 °C. A-r-Butoxycarbonylpyrrolidine-2-one (124) (0.92 g, 5 mmol) in THF (5 
mL) was added over 30 minutes at -78 °C, and the solution warmed to 25 °C and left
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to stir for 18 hours. Saturated aqueous ammonium chloride (100 mL) was added and 
the solution extracted with dichloromethane (3 x 100 mL). The combined organic 
layers were washed with brine (2 x 150 mL), dried over magnesium sulphate and the 
solvent removed in vacuo to give the title compound (1.8 g, 96 %) as an orange oil 
which solidified upon standing to give a waxy solid.
*H NMR (400 MHz; CDC13): 8 = 7.82 (d, J = 7.4, 2 H, aromatic CH), 7.62 (t, J  = 7.5, 
1 H, aromatic CH), 7.52 (apparent t, J = 7.7, aromatic CH), 4.62 (broad s, 1 H, NH), 
4.15 (s, 2 H, OCCH2CO), 3.03 (apparent q, J  = 6.4, 2 H, CH2NH), 2.70 (t, J=  6.8, 2 
H, COCH2 ), 1.69 (apparent quintet, J - 6.8, CH2CH2CH2), 1.36 (s, 9 H, C(CH3)3).
13C NMR (100 MHz; CDCI3): 8 = 197.8 (CH2COCH2), 156.1 (OCON), 138.7 
(aromatic C), 134.4 (aromatic CH), 129.4 (aromatic CH), 128.3 (aromatic CH), 79.3 
(OCCMe3), 67.0 (CH20), 41.4 (CH2N), 39.3 (COCH2CO), 28.4 (C(CH3)3), 23.7 
(CH2CH2N).
2-Phenylsulphonylmethyl-(Z)-ylidenepyrrolidine (126).67
NHBoc
jV-r-Butoxycarbonyl-4-oxo-5-phenylsulphonylpentylamine (125) (1.4 g, 4.1 mmol) 
was dissolved in dichloromethane (5 mL). TFA (3.48 mL, 45 mmol) was added and 
the solution stirred for 18 hours at 25 °C. The volatiles were removed in vacuo and 
the resulting oil was dissolved in dichloromethane (5 mL). Saturated aqueous sodium 
bicarbonate was added until neutral to pH paper, and the organic material was 
extracted into dichloromethane (3 x 50 mL). The combined organic layers were dried 
over magnesium sulphate and the solvent removed in vacuo. The residual yellow oil 
was purified by flash column chromatography (eluent 4:1 hexane:ethyl acetate) to 
give the title compound (620 mg, 67 %) as a yellow oil.
‘H NMR (400MHz; CDCI3): 8 = 7.78 (d, J  = 6.7, 2 H, aromatic CH), 7.43 -  7.34 (m, 
3 H, aromatic CH), 7.05 (broad s, 1 H, NH), 4.58 (s, 1 H, CCH), 3.38 (t, J = 6.9, 2 H,
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CH2N), 2.48 (t, J = 7.8, 2 H, CH2CO), 1.86 (apparent quintet, J  = 7.3, 2 H, 
CH2C//2CH2).
13C NMR (100MHz; CDC13): 8 = 161.9 (alkene C), 145.4 (aromatic C), 131.8 
(aromatic CH), 128.1 (aromatic CH), 125.6 (aromatic CH), 80.8 (alkene CH), 47.5 
(CH2N), 33.2 (CH2C=C), 21.7 (CH2CH2N).
(S)-l-terf-Butyl 2-ethyl 5-oxopyrrolidine-l,2-dicarboxylate (128).94
N B oc
C 0 2Et C 0 2Et
8 7  128
Di-terf-butyl dicarbonate (10.6 g, 48.4 mmol) in dichloromethane (25 mL) was 
added to a solution of (5)-ethyl 5-oxopyrrolidine-2-carboxylate (87) (7.6 g, 48.4 
mmol), DMAP (10 mg) and triethylamine (5 mL) in dichloromethane (100 mL) over 
10 minutes at 0 °C. The solution was warmed to 25 °C and stirred for 18 hours. The 
resulting mixture was quenched with aqueous saturated ammonium chloride solution 
(100 mL) extracted into dichloromethane (3 x 100 mL). The combined 
dichloromethane layers were washed with brine (2 x 150 mL) and dried over 
magnesium sulphate. The solvent was removed in vacuo to give a dark oil which 
upon purification by flash column chromatography (eluent; hexane:ethyl acetate 4:1) 
gave the title compound (10.5 g, 84 %) as a pale yellow oil.
!H NMR (400 MHz; CDC13): 8 = 4.50 (dd, J = 9.5 and 2.9, 1 H, CHN), 4.15 (q, J =
7.1, 2 H, CH20), 2.56 (apparent dt, J  = 17.5 and 9.5, 1 H, one of CH2CO), 2.41 (ddd, 
J  = 17.5, 9.5 and 3.5, 1 H, one of CH2CO), 2.25 (ddd, J  = 19.5, 13.3 and 3.8, one of 
CH2Ctf2), 1.96 (ddt, J  = 13.3, 9.6 and 3.3, 1 H, one of CH2CO), 1.39 (s, 9 H, 
(CH3)3), 1.25 (t, J  = 7.1, 3 H, CH3).
13C NMR (63 MHz; CDC13): 8 = 173.4 (ester C=0), 171.3 (amide C=0), 149.3 
(carbamate C=0), 83.5 (OC(CH3)3), 61.7 (CHN), 58.9 (CH20), 27.4 (CH2CH2), 21.5 
((CH3)3), 14.2 (CH3).
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(S)-5-(Hydroxymethyl)pyrrolidin-2-one (129).95
Sodium borohydride (2.53 g, 66.8 mmol) was added to a solution of (S')-ethyl
5-oxopyrrolidine-2-carboxylate (87) (10.5 g, 66.8 mmol) in ethanol (150 mL) portion 
wise over 30 minutes at 0 °C. The resulting solution was warmed to 25 °C and stirred 
for 4 hours. The resulting mixture was acidified with concentrated hydrochloric acid 
and the solvent removed in vacuo. The resulting oily solid was dissolved in 
chloroform / methanol (10:1) and filtered through celite. The solvent was removed in 
vacuo to give the title compound (6.2 g, 81 %) as a waxy solid.
*H NMR (400 MHz; CDC13): 5 = 8.67 (s, 1 H, NH), 5.54 (broad s, 1 H, OH), 3.88 
(m, 1 H, CHN), 3.69 (dd, J=  11.8 and 3.1, 1 H, one of CH20), 3.45 (dd, J = 11.8 and
6.1, 1 H, one of CH20), 2.50 (m, 2 H, CH2CO), 2.17 (m, 1 H, one of CH2CH2) 1.87 
(m, 1 H, one ofCH2CH2).
13C NMR (62.5 MHz; CDC13): 8 = 180.3 (C=0), 64.9 (CHN), 57.9 (CH20), 30.5 
(CH2CO), 22.4 (CH2CH2).
(S)-te/*-Butyl 2-((terf-butyldimethylsilyloxy)methyl)-5-oxopyrrolidine-l- 
carboxylate (130).96
tert-Butyldimethylsilyl chloride (7.46 g, 49.5 mmol) was added to a solution of 
(S)-5-(hydroxymethyl)pyrrolidin-2-one (129) (4.0 g, 34.7 mmol), imidazole (2.35 g,
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35.0 mmol) and DMAP (10 mg) in dry dimethylformamide (100 mL). The resulting 
solution was stirred at 25 °C for 18 hours. Excess solvent was removed in vacuo, and 
the resulting oily solid was dissolved in dichloromethane and washed with saturated 
aqueous ammonium chloride solution (2 x 50 mL) and saturated brine (3x 50 mL). 
The dichloromethane layer was concentrated in vacuo to give a yellow oil. 
Purification by flash column chromatography on silica gel (eluent hexane:ethyl 
acetate 1:1) gave the title compound (5.26 g, 66 %) as a pale yellow oil.
lH NMR (250 MHz; CDC13): 8 = 6.2 (s, 1 H, NH), 3..75 -  3.64 (m, 1 H, CHN), 3.55 
(dd, J  = 10.1 and 4.1, 1 H, one of CH2OTBS), 3.40 (dd, J  = 10.1 and 7.3, 1 H, one of 
CH2OTBS), 2.33 -  2.23 (m, 2 H, CH2CO), 2.18 -  2.02 (m, 1 H, one of CH2CH2), 
1.71 (dddd, J=  18.1, 9.1, 7.0 and 5.3, 1 H, one of CH2CH2), 0.82 (s, 9 H (CH3)3), 0.0 
(s, 6 H, 2 x CH3).
13C NMR (62.5 MHz; CDC13): 8 = 178.2 (C=0), 66.8 (CH20), 55.8 (CHN), 29.9 
(CH2CO), 25. 8 ((CH3)3), 22.8 (CH2CH2), 18.2 (C(CH3)3), -5.4 (2 x CH3).
(S)-terf-Butyl 2-((terf-butyldimethylsilyloxy)methyl)-5-oxopyrroIidine-l-
carboxylate (131).97
6 *  -
"— OTBS
130
di-terr-Butyl dicarbonate (1.20 g, 5.5 mmol) in dichloromethane (5 mL) was added to 
a solution of (S)-tert-butyl 2-((ter?-butyldimethylsilyloxy)methyl)-5-oxopyrrolidine- 
1-carboxylate (130) (1.25 g, 5.5 mmol), triethylamine (1.5 mL) and DMAP (10 mg) 
in dichloromethane (50 mL) over 5 minutes at 0 °C. The resulting solution was 
warmed to 25 °C and stirred for 18 hours. The reaction mixture was quenched with 
saturated aqueous ammonium chloride solution (50 mL) and extracted with 
dichloromethane (2 x 100 mL). The combined dichloromethane layers were washed 
with brine (2 x 100 mL) and dried over magnesium sulphate. Excess solvent was 
removed in vacuo to give a light brown oil. Purification by flash column
N B oc
'— O T B S
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chromatography on silica gel (eluent hexane:ethyl acetate 4:1) gave the title 
compound (1.43 g, 79 %) as a colourless oil.
*H NMR (250 MHz; CDCI3): 5 = 4.14 (ddt, J  = 5.0, 4.2 and 2.1, 1 H, CHN), 3.89 
(dd, J  = 10.4 and 3.8, 1 H, one of CH20), 3.65 (dd, J  = 10.4 and 3.8, 1 H, one of 
CH20), 2.68 (dt, J  = 17.4 and 10.4, 1 H, one of CH2CO), 2.34 (ddd, J  = 17.5 9.3 and 
2.6, 1 H, one of CH2CO), 2.17 -  1.91 (m, 2 H, CH2CH2), 1.49 (s, 9 H, OC(Ctf3)3), 
0.82 (s, 9 H, SiC(Ctf3)3), 0.0 (s, 6 H, 2 x CH3).
13C NMR (62.5 MHz; CDC13): 6 = 174.9 (amide C=0), 150.0 (carbamates C=0),
82.6 (OC), 64.3 (OCH2), 58.9 (CHN), 32.3 (CH2CO), 28.1 (OC(CH3)3), 25.8 
(SiC(CH3)3), 21.1 (CH2CH2), 18.1 (SiC), -5.6 (CH3), -5.6 (CH3).
Ethyl 6-t-butoxycarbonylamino-3-oxohexanoate (132).
N B oc
124 132
A solution of lithium diisopropylamide (13.5 mL, 2 M in heptane, 27 mmol) in THF 
(100 mL) was cooled to -78 °C. Ethyl acetate (2.58 mL, 27 mmol) in THF (3 mL) 
was added dropwise over 30 minutes, and the solution allowed to stir for a further 30 
minutes. 7V-r-Butoxycarbonylpyrrolidine-2-one (124) (5.0 g, 27 mmol) in THF (5 
mL) was added over 30 minutes at -78 °C, and the solution warmed to 25 °C and left 
to stir for 18 hours. Saturated aqueous ammonium chloride solution (100 mL) was 
added and the organic material extracted with into dichloromethane (3 x 100 mL). 
The combined organic layers were washed with brine (2 x 150 mL), dried over 
magnesium sulphate and the solvent removed in vacuo. Purification by flash column 
chromatography (eluent 2:1 hexane.ethyl acetate) gave the title compound (6.46 g, 
88 %) as a pale yellow oil.
IR (neat): 3380, 2977, 2925, 1739, 1709, 1521 cm'1.
*H NMR (400 MHz; CDC13): 6 = 4.60 (broad s, 1 H, NH), 4.12 (q, J = 7.1, 2 H, 
CH2Q), 3.41 (s, 2 H, COCH2CO), 3.06 (apparent q, / =  6.5, 2 H, Ctf2NHBoc), 2.53
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(t, 7 = 7.1, 2 H, COC//2), 1.72 (apparent quintet, 7 = 6.9, 2 H, CH2C//2CH2), 1.37 (s, 
9 H, f-Bu), 1.21 (t, 7 = 7.1, 3 H, Ctf3CH20).
13C NMR (100 MHz; CDC13): 6 = 203.7 (C=0), 168.3 (C=0), 157.0 (C=0), 79.7 
(OC(CH3)3), 61.8 (OCH2), 49.6 (NCH2), 40.2 (COCH2CO), 39.9 (COCH2CH2), 28.6 
((CH3)3), 24.0 (CH2CH2N), 14.2 (OCH2CH3).
MS-ES: m/z (%) = 296 (M + Na, 83), 240 (7), 156 (100), 128 (16).
HRMS-ES: m/z [M + Na]+ calcd for Ci3H23N 05Na: 296.1474; found: 296.1473.
(-)-Menthyl 6-t-butoxycarbonylamino-3-oxohexanoate (133).
A solution of lithium diisopropylamide (1.5 mL, 2 M in heptane, 3 mmol) in THF 
(10 mL) was cooled to -78 °C. (-)-Menthyl acetate (595 mg, 3 mmol) in THF (3 mL) 
was added over 30 minutes. After stirring for 30 minutes at -78 °C, N-t- 
butoxycarbonylpyrrolidine-2-one (124) (555 mg, 3 mmol) in THF (5 mL) was added 
over 30 minutes at -78 °C, and the solution warmed to 25 °C and left to stir for 18 
hours. Saturated aqueous ammonium chloride (100 mL) was added and the solution 
extracted with dichloromethane (3 x 50 mL). The combined organic layers were 
washed with brine (2 x 50 mL), dried over magnesium sulphate and the solvent 
removed in vacuo to give a yellow crystalline solid which was recrystallised from 
hexane/diethyl ether to give the title compound (965 mg, 84 %) as an off-white 
crystalline solid.
Mp. 88 -  89 °C.
IR (CHC13): 3398, 2958, 1735, 1715, 1170 c m 1.
lU NMR (500 MHz; CDC13): 6 = 4.65 (apparent dt, 7 = 4.4, 10.9, 1 H, menthyl 1-H), 
4.59 -  4.52 (broad s, 1 H, NT/), 3.37 and 3.35 (AB quartet, 7 = 15.5, 2 H, 
COCH2CO), 3.05 (apparent q, 7 = 6.3, 2 H, CH2N), 2.52 (t, 7 = 7.1, 2 H, CH2CO),
NBoc
O
NHBoc
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1 .9 8  -  1 .9 2  (m, 1 H , menthyl 6 -H eq ), 1 .8 2  -  1 .7 5  (apparent doubled septet, J  = 2 . 7 ,
7 .0 ,  1 H ,  C / / ( C H 3) 2 ) ,  1 .7 2  (apparent quintet, J = 6 .9 ,  2  H , C H 2 C / / 2C H 2 ) ,  1 .6 4  -  1 .5 8  
(m, 2  H , menthyl 3 -H eq  and 4 -H eq ), 1 .4 8  -  1 .4 0  (m, 1 H , menthyl 5 -H a x ), 1 .3 7  (s, 9  H ,  
(C H3)3C), 1 .3 5  -  1 .2 7  (m, 1 H , menthyl 2-H a * ), 1 .0 3  -  0 . 9 6  (m, 1 H , menthyl 3 -H a x ),
13C NMR (125 MHz; CDCI3): 8 = 202.5 (ketone C=0), 166.9 (ester C=0), 156.1 
(carbamate C=0), 79.2 (C-O), 75.5 (menthyl 1-CH), 49.6 (COCH2CO), 46.8 
(menthyl 2-CH), 40.7 (menthyl 6-CH2), 40.0 (CH2), 39.7 (CH2), 34.1 (menthyl 4- 
CH2), 31.4 (menthyl 5-CH), 28.4 ((CT^sCO), 26.1 (CH), 23.8 (menthyl 3-CH2),
23.2 (CH2), 22.0 (CH3), 20.7 (CH3), 16.1 (CH3).
MS-ES: m/z (%) = 406 (M + Na, 100), 266 (73), 128 (32).
HRMS-ES: m/z [M + Na]+ calcd for C2iH37N0 5Na: 406.2569; found: 406.2585.
Benzyl 6-t-butoxycarbonylamino-3-oxohexanoate (134).
A solution of lithium diisopropylamide (2.7 mL, 2 M in heptane, 5.4 mmol) in THF 
(40 mL) was cooled to -78 °C. Benzyl acetate (810 mg, 5.4 mmol) in THF (3 mL) 
was added over 30 minutes. After stirring for 30 minutes at -78 °C, N-t- 
butoxycarbonylpyrrolidine-2-one (124) (1.0 g, 5.4 mmol) in THF (8 mL) was added 
over 30 minutes at -78 °C, and the solution allowed to warm to 25 °C and the 
resulting solution stirred for 18 hours. Saturated aqueous ammonium chloride (100 
mL) was added and the organic material extracted into dichloromethane (3 x 50 mL). 
The combined organic layers were washed with brine (2 x 50 mL), dried over 
magnesium sulphate and the solvent removed in vacuo to give a yellow oil. 
Purification by flash column chromatography (eluent 5:1 hexane:ethyl acetate) gave 
the title compound (1.2 g, 68 %) as a colourless oil.
0 . 9 2  (apparent q, J  = 1 1 .7 ,  1 H , menthyl 4-H a x ), 0 . 8 4  (d, J  = 6.6, 3 H , C//3), 0 . 8 2  (d, J  
=  7 .1 ,  3 H , C H3), 0 . 8 2  -  0 . 7 7  (m, 1 H , menthyl 4 -H a x ), 0 . 7 0  (d, J = 7 .0 ,  3 H , CH3).
O
NHBoc
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IR (neat): 3402, 2976, 2925, 1739, 1714,1519, 1167, 751, 698 cm’1.
*H NMR (400 MHz; CDCI3): 6 = 7.36 - 7.26 (m, 5 H, aromatic CH), 5.10 (s, 2 H, 
OCH2), 4.50 (broad s, 1 H, NH), 3.42 (s, 2 H, COCH2CO), 3.01 (apparent q, J = 6.4 
CH2N), 2.50 (t, J  = 7.1, 2 H, CH2CO), 1.68 (apparent quintet, J  = 6.8, 2 H, 
CH2C//2CH2), 1.37 (s, 9H, C(CH3)3).
13C NMR (125 MHz; CDC13): 6 = 202.7 (ketone C=0), 167.1 (ester C=0), 156.1 
(carbamate C=0), 135.2 (aromatic C), 128.7 (aromatic CH), 128.6 (aromatic CH),
128.5 (aromatic CH), 79.3 ((CH3)3CO), 67.2 (CH20), 49.2 (CH2N), 45.0 
(COCH2CO), 39.6 (COCH2), 28.4 ((CH3)3C), 23.8 (CH2CH2N).
MS-ES: m/z (%) = 358 (M + Na, 62), 218 (100).
HRMS-ES: m/z [M + Na]+ calcd for Ci8H25N 05Na: 358.1630; found: 358.1623.
iV-t-Butoxycarbonyl-4,6-dioxoheptylamine (135).
N Boc + /N H B o c
Me Me
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A solution of lithium diisopropylamide (1.5 mL, 2 M in heptane, 3 mmol) in THF 
(10 mL) was cooled to -78 °C. Acetone (174 mg, 3 mmol) in THF (3 mL) was added 
over 30 minutes. After stirring for 30 minutes at -78 °C, N-t-
butoxycarbonylpyrrolidine-2-one (124) (555 mg, 3 mmol) in THF (5 mL) was added 
over 30 minutes at -78 °C, and the solution warmed to 25 °C and left to stir for 18 
hours. Saturated aqueous ammonium chloride (100 mL) was added and the solution 
extracted with dichloromethane (3 x 50 mL). The combined organic layers were 
washed with brine (2 x 50 mL), dried over magnesium sulphate and the solvent 
removed in vacuo. The resulting yellow oil was purified by flash column 
chromatography (eluent 4:1 hexane:ethyl acetate) to give the title compound (535 
mg, 74 %) as a colourless oil (5:1 mixture of enol and keto tautomers).
IR (CH2CI2): 3357, 2976, 1703, 1619, 1170 cm'1.
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*H NMR (500 MHz; CDC13): (enol tautomer) 8 = 5.44 (s, 1 H, enol CH), 4.58 (broad 
s, 1 H, NH), 3.09 (apparent q, J  = 6.5, 2 H, CH2N), 2.25 (t, J  = 7.3, COCH2), 1.98 (s, 
3 H, CH3), 1.73 (apparent quintet, J  = 7.5, 2 H, CH2), 1.37 (s, 9 H, ( ^ 3)3).
13C NMR (125 MHz; CDC13): (enol tautomer) 8 = 194.0 (C=0), 190.7 (enol C-O),
156.0 (C=0), 100.0 (enol CH), 79.3 (C-O), 40.0 (CN2N), 35.7 (CH2), 28.4 
((CH3)3C), 25.9 (CH2), 24.8 (CH3).
MS-ES: m/z (%) = 266 (M + Na, 100), 127 (28).
HRMS-ES: m/z [M + Na]+ calcd for Ci2H2iN04Na: 266.1368; found: 266.1355.
A-t-Butoxy carbonyl-4,6-dioxo-6-phenylhexylamine (136).
NBoc
124 136
A solution of lithium diisopropylamide (2.8 mL, 2 M solution in heptane, 5.6 mmol) 
in THF (10 mL) was cooled to -78 °C. Acetophenone (0.67 mL, 5.6 mmol) in THF 
(2 mL) was added over 20 minutes. After stirring for 25 minutes at -78 °C, N-t- 
butoxycarbonylpyrrolidine-2-one (124) (1.0 g, 5.4 mmol) in THF (5 mL) was added 
over 30 minutes at -78 °C and the solution warmed to 25 °C and left to stir for 18 
hours. Saturated aqueous ammonium chloride (100 mL) was added and the solution 
extracted with dichloromethane (3 x 100 mL). The combined organic layers were 
washed with brine (2 x 150 mL), dried over magnesium sulphate and the solvent 
removed in vacuo to give an oily solid which was recrystallised from ethyl 
acetate/hexane to give the title compound (1.23 g, 75 %), as a off-white crystalline 
solid existing exclusively as the enol tautomer.
Mp. 72 - 73 °C.
IR (CHCI3): 3360,2975, 2929, 1702, 1601, 1169 cm'1.
‘H NMR (400 MHz; CDCI3): 8 = 7.81 (d, 7 = 7.3,2 H, aromatic CH), 7.43 (t, J  = 7.3, 
1 H, aromatic CH), 7.34 (apparent t, J  = 7.4, 2 H, aromatic CH), 6.12 (s, 1 H, enol
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CH), 4.60 (broad s, 1 H, NH), 3.11 (apparent q, J = 6.5, 2 H, CH2N), 2.40 (t, J  = 7.4, 
2 H, CH2CO), 1.81 (apparent quintet, J 7.2,2 H, CH2C//2CH2), 1.35 (s, 9 H, (CH3)3).
13C NMR (125 MHz; CDCI3): 6 = 196.5 (ketone C), 182.9 (enol C), 156.0 
(carbamate C), 134.8 (aromatic C), 132.3 (aromatic CH), 128.6 (aromatic CH), 127.0 
(aromatic CH), 96.2 (enol CH), 78.9 ((CH3)3CO), 40.1 (CH2N), 36.6 (CH2), 28.4 
((CH3)3C), 26.0 (CH2).
MS-ES: m/z (%) = 328 (M + Na, 89), 188 (100).
HRMS-ES: m/z [M + Na]+ calcd for Ci7H23N04Na: 328.1525; found: 328.1499.
(E)-tert-Butyl 2-(2-ethoxy-2-oxoethylidene)pyrrolidine-l-carboxylate ester 
(137).98
NHBoc N Boc
132 137
To a solution of trifluoroacetic acid (1 mL) in dichloromethane (10 mL) was added 
Ethyl 6-r-butoxycarbonylamino-3-oxohexanoate (132) (1.0 g, 3.6 mmol) and the 
resulting solution stirred for 2 hours. The reaction was quenched with aqueous 
sodium bicarbonate and extracted into dichloromethane (3 x 50 mL). The combined 
dichloromethane layers were dried over magnesium sulphate and the solvent 
removed in vacuo to give a dark oil. Purification by flash chromatography on silica 
gel (eluent ethyl acetate:hexane 1:4) gave the title compound (0.82 g, 89 5) as a white 
crystalline solid.
Mp: 70-70 .5  °C.
IR (DCM): 2979, 2936, 1718, 1617, 736 cm"1.
NMR (500 MHz; CDC13): 8 = 4.49 (q, J=  7.1, 2 H, CH20), 3.60 (apparent t, J  =
7.2, 2 H, J = 7.2, 2 H, CH2N), 3.10 (apparent dt, J  = 1.8 and 7.7, 2 H, CH2C=CH),
1.81 (apparent quintet, J  = 7.5, 2 H, CH2CH2), 1.45 (s, 9 H, (CH3)3), 1.18 (t, J  = 7.1, 
CH3).
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13C NMR (125 MHz; CDC13): 8 = 169.0 (ester C=0), 157.4 (carbamate C=0), 152.0 
(NC=CH), 96.1 (NC=CH), 82.0 (OC(CH3)3), 59.1 (CH20), 49.7 (CH2N), 31.8 
(CH2C=CH), 28.2 ((CH3)3), 21.0 (CH2CH2), 14.4 (CH3).
MS-ES: m/z (%) = 110 (100), 256 (M + H, 30).
HRMS-ES: m/z [M + H]+ calcd for Ci3H22N 04: 256.1549; found: 256.1560.
Pyrrolidin-(2Z)-ylidene-acetic acid ethyl ester (138).99
.C 0 2Et
EtO' ^  v  — ^NHBoc ^  NH
132 138
Ethyl 6-r-butoxycarbonylamino-3-oxohexanoate (132) (0.5 g, 1.8 mmol) was 
dissolved in TFA (0.3 mL, 3.6 mmol) and the resulting solution stirred for 3 hours at 
25 °C. Saturated aqueous sodium bicarbonate was added until neutral to pH paper, 
and the organic materials extracted with dichloromethane (3 x 20 mL). The 
combined organic layers were dried over magnesium sulphate and the solvent 
removed in vacuo. The resulting yellow solid was purified by flash column 
chromatography (eluent 4:1 hexane:ethyl acetate) to give the title compound (0.22 g, 
78 %) as a yellow / orange crystalline solid.
Mp. 62 - 62.5 °C (Lit. 60 -  62 °C).
IR (CH2CI2): 3360, 2983, 1652, 1590, 1143 c m 1.
'H NMR (400MHz; CDCI3): 8 = 7.85 (broad s, 1 H, NH), 4.49 (broad s, 1 H, alkene 
CH), 4.05 (q, 7 = 77.1, 2 H, CH20), 3.45 (t, J = 6.9, 2 H, CH2N), 2.51 (t, J  = 7.8, 2 
H, CH2CO), 1.91 (apparent quintet, J  7.3, 2 H CH2C//2CH2), 1.19 (q, J = 7.1, 3 H, 
Ctf3CH2).
13C NMR (125 MHz; CDC13): 8 = 170.8 (C=0), 166.6 (alkene C), 76.5 (alkene CH),
58.4 (CH20), 47.1 (CH2N), 32.2 (CH2), 22.0 (CH2), 14.7 (CH3).
MS-ES: m/z (%) = 156 (MH+, 100), 128 (37).
HRMS-ES: m/z [M + Na]+ calcd for C8Hi4N 02Na: 156.1025; found: 156.1015.
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Pyrrolidin-(2Z)-ylidene-acetic acid ethyl ester (138).
One-pot reaction from compound 124 to 138.
C 0 2Et
NBoc NH
124 138
A solution of lithium diisopropylamide (13.5 mL, 2 M in heptane, 27 mmol) in THF 
(100 mL) was cooled to -78 °C. Ethyl acetate (0.26 mL, 2.7 mmol) in THF (3 mL) 
was added dropwise over 30 minutes, and the solution allowed to stir for a further 30 
minutes. A-f-Butoxycarbonylpyrrolidine-2-one (124) (0.50 g, 2.7 mmol) in THF (5 
mL) was added over 30 minutes at -78 °C, and the solution warmed to 25 °C and left 
to stir for 18 hours. TFA (0.65 mL, 8.37 mmol) was added and the solution stirred for 
2 hours at 25 °C. The volatiles were removed in vacuo and the resulting oil was 
dissolved in dichloromethane (5 mL). Saturated aqueous sodium bicarbonate was 
added until neutral to pH paper, and the organic material was extracted into 
dichloromethane (3 x 50 mL). The combined organic layers were dried over 
magnesium sulphate and the solvent removed in vacuo. The residual yellow oil was 
purified by flash column chromatography on silica gel (eluent 4:1 hexane:ethyl 
acetate) to give the title compound (275 mg, 63 %) as a crystalline solid.
Data as previously reported.
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Pyrrolidin-(2Z)-ylidene-acetic acid (-)-menthyl ester (139).
NHBoc
NH
139
(-)-Menthyl 6-r-butoxycarbonylamino-3-oxohexanoate (133) (900 mg, 2.3 mmol) 
was dissolved in TFA (0.35 mL, 4.6 mmol) and the resulting solution stirred for 3 
hours at 25 °C. Saturated aqueous sodium bicarbonate was added until neutral to pH 
paper, and the organic material was extracted into dichlorormethane (3 x 20 mL). 
The combined organic layers were dried over magnesium sulphate and the solvent 
removed in vacuo. The resulting yellow solid was purified by flash column 
chromatography (eluent 4:1 hexane:ethyl acetate) to give the title compound (485 
mg, 80 %) as a yellow oil.
IR (CHC13): 3365, 2951, 2868, 1651, 1603, 1236 cm'1.
!H NMR ( 5 0 0  MHz; C D C 1 3): 8  =  7 . 8 2  (broad s, 1 H , NH). 4 . 5 8  (apparent dt, J =  4 .2 ,
1 0 .8 ,  1 H , menthyl 1 -H ) ,  4 . 5 0  -  4 .3 5  (broad s, 1 H , alkene C H ) ,  3 .4 3  (t, J  =  6 .8 ,  2  H ,  
CH2N), 2 .5 0  (t, J  =  7 .6 ,  2  H , CH2C=C ) ,  1 .9 7  -  1 .8 2  (m, 4  H , CH2CH2CH2 + menthyl
6 -H eq  +  C H ( C H 3) 2) ,  1 .6 3  -  1 .5 5  (m, 2  H , menthyl 3-H eq  +  4 -H e q ), 1 .4 7  -  1 .3 6  (m, 1 
H , menthyl 5 -H a x ), 1 .2 7  (apparent broad t, J =  1 1 .5 ,  1 H , menthyl 2 -H a x ), 0 .9 9  
(apparent dq, J  =  2 .7 ,  1 2 .7 ,  1 H , menthyl 3 -H a x ), 0 . 8 8  (apparent q, J =  1 1 .7 ,  1 H ,  
menthyl 6 -H a * ), 0 .8 7  -  0 . 7 6  (m, 1 H , menthyl 4 -H a x ), 0 .8 1  (d, J  =  6 .5 ,  3  H , C H 3), 
0 . 8 0  (d, J  =  7 . 0 ,  3  H , C H 3) , 0 . 7 0  (d, J  =  7 .0 ,  3  H , C H 3).
13C NMR (125 MHz; CDCI3): 8 = 170.5 (C=0), 166.4 (C-N), 76.8 (alkene CH), 71.7 
(CH-O), 47.3 (CH), 47.1 (CH2N), 41.6 (CH2), 34.5 (CH2), 32.2 (CH2), 31.5 (CH),
26.3 (CH), 23.7 (CH2), 22.1 (CH3), 22.0 (CH2), 20.8 (CH3), 16.6 (CH3).
MS-ES: m/z (%) = 266 (MH+, 100), 128 (39).
HRMS-ES: m/z [M + H f  calcd for C16H28N 02: 266.2120; found: 266.2139.
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Pyrrolidin-(2Z)-ylidene-acetic acid benzyl ester (140).100
C 02Bn
NHBoc
NH
134 140
Benzyl 6-r-butoxycarbonylamino-3-oxohexanoate (134) (2.0 g, 7.42 mmol) was 
dissolved in TFA (5.11 g, 44.5 mmol) and the resulting solution stirred for 3 hours at 
25 °C. Saturated aqueous sodium bicarbonate was added until neutral to pH paper, 
and the organic material extracted into dichloromethane (3 x 80 mL). The combined 
organic layers were dried over magnesium sulphate and the solvent removed in 
vacuo. The resulting yellow oil was purified by flash column chromatography (eluent 
4:1 hexane:ethyl acetate) to give the title compound (1.5 g, 86 %) as a waxy solid.
lU NMR (500MHz; CDC13): 8 = 7.85 (broad s, 1 H, NH), 5.04 (s, 2 H, CH2Q), 4.54
CH2CO), 1.90 (apparent quintet, J  7.3, 2 H CH2C//2CH2).
I3C NMR (125 MHz; CDCI3): 8 = 170.4 (C=0), 167.0 (alkene C), 137.7 (aromatic 
C), 128.4 (aromatic CH), 127.8 (aromatic CH), 127.6 (aromatic CH), 76.3 (alkene 
CH), 64.4 (CH20), 47.1 (CH2N), 32.3 (CH2), 22.0 (CH2).
MS-ES: m/z (%) = 218 (MH+, 100), 91 (36).
HRMS-ES: m/z [M + H]+ calcd for CnHisNC^Na: 240.1000; found: 240.0995.
Mp. 57 -  58 °C (Lit. 75 -  76 °C).
IR (neat): 3372, 2946, 1651, 1600, 1495, 1454, 1235, 1141, 740, 697 cm 1.
(broad s, 1 H, alkene CH), 3.45 (t, J = 6.9, 2 H, CH2N), 2.52 (t, J  = 7.8, 2 H,
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l-Pyrrolidin-(2Z)-ylidene-propan-2-one (141).101
Me'
N H B oc +
Me
NHBoc
Me
135 141
/V-?-Butoxycarbonyl-4,6-dioxoheptylamine (135) (530 mg, 2.2 mmol) was dissolved 
in TFA (0.34 mL, 4.4 mmol) and the resulting solution stirred for 3 hours at 25 °C. 
Saturated aqueous sodium bicarbonate was added until neutral to pH paper, and the 
organic material extracted into dichloromethane (3 x 50 mL). The combined organic 
layers were dried over magnesium sulphate and the solvent removed in vacuo. The 
resulting yellow solid was purified by recrystallisation from hexane/diethyl ether to 
give the title compound (233 mg, 85 %) as a yellow crystalline solid.
quintet, J  = 7.4, CH2).
13C NMR (125 MHz; CDC13): 6 = 195.0 (C=0), 167.4 (C-N), 89.8 (alkene CH), 47.5 
(CH2N), 32.3 (CH2), 28.7 (CH3), 21.4 (CH2).
MS-ES: m/z (%) = 126 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for C7Hi2NO: 126.0919; found: 126.0917.
Mp. 52 -  52.5 °C.
IR (CHCI3): 3272, 1618, 1556, 1505, 1258 cm’1.
*H NMR (500 MHz; CDC13): 8 = 9.72 (broad s, 1 H, NH), 5.04 (s, 1 H, alkene CH),
3.50 (t, J  = 7.0, CH2N), 2.52 (t, J = 7.8, CH2), 1.96 (s, 3 H, CH3CO), 1.91 (apparent
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l-Phenyl-2-pyrrolidin-(2Z)-ylidene-ethanone (142).102
Ph
NHBoc
Ph-
NH
142136
7V-/-Butoxycarbonyl-4,6-dioxo-6-phenylhexylamine (136) (200 mg, 0.65 mmol) was 
dissolved in dichloromethane (5 mL). TFA (0.10 mL, 1.3 mmol) was added and the 
resulting solution stirred for 3 hours at 25 °C. The volatiles were removed in vacuo 
and the resulting oil dissolved in dichloromethane (2 mL). Saturated aqueous sodium 
carbonate was added until neutral to pH paper, and the organic material extracted 
into dichloromethane (3 x 50 mL). The combined organic layers were dried over 
magnesium sulphate and the solvent removed in vacuo. Purification by flash column 
chromatography (eluent 5:1 hexane:ethyl acetate) gave the title compound (90 mg, 
74 %) as a yellow solid.
Mp. 108 -  109 °C (Lit. 108 -  109 °C).
IR (CHCI3): 3278, 2956,1700, 1610, 1521, 1260 c m 1.
'H NMR (400MHz; CDCb): 6 = 10.23 (broad s, 1 H, NH), 7.80 (dd, J  = 7.6, 1.9, 
aromatic CH), 7.35 -  7.29 (m, 3 H, aromatic CH), 5.70 (s, 1 H, alkene CH), 3.56 (t, J 
= 7.0, 2 H, CH2NH), 2.65 (t, J  = 7.9, 2 H, CH2CCH), 1.95 (apparent quintet, J = 7.5, 
2 H, CH2CH2CH2).
13C NMR (125 MHz; CDCI3): 8 = 188.1 (C=0), 169.4 (C-N), 140.3 (aromatic C),
130.5 (aromatic CH), 128.2 (aromatic CH), 127.0 (aromatic CH), 86.6 (alkene CH), 
47.8 (CH2N), 33.0 (CH2), 21.4 (CH2).
MS-ES: m/z (%) = 188 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for C12H14NO: 188.1075; found: 188.1062.
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(2S)-2-t-Butoxycarbonylamino-5-oxoheptanedioic acid diethyl ester (143).64a
87
N B oc EtO
C 0 2Et
C 0 2Et
143
NHBoc
A solution of lithium diisopropylamide (3.9 mL, 2 M solution in heptane, 7.8 mmol) 
in THF (15 mL) was cooled to -78 °C. Ethyl acetate (0.76 mL, 7.8 mmol) in THF (4 
mL) was added over 25 minutes. After stirring for 20 minutes at -78 °C, ethyl (S)-l- 
terr-butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (87) (2.0 g, 7.8 mmol) in THF 
(5 mL) was added over 30 minutes at -78 °C. The solution was then allowed to warm 
to 25 °C and left to stir for 18 hours. Saturated aqueous ammonium chloride (100 
mL) was added and the solution extracted with dichloromethane (3 x 100 mL). The 
combined organic layers were washed with brine (2 x 150 mL), dried over 
magnesium sulphate and the solvent removed in vacuo. Filtration through a short 
plug of silica, eluting with ethyl acetate, gave the title compound (2.1 g, 78 %), as a 
yellow oil.
IR (neat): 3368, 2979, 2934, 1741,1713, 1512 cm 1.
lH NMR (400 MHz; CDC13): 8 = 5.07 (broad d, J  = 7.6, 1 H, NH), 4.23 -  4.05 (m, 1 
H, CHNH), 4.12 (apparent q, J = 7.2, 4 H, CH20), 3.39 (s, 2 H, COCH2CO), 2.70 -
2.50 (m, 2 H, m, Ctf2CO), 2.16 -  2.05 (m, 1 H, one of Ctf2CHN), 1.89 -  1.76 (m, 1 
H, one of C//2CHN), 1.39 (s, 9 H, C(Ctf3)3), 1 21 (apparent t, J  = 7.2, 6 H, CH2CH3).
13C NMR (100 MHz; CDC13): 8 = 201.7 (ketone C=0), 172.2 (ester C=0), 167.1 
(ester C=0), 155.5 (carbamate C=0), 80.0 (OC(CH3)3), 61.6 (OCH2), 61.5 (OCH2),
52.7 (CHNH), 49.3 (CH2NH), 38.8 (CH2CO), 28.3 (C(CH3)3), 26.5 (CH2) 14.2 
(CH2CH3), 14.1 (CH2CH3).
MS-ES: m/z (%) = 384 (M + K, 34), 368 (M + Na, 100), 328 (17).
HRMS-ES: m/z [M + Na]+ calcd for Ci6 H27 NC>7 Na: 368.1685; found: 368.1659.
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(2S)-2-f-Butoxycarbonylamino-5-oxoheptanedioic acid 1-ethyl ester 7-benzyl
ester (144).
1
C  N Boc  
C 0 2Et
87
A solution of lithium diisopropylamide (5.93 mL, 2 M in heptane, 11.87 mmol) in 
THF (60 mL) was cooled to -78 °C. Benzyl acetate (1.78 g, 11.87 mmol) in THF (10 
mL) was added over 30 minutes. After stirring for 30 minutes at -78 °C, ethyl (S)-l- 
terf-butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (87) (3.05 g, 11.87 mmol) in 
THF (10 mL) was added over 30 minutes at -78°C. The solution was allowed to 
warm to 25 °C and the resulting solution stirred for 18 hours. Saturated aqueous 
ammonium chloride (100 mL) was added and the organic material extracted into 
dichloromethane (3 x 100 mL). The combined organic layers were washed with brine 
(2 x 100 mL), dried over magnesium sulphate, and the solvent removed in vacuo to 
give a yellow oil. Purification by flash column chromatography (eluent 6:1 
hexane:ethyl acetate) gave the title compound (3.1 g, 67 %) as a pale oil.
IR (neat): 3384, 2977,1740, 1710,1368 cm'1.
lH NMR (500 MHz; CDC13): 5 = 7.36 -  7.27 (m, 5 H, aromatic CH), 5.12 (s, 2 H, 
OCH2), 5.05 (broad d, J = 6.5, 1 H, NH), 4.22 -  4.09 (m, 3 H, CHNH and CH20), 
3.45 (s, 2 H, COCH2CO), 2.67 -  2.50 (m, 2 H, m, CH2CO), 2.18 -  2.06 (m, 1 H, one 
of C//2CHN), 1.90 -  1.78 (m, 1 H, one of CH2CHN), 1.39 (s, 9 H, C{CH3)3), 1.22 (t, 
7 = 7.1, 3 H, CH2CH3).
13C NMR (125 MHz; CDCI3): 6 = 201.4 (ketone C=0), 172.2 (ester C=0), 166.9 
(ester C=0), 155.5 (carbamate C=0), 135.3 (aromatic C), 128.7 (aromatic CH),
128.5 (aromatic CH), 128.4 (aromatic CH), 80.0 (OC(CH3)3), 67.2 (OCH2), 61.6 
(OCH2), 52.7 (CHNH), 49.2 (CH2NH), 38.9 (CH2CO), 28.3 (C(CH3)3), 26.5 (CH2)
14.2 (CH2CH3).
MS-ES: m/z (%) = 430 (M + Na, 18), 352 (40), 290 (100).
HRMS-ES: m/z [M + Na]+ calcd for C2iH29N07Na: 430.1842; found: 430.1842.
„  ^  ^  _  NHBoc
BnO
C 0 2Et
144
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Ethyl (2S)-2-f-butoxycarbonylamino-5,7-dioxooctanoate (145).
N Boc
87
NHBoc
Me
C 0 2Et
145
A solution of lithium diisopropylamide (2.5 mL, 2 M solution in heptane, 5 mmol) in 
THF (10 mL) was cooled to -78 °C. Acetone (0.31 mL, 4.3 mmol) in THF (2 mL) 
was added over 20 minutes. After stirring, for 25 minutes at -78 °C, ethyl (S)-l-tert- 
butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (87) (1.0 g, 3.9 mmol) in THF (5 
mL) was added over 30 minutes at -78 °C. The solution was then allowed to warm to 
25 °C and the resulting solution stirred for 18 hours. Saturated aqueous ammonium 
chloride (100 mL) was added and the solution extracted with dichloromethane (3 x 
100 mL). The combined organic layers were washed with brine (2 x 150 mL), dried 
over magnesium sulphate and the solvent removed in vacuo. The residue was 
purified by flash column chromatography (eluent 4:1 hexane:diethyl ether) to give 
the title compound (900 mg, 72%) as a yellow oil, existing as the enol tautomer.
IR (CHC13): 3372, 2979, 1712 (v. broad), 1164 cm 1.
lU NMR (400 MHz; CDCI3): 8 = 5.41 (s, 1 H, enol CH), 5.04 (broad d, J  = 7.3, 1 H, 
NH), 4.23 (m, 1 H, CHNH), 4.13 (q, J = 7.1, 2 H, CH20), 2.35 -  2.29 (m, 2 H, 
CH2CH2), 2.15 -  2.05 (m, 1 H, one of CH2CHN), 1.97 (s, 3 H, CH3CO), 1.93 -  1.83 
(m, 1 H, one of CH2CHN), 1.37 (s, 9 H, C(C//3)3), 1.21 (t, J  = 7.1, 3 H, CH2CH3).
13C NMR (125 MHz; CDC13): 8 = 194.0 (C=0), 189.7 (enol C-O), 172.3 (C=0),
155.4 (C=0), 100.0 (enol C-H), 79.9 (C-O), 61.5 (CH20), 53.1 (CH-N), 34.5 (CH2),
28.3 ((CH3)3C), 28.0 (CH2), 24.4 (CH3), 14.1 (CH3).
MS-ES: m/z (%) = 354 (M + K, 62), 338 (100), 282 (21).
HRMS-ES: m/z [M + Na]+ calcd for Cis^sNOeNa: 338.1580; found: 338.1569.
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Ethyl (2S)-2-Mmtoxycarbonylamino-5,7-dioxo-7-phenylheptanoate (146).103
NHBoc
N B oc
A solution of lithium diisopropylamide (2.5 mL, 2 M solution in heptane, 5 mmol) in 
THF (10 mL) was cooled to -78 °C. Acetophenone (0.53 mL, 4.3 mmol) in THF (2 
mL) was added over 20 minutes. After stirring for 25 minutes at -78 °C, ethyl (5)-l- 
terf-butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (87) (1.0 g, 3.9 mmol) in THF 
(5 mL) was added over 30 minutes at -78 °C. The solution was then allowed to warm 
to 25 °C and left to stir for 18 hours. Saturated aqueous ammonium chloride (100 
mL) was added and the solution extracted with dichloromethane (3 x 100 mL). The 
combined organic layers were washed with brine (2 x 150 mL), dried over 
magnesium sulphate and the solvent removed in vacuo to give a orange oil which 
was purified by flash column chromatography (eluent 10:3 hexane:diethyl ether) to 
give the title compound (1.1 g, 74 %) as a yellow crystalline solid.
Mp. 63 -  64 °C.
IR (CHCI3): 3367, 2979,1715 (v. broad), 1606,1164 cm'1.
‘H NMR (500 MHz; CDCI3): 8 = 7.79 (apparent d, J = 7.2, 2 H, aromatic CH), 7.40 
(apparent tt, J  = 7.4, 1.2, 1 H, aromatic CH), 7.32 (apparent t, J  = 7.6, 2 H, aromatic 
CH), 6.10 (s, 1 H, Cff=CCOH), 5.11 (broad d, J  = 8.3, 1 H, NH), 4.28 -  4.22 (m, 1 
H, C//NH), 4.09 (q, J  = 7.2, 2 H, CH20), 2.52 -  2.41 (m, 2 H, Ctf2CH2), 2.19 -  2.10 
(m, 1 H, one of Ctf2CHN), 1.99 -  1.90 (m, 1 H, one of Ctf2CHN), 1.35 (s, 9 H, 
(C(C//3)3), 1.21 (t, / =  7.2, 3 H, CH2C//3).
13C NMR (125 MHz; CDC13): 5 = 196.4 (PhCOCH2), 182.0 (enol ether C), 172.3 
(ester C=0), 155.5 (carbamate C=0), 134.4 (aromatic C), 132.5 (aromatic CH),
128.6 (aromatic CH), 126.9 (aromatic CH), 79.7 (Me3CO), 61.4 (OCH2), 53.1 
(NCH), 35.4 (CH2COH), 28.2 ((CH3)3), 28.0 (CH2CHN), 14.1 (CH3).
MS-ES: m/z (%) = 416 (M + K, 75), 400 (M + Na, 100), 378 (M+, 24).
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HRMS-ES: m/z [M + Na]+ calcd for C2oH27N06Na: 400.1736; found: 400.1729.
(2S)-2-f-Butoxycarbonylamino-5-oxoheptanedioic acid 1-ethyl ester 7-(-)- 
menthyl ester (147).
A solution of lithium diisopropylamide (3.1 mL, 2 M in heptane, 6.2 mmol) in THF 
(10 mL) was cooled to -78 °C. (-)-Menthyl acetate (1.23 g, 6.2 mmol) in THF (3 
mL) was added over 30 minutes. After stirring for 30 minutes at -78 °C, ethyl 
(S)-1 -terr-butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (87) (1.6 g, 6.2 mmol) in 
THF (5 mL) was added over 30 minutes at -78 °C, and the solution warmed to 25 °C 
and allowed to stir for 18 hours. Saturated aqueous ammonium chloride (100 mL) 
was added and the solution extracted with dichlorormethane (3 x 100 mL). The 
combined organic layers were washed with brine (2 x 150 mL), dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 4:1 hexane:ethyl acetate) to give 
the title compound (2.0 g, 71 %) as an off-white solid.
Mp. 82 - 82.5 °C.
ER (CHC13): 3367, 2957, 1717 (v. broad), 1168 cm 1.
!H N M R  ( 5 0 0  MHz; C D C 1 3 ) :  8  =  5 . 0 3  (broad d, J =  6 . 3 ,  1 H ,  N H ) ,  4 . 6 5  (apparent dt, 
J  =  4 . 4 ,  1 0 . 9 ,  1 H ,  menthyl 1 - H ) ,  4 . 2 2  -  4 . 1 4  (m, 1  H ,  CH-N ) ,  4 . 1 1  (q, J  =  7 . 1 ,  2  H ,  
C H 2 0 ) ,  3 . 3 8  and 3 . 3 5  ( A B  quartet, J  =  1 5 . 5 ,  2  H ,  C O C H 2 C O ) ,  2 . 6 5  -  2 . 5 0  (m, 2  H ,  
C H 2 C O ) ,  1 . 9 8  -  1 . 9 2  (m, 1 H ,  menthyl 6 - H e q ) ,  1 . 8 7  -  1 . 7 5  (m, 3  H ,  CH2C H 2 C O  and 
CH(CH 3 ) 2 ) ,  1 . 6 4  -  1 . 5 8  (m, 2  H ,  menthyl 3 - H e q  and 4 - H e q ) ,  1 . 4 7  -  1 . 3 9  (m, 1  H ,  
menthyl 5 - H a x ) ,  1 . 3 7  (s, 9  H ,  C ( C / / 3 ) 3 ) ,  1 . 3 4  -  1 . 2 6  (m, 1 H ,  menthyl 2 - H a x ) ,  1 . 2 1  (t, 
J -  7 . 1 ,  3  H ,  C / f 3 C H 2 ) ,  1 . 0 3  -  0 . 9 3  (m, 1 H ,  menthyl 3 - H a * ) ,  0 . 9 2  (apparent q, J  =
N B oc
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11.8, 1 H, menthyl 6-Hax), 0.84 (d, J  = 6.6, 3 H, CH/), 0.82 (d, J -  7.0, 3 H, CH/),
0.81 -  0.76 (m, 1 H, menthyl 4 -H a x ), 0.69 (d, J  = 7.0, 3 H , CH/).
13C NMR (125 MHz; CDCI3): 8 = 201.7 (ketone C=0), 172.2 (ester C=0), 166.7 
(ester C=0), 155.5 (carbamate C=0), 80.0 ((CH3)3CO), 75.6 (menthyl 1-CH), 61.2 
(CH20), 52.8 (CHN), 49.6 (CH2), 46.9 (menthyl 2-CH), 40.7 (menthyl 6-CH2), 38.8 
(CH2), 34.2 (menthyl 4-CH2), 31.4 (menthyl 5-CH), 28.3 ((CH3)3C), 26.6 (CH2), 26.2 
(CH), 23.3 (menthyl 3-CH2), 22.0 (CH3), 20.7 (CH3), 16.2 (CH3), 14.2 (CH3).
MS-ES: m/z (%) = 494 (M + K, 13), 478 (M + Na, 24), 338 (100).
HRMS: m/z [M + Na]+ calcd for C24H4iN0 7Na: 478.2781; found: 478.2795.
(2S)-2-f-Butoxycarbonylaimno-5-oxoheptanedioic acid 1-ethyl ester
7-(+)-menthyl ester (148).
A solution of lithium diisopropylamide (1.15 mL, 2 M in heptane, 2.3 mmol) in THF 
(10 mL) was cooled to -78 °C. Menthyl acetate (0.46 g, 2.3 mmol) in THF (3 mL) 
was added over 30 minutes. After stirring for 30 minutes at -78 °C, ethyl 
(S)-1 -terr-butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (87) (0.6 g, 2.3 mmol) in 
THF (5 mL) was added over 30 minutes at -78 °C, and the solution warmed to 25 °C 
and allowed to stir for 18 hours. Saturated aqueous ammonium chloride (100 mL) 
was added and the solution extracted with dichloromethane (3 x 100 mL). The 
combined organic layers were washed with brine (2 x 150 mL), dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 4:1 hexane:ethyl acetate) to give 
the title compound (764 mg, 73 %) as an off-white solid.
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lU NMR and 13C NMR data are in line with compound 147; additional peaks are
observed due to the existence of diastereoisomers in a 1:1 ratio.
(2S)-5-[l-(-)-Menthyloxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic 
acid ethyl ester (149).
TFA (0.23 mL, 3 mol) was added to a solution of (25')-2-r-Butoxycarbonylamino-5- 
oxoheptanedioic acid 1-ethyl ester 7-(-)-menthyl ester (147) (696 mg, 1.53 mmol) in 
dichloromethane (10 mL). After stirring for 3 hours at 25 °C, the solution was 
neutralized with saturated aqueous sodium carbonate and extracted with 
dichloromethane (3 x 20 mL). The combined organic layers were dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 10:1 dichloromethane:methanol) to 
give the title compound (387 mg, 75 %) as a white crystalline solid.
Mp. 72.0-72.5 °C.
IR (nujol): 3370, 1738, 1661,1605, 1200 cm 1.
!H N M R  ( 5 0 0  MHz; C D C I 3 ) :  8  =  8 . 0 5  (broad s, 1 H ,  NH), 4 . 5 8  (apparent dt, J  =  4 . 3 ,
1 0 . 8 ,  1 H ,  menthyl 1 - H a x ) ,  4 . 5 2  (s, 1 H ,  alkene C H ) ,  4 . 2 8  (dd, J  =  8 . 3 ,  5 . 4 ,  1 H ,  
C H N ) ,  4 . 1 7  -  4 . 0 9  (m, 2  H ,  O C H 2 ) ,  2 . 6 3  (dddd, J =  1 6 . 6 ,  8 . 9 ,  6 . 8 ,  0 . 7 ,  1  H ,  one of 
C H 2 C O ) ,  2 . 5 2  (dddd, J  =  1 6 . 6 ,  8 . 9 ,  6 . 3 ,  0 . 7 ,  1 H ,  one of C H 2 C O ) ,  2 . 2 2  (apparent ddt, 
J =  1 2 . 8 ,  6 . 9 ,  8 . 6 ,  1 H ,  one of C H 2 C H 2 C O ) ,  2 . 0 9  -  2 . 0 1  (m, 1 H ,  one of CH2CH 2 C O ) ,
1 . 9 8  -  1 . 9 2  (m, 1 H ,  menthyl 6 - H e q ) ,  1 . 8 7  (apparent doubled septet, J -  2 . 6 ,  7 . 0 ,  1 H ,  
C / / ( C H 3 ) 2 ) ,  1 . 6 3  -  1 . 5 6  (m, 2  H ,  menthyl 3 - H e q  +  4 - H e q ) ,  1 . 4 7  -  1 . 3 9  (m, 1 H ,  
menthyl 5 - H . 0 ,  1 - 3 2  -  1 . 2 5  (m, 1 H ,  menthyl 2 - H « ) ,  1 . 2 1  (t, J  =  7 . 1 ,  3  H ,  C H 3 C H 2 ) ,
1 . 0 0  (apparent dq, J  =  3 . 5 ,  1 3 . 0 ,  1 H ,  menthyl 3 - H a x ) ,  0 . 8 9  (apparent q, J  =  1 1 . 7 ,  1 H ,
N H Boc
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menthyl 6 -H ax), 0 . 8 2  (d, J  = 6 .5 ,  3 H , C H 3 ) ,  0 .8 1  (d, J  = 7 .0 ,  3 H , C H 3 ) ,  0 . 8 0  -  0 .7 5  
(m, 1 H , menthyl 4 -H a x ), 0 . 7 0  (d, J  = 7 .0 ,  3 H , C H 3 ) .
13C NMR (125 MHz; CDC13): 8 = 172.0 (ester C=0), 170.0 (ester C=0), 164.7 
(C=CH), 79.2 (C=CH), 72.1 (menthyl 1-CH), 61.5 (CH20), 60.4 (CH-N), 47.2 
(menthyl 2-CH), 41.5 (menthyl 6-CH), 34.4 (menthyl 4-CH2), 31.4 (menthyl 5-CH2),
31.1 (CH2C=C), 26.2 (CH(CH3)2), 26.1 (CH2CH2CH-N), 23.6 (menthyl 3-CH2), 22.1 
(CH3), 20.8 (CH3), 16.5 (CH3), 14.2 (CH3).
MS-ES: m/z (%) = 360 ([M+Na]+, 12), 339 (22), 338 (100).
HRMS-ES: m/z [M + Na]+ calcd for C19H3iN04Na: 360.2151; found: 360.2155.
(25)-5-[l-(±)-Menthyloxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic 
acid ethyl ester (150)
NHBoc
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TFA (0.17 mL, 2.2 mmol) was added to a solution of (25)-2-t-Butoxycarbonylamino- 
5-oxoheptanedioic acid 1-ethyl ester 7-(+)-menthyl ester (148) (500 mg, 1.1 mmol) 
in dichloromethane (10 mL). After stirring for 3 hours at 25 °C, the solution was 
neutralized with saturated aqueous sodium carbonate and extracted with 
dichloromethane (3 x 20 mL). The combined organic layers were dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 10:1 dichloromethane:methanol) to 
give the title compound (256 mg, 69 %) as a pale yellow oil.
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!H NMR and 13C NMR data are in line with compound 149; additional peaks are
observed due to the existence of diastereoisomers in a 1:1 ratio.
13C NMR spectrum for compound 150
c n i  c o  o  e q
| I I I I | I I I I | I I I I | I 1 I I ]------- 1--------1 I 1-------1------ 1-------1-------1-------1--------- 1----1-------1-------1-------1 p
150  125  100  75  50  2 5  0
ppm (f1)
Selected peaks: 8 = 172.0 and 171.9 (ester C=0), 170.1 (ester C=0), 164.6 (NC=C),
79.2 and 79.1 (NC=C), 72.1 and 71.9 (CHO), 61.4 (CH20), 60.4 (CHN), 47.3 and
47.2 (menthyl 2-CH), 41.6 (menthyl 6-CH), 34.5 (menthyl 4-CH2), 31.5 and 31.4 
(menthyl 5-CH2), 31.1 (CH2C=C), 26.3 and 26.2 (CH(CH3)2), 26.1 (CH2CH2 
pyrrolidine), 23.6 (menthyl 3-CH2), 22.1 (CH3), 20.9 and 20.8 (CH3), 16.6 (CH3),
14.2 and 14.1 (ester CH3).
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(25)-5-[l-Ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl
ester (151).
.C 0 2Et
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(25)-2-r-Butoxycarbonylamino-5-oxoheptanedioic acid diethyl ester (143) (4.9 g,
14.2 mmol) was dissolved in TFA (2.1 mL, 28 mmol) and the solution stirred for 3 
hours at 25 °C. Excess TFA was removed in vacuo and the resulting, oil dissolved in 
dichloromethane (5 mL). Saturated aqueous sodium carbonate was added until 
neutral to pH paper, and the organic material extracted into dichloromethane (3 x 150 
mL). The combined organic layers were dried over magnesium sulphate and the 
solvent removed in vacuo. The resulting yellow oil was purified by flash column 
chromatography (eluent 4:1 hexaneiethyl acetate) to give the title compound (2.6 g, 
82 %) as a pale yellow oil.
IR (CHC13): 3372, 2980, 1738, 1664, 1604,1196 cm 1.
lH NMR (500 MHz; CDC13): 6 = 8.05 (broad s, 1 H, NH), 4.53 (broad s, 1 H, alkene 
CH), 4.29 (dd, J  = 8.3, 5.2, CH-N), 4.16 -  4.11 (m, 2 H, CH20), 4.03 (q, J = 7.1, 
CH20), 2.63 (ddd, J  = 16.7, 8.1, 7.0, 1 H, one of CH2C=C)), 2.57 -  2.50 (m, 1 H, one 
of CH2C=C), 2.23 (apparent ddt, J  = 12.9, 7.1, 8.6, 1 H, one of CH2), 2.05 (apparent 
ddt, J  = 12.9, 9.0, 5.6, 1 H, one ofCH2), 1.21 (t, 7=7.1 , 3 H, CH3), 1.19 (t, 7=  7.1, 3 
H, CH3).
13C NMR (125 MHz; CDC13): 6 = 171.9 (C=0), 170.4 (C=0), 164.9 (C-N), 78.8 
(alkene CH), 61.5 (OCH2), 60.5 (Cff-N), 58.7 (OCH2), 31.1 (CH2), 26.2 (CH2), 14.6 
(CH3), 14.2 (CH3).
MS-ES: m/z (%) = 250 (M + Na, 34), 228 (MH+, 100), 182 (13).
HRMS-ES: m/z [M + H]+ calcd for CnH18N 02: 228.1236; found: 228.1239.
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(2S)-5-[l-(-)-Benzyloxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid
ethyl ester (152)
,-N H Boc
BnO
C 0 2Et
1 4 4  152
C 0 2Bn
(25)-2-f-Butoxycarbonylamino-5-oxoheptanedioic acid 1-ethyl ester 7-benzyl ester 
(144) (2.45 g, 6.01 mmol) was dissolved in TFA (4.11 g, 36 mmol) and the resulting 
solution stirred for 3 hours at 25°C. Saturated aqueous sodium bicarbonate was 
added until neutral to pH paper, and the organic material extracted into 
dichloromethane (3 x 80 mL). The combined organic layers were dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 4:1 hexane:ethyl acetate) to give 
the title compound (1.26 g, 72 %) as a yellow oil.
IR (neat): 3366, 2979, 2905, 1738, 1665, 1602, 1454, 1373, 1198, 1144, 1023, 739, 
698 cm 1.
lH NMR (400 MHz; CDC13): 6 = 8.08 (broad s, 1 H, NH), 7.32 -  7.16 (m, 5 H, 
aromatic CH), 5.07 and 5.02 (AB quartet, J  = 12.6, 2 H, PhC//20), 4.28 (dd, J  = 8.3,
5.2, CHN), 4.16 -  4.09 (m, 2 H, CH20), 2.68 -  2.45 (m, 2 H, CH2C=C), 2.28 -  2.16 
(m, 1 H, one of CH2), 2 .10-1.97 (m, 1 H, one of CH2), 1.21 (3 H, t, 7 = 7.1, CH3).
13C NMR (100 MHz; CDCI3): 8 = 171.9 (C=0), 170.0 (C=0), 165.4 (C=CH), 135.2 
(aromatic C), 128.5 (aromatic CH), 127.9 (aromatic CH), 127.7 (aromatic CH), 78.5 
(alkene CH), 64.6 (OCH2Ph), 61.5 (OCH2), 60.5 (CHN), 31.2 (CH2), 26.1 (CH2),
14.2 (CH3).
MS-ES: m/z (%) = 290 (MH+, 100%).
HRMS-ES: m/z [M + H]+ calcd for Ci6 H2qN0 4 : 290.1392; found: 290.1382.
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(2S)-5-[2-Oxo-prop-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl ester
(153).103
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Ethyl (2S)-2-f-butoxycarbonylamino-5,7-dioxooctanoate (145) (400 mg, 1.27 mmol) 
was dissolved in dichloromethane (3 mL) and TFA (0.16 mL, 2.4 mmol) and the 
resulting solution stirred for 3 hours at 25 °C. After removal of the volatiles in vacuo, 
the resulting, oil was dissolved in dichloromethane (5 mL) and saturated aqueous 
sodium carbonate was added until neutral to pH paper. The organic material was 
extracted into dichloromethane (3 x 50 mL), the combined organic layers dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 4:1 hexane:ethyl acetate) to give 
the title compound (138 mg, 55 %) as a pale yellow oil.
IR (neat): 3297, 2982, 1740, 1628, 1555, 1202 cm'1.
lU NMR (500 MHz; CDC13): 5 = 9.80 (broad s, 1 H, NH) 5.10 (broad s, 1 H, alkene 
CH), 4.35 (dd, J  = 8.5, 5.1, CHN), 4 .18 -4 .10  (m, 2 H, OCH2), 2.65 (ddd, J  = 16.9, 
8.9, 7.3, one of CH2C=C), 2.54 (ddd, J  = 16.9, 9.1, 5.9, one of CH2C=C), 2.27 -  2.19 
(m, 1 H, one of CH2), 2.10 -  2.02 (m, 1 H, one of CH2), 1.98 (s, 3 H, CH3), 1.22 (t, J 
= 7.1, Cff3CH2).
13C NMR (125 MHz; CDC13): 8 = 196.0 (ketone C=0), 171.6 (ester C=0), 165.8 
(alkene C), 91.0 (alkene CH), 61.6 (OCH2), 61.0 (CH), 31.3 (CH2), 28.9 (CH3), 25.6 
(CH2) and 14.1 (CH3).
MS-ES: m/z (%) = 198 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for Ci0Hi6NO3: 198.1130; found: 198.1131.
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(2S)-5-[2-Oxo-2-phenyl-eth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl
ester (154).
NHBoc 
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Ethyl (25)-2-/-butoxycarbonylamino-5,7-dioxo-7-phenylheptanoate (146) (377 mg,
1.0 mmol) was dissolved in dichloromethane (5 mL) and TFA (0.13 mL, 2 mmol) 
and the resulting solution stirred for 3 hours at 25 °C. After removal of the volatiles 
in vacuo, the resulting, oil was dissolved in dichloromethane (5 mL) and saturated 
aqueous sodium carbonate was added until neutral to pH paper. The organic material 
was extracted into dichloromethane (3 x 50 mL), the combined organic layers dried 
over magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil 
was purified by flash column chromatography (eluent 7:1 hexane:ethyl acetate) to 
give the title compound (114 mg, 44 %) as a pale yellow crystalline solid.
Mp. 64-64 .5  °C.
IR (CHC13): 3288, 2981, 1740 (v. broad), 1615, 1522, 1210 cm 1.
lH NMR (500 MHz; CDC13): 6 = 10.32 (broad s, 1 H, NH), 7.87 -  7.84 (m, 2 H, 
aromatic CH), 7.42 -  7.35 (m, 3 H, aromatic CH), 5.84 (s, 1 H, alkene CH), 4.47 (dd, 
7 = 8.6, 5.4, 1 H, C//-N), 4 .24-4 .16 (m, 2 H, OCH2), 2.84 (ddd, 7=  17.1, 9.1, 7.0, 1 
H, one of CH2C=C), 2.73 (ddd, 7=  17.1, 8.9, 5.8, 1 H, one of CH2C=C), 2.34 (dddd, 
7 = 13.0, 8.9, 8.6, 7.0, 1 H, one of CH2), 2.18 (dddd, 7 = 13.0, 9.1, 5.8, 5.4, 1 H, one 
of CH2), 1.27 (t, 7=  7.1, 3 H, CH3).
13C NMR (125 MHz; CDC13): 8 = 188.8 (ketone C=0), 171.4 ester C=0), 167.7 
(alkene C), 139.9 (aromatic C), 130.8 (aromatic CH), 128.2 (aromatic CH), 127.2 
(aromatic CH), 87.5 (alkene CH), 61.7 (OCH2), 61.3 (CH), 31.9 (CH2), 25.6 (CH2),
14.2 (CH3).
MS-ES: m/z (%) = 260 (MH+, 100).
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HRMS-ES: m/z [M + H]+ calcd for Ci5 Hi8N 03: 260.1287; found: 260.1271.
(25)-2-(t-Butyldimethylsilyloxymethyl)-5-[l-ethoxycarbonyl-meth-(£')-ylidene]- 
pyrrolidine-l-carboxylic acid t-butyl ester (155).104
xC NBoc
/
/
TBSO  
131
A solution of lithium diisopropylamide (0.25 mL, 2 M in heptane, 0.5 mmol) in THF 
(5 mL) was cooled to -78 °C. Ethyl acetate (43 mg, 0.5 mmol) in THF (3 mL) was 
added over 20 minutes. After stirring for 25 minutes at -78 °C,
(25)-2-(r-butyldimethylsilyloxymethyl)-5-oxo-pyrrolidine-1 -carboxylic acid tert- 
butyl ester (131) (164 mg, 0.5 mmol) in THF (2 mL) was added over 20 minutes at -  
78 °C. The solution was allowed to warm to 25 °C and left to stir for 18 hours. 
Saturated aqueous ammonium chloride (20 mL) was added and the solution extracted 
with dichloromethane (3 x 15mL). The combined organic layers were washed with 
brine (2x15 mL), dried over magnesium sulphate and the solvent removed in vacuo. 
The resulting yellow oil was purified by flash column chromatography (eluent 4:1 
hexane:ethyl acetate) to give the title compound (123 mg, 63 %), as a yellow oil.
IR (neat): 3368, 2955, 2857, 1739, 1709, 1501, 1471 cm 1.
NMR (500 MHz; CDCI3): 6 = 6.42 (broad s, 1 H, alkene CH), 4.19 -  4.15 (m, 1
H, CH-N), 4.08 (q, J  = 7.1, 2 H, CH20), 3.68 -  3.62 (m, 2 H, CH2OSi), 3.36 
(apparent ddt, J = 18.4, 9.5, 1.5, 1 H, one of CH2C=C), 2.96 (dddd, J  = 18.4, 11.3,
9.1, 2.3, 1 H, one of CH2C=C), 2.03 -  1.85 (m, 2 H, CH2), 1.50 (s, 9 H, (CH3)3CO),
I.21 (t, J  = 7.1, 3 H, CH3CH2), 0.83 (s, 9 H, (CH3)3Si), 0.00 (s, 3 H, one of CH3Si), - 
0.02 (s, 3 H, one of CH3Si).
13C NMR (125 MHz; CDC13): 6 = 169.0 (ester C=0), 158.4 (carbamate C=0), 151.6 
(alkene C), 96.1 (alkene CH), 82.1 ((CH3)3CO), 63.7 (CH2OSi), 62.2 (CH-N), 59.1
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(CH20), 31.0 (CH2), 28.3 ((CH3)3CO), 25.8 ((CH3)3)CSi), 23.8 (CH2), 18.2 (C-Si),
14.5 (CH3CH2), -5.4 (one of CH3Si), -5.5 (one of CH3Si).
MS-ES: m/z (%) = 400 (MH+, 9), 300 (100).
HRMS-ES: m/z [M + H]+ calcd for C20H38NO5Si: 400.2519; found: 400.2510
(25)-2-(Hydroxymethyl)-5-[l-ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine
(156).
NBoc
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Pyrrolidine-1-carboxylic acid /-butyl ester (155) (200 mg, 0.50 mmol) was dissolved 
in dichloromethane (3 mL). TFA (115 mg, 1.0 mmol) was added and the solution 
stirred for 3 hours at 25 °C. Saturated aqueous sodium carbonate was added until 
neutral to pH paper, and the organic material extracted into dichloromethane (3 x 20 
mL). The organic layer was dried over magnesium sulphate and the solvent removed 
in vacuo to give a yellow oil which was purified by flash column chromatography 
(eluent 5:1 hexane:ethyl acetate) to give the title compound (81 mg, 87 %) as a 
colourless oil.
IR (neat): 3402, 2955, 1714, 1689, 1171 cm'1.
!H NMR (400 MHz; CDC13): 5 = 8.00 (broad s, 1 H, NH), 4.46 (s, 1 H, alkene CH),
4.01 (q, J = 7.1, 2 H, C //2CH3), 3.87 (apparent quintet, J = 5.6, 1 H, CT/NH), 3.62 
(dd, J = 11.2, 3.9, 1 H, one of CH2OH), 3.45 (dd, J  = 11.2, 6.3, 1 H, one of CH2OH), 
2.53 (m, 2 H, CH2C=C), 1.99 (m, 1 H, one of Ctf2CHN), 1.69 (m, 1 H, one of 
Ctf2CHN), 1.19 (t, 7 7.1, 3 H, C112C//,).
13C NMR (100MHz; CDCI3): 8 = 171.9 (C=0), 167.3 (alkene CH), 77.7 (alkene C), 
65.9 (CH20), 61.4 (CH), 59.0 (CH), 32.0 (CH2CO), 24.0 (CH2), 14.8 (CH3).
MS-ES: m/z (%) = 186 (MH+, 100).
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HRMS-ES: m/z [M + H]+ calcd for C9 H16NO3 : 186.1130; found: 186.1125.
(S,Z)-ethyl 2-(5-((tert-butyldimethylsilyloxy)methyl)pyrrolidin-2-ylidene)acetate
(83).24a
(25)-2-(Hydroxymethyl)-5-[l-ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine (156) 
(600 mg, 3.2 mmol) in dimethyl formamide (3 mL), was added to a solution of 
terf-butyldimethylsilyl chloride (530 mg, 3.5 mmol), imidazole (238 mg, 3.5 mmol) 
and DMAP (20 mg) in dimethyl formamide (10 mL). The resulting solution was 
stirred at 25 °C for 18 hours. The reaction was quenched with saturated aqueous 
ammonium chloride (100 mL) and extracted into dichloromethane (2 x 100 mL). The 
combined dichloromethane layers where washed with water (3 x 100 mL), brine (2 x 
100 mL) and dried over magnesium sulphate. Solvent was removed in vacuo to give 
a yellow oil which was purified by flash column chromatography on silica gel (eluent 
3:1 hexane:ethyl acetate) to give the title compound (721 mg, 78 %) as a colourless 
oil which solidified on standing.
Mp: 5 0 -5 1  °C (lit 4 9 -5 0  °C).
lH NMR (500 MHz; CDC13): 8 = 7.91 s, 1 H, NH), 4.42 (s, 1 H, C=CH), 4.05 (q, J =
7.1, 2 H, CH20), 3.84 -  3.78 (m, 1 H, CHN), 3.53 (dd, J  = 10.1 and 4.6, one of 
CH2OTBS), 3.45 (dd, J = 10.1 and 6.5, 1 H, one of CH2OTBS), 2.62 -  2.46 (m, 2 H, 
CH2C=CH), 2.01 -  1.92 (m, 1 H, one of CH2Ctf2), 1.66 -  1.58 (m, 1 H, one of 
CH2CH2), 1.19 (t, J  = 7.1, 3 H, CH3CH2), 0.83 (2, 9 H, (CH3)C), 0.00 (s, 3 H, one of 
CH3Si), -0.01 (s, 3 H, one of CH3Si).
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6.4 Experimental Data for Chapter 4
Silicon tetraisothiocyanate (176).105
SiCI4 S i(N C S)4
176
Note: All reagents glassware and solvents were dried prior to use and at all times an 
atmosphere of nitrogen was employed.
Ammonium thiocyanate (19 g, 0.25 mol) was suspended in dry benzene (80 mL) and 
silicon tetrachloride (5.74 mL, 0.05 mol) added over 10 minutes. The resulting 
suspension was refluxed for 3 hours, cooled to 70 °C and filtered through a glass 
sinter. 75 % of the solvent was removed by distillation at atmospheric pressure, with 
the remaining being cooled to 25 °C and left to stand for 18 hours. The resulting 
suspension was filtered and the solids washed with cold benzene. Excess benzene 
was removed from the crystals to give the title compound (10.5 g, 81 %) as a pale 
yellow crystalline solid.
Mp: 143 -  143.5 °C (lit 143.5 -  144 °C).
Ethyl 3-phenyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-4- 
carboxylate (180).
Reaction o f compound 138 with benzaldehyde and silicon tetraisothiocyanate.
Benzaldehyde (0.55 mL, 0.5 mmol) was added to a suspension of silicon 
tetraisothiocyanate (130 mg, 0.5 mmol) in dry benzene (10 mL). The mixture was 
stirred for 20 minutes at 25 °C under a nitrogen atmosphere. Pyrrolidin-(2Z)-ylidene- 
acetic acid ethyl ester (138) (78 mg, 0.5 mmol) in dry benzene (5 mL) was added and 
the mixture stirred at 25 °C under a nitrogen atmosphere for a further 3 hours. The
138 180
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solvent was removed in vacuo. The resulting residue was dissolved in chloroform 
and filtered through celite. The solvent was removed in vacuo to give a yellow oil 
purified by flash chromatography on silica gel (eluent hexane:ethylacetate 4:1) to 
give the title compound (117 mg, 78 %) as a pale oil.
IR (Neat): 3300, 3243, 2979, 2919, 1689,1650,1454, 1373, 698 cm'1. 
lH NMR (500 MHz; CDC13): 6 = 7.44 (s, 1 H, NH), 7.26 -  7.19 (m, 5 H, aromatic 
CH), 5.29 (d, J  = 3.1, 1 H, CH), 4.29 -  3.94 (m, 4 H, CH2O and CH2N), 3.27 (ddd, J 
= 18.3, 8.5 and 4.3, 1 H, one of CH2C=C), 3.01, (apparent dt, J  = 18.2 and 9.0, 1 H, 
one of CH2C=C), 2.04 -  1.89 (m, 2 H, pyrrolidine CH2CH2), 1.11 (t, J = 7.1, 3 H, 
CH3).
13C NMR (125 MHz; CDC13): 6 = 175.2 (C=S), 165.4 (C=0), 149.5 (C=CN), 142.9 
(aromatic C), 128.7 (2 x aromatic CH), 128.1 (aromatic CH), 126.7 (2 x aromatic 
CH), 100.7 (C=CN), 60.3 (CH20), 55.5 (CHN), 52.1 (CH2N), 32.2 (CH2C=C), 21.1 
(CH2CH2), 14.2 (CH3).
MS-ES: m/z {%) = 303 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for Ci6Hi9N20 2S: 303.1167; found: 303.1165.
Ethyl 3-phenyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyriinidine-4- 
carboxylate (180).
Reaction o f compound 138 with benzaldehyde and trimethylsilyl isothiocyanate.
Ph
EtOoC
NH
180138
Trimethylsilyl isothiocyanate (131 mg, 1.0 mmol) was added to a solution of 
benzaldehyde (106 mg, 1.0 mmol) in dichloromethane (5 mL) and the resulting 
solution stirred for 30 minutes at 25 °C under a nitrogen atmosphere. Pyrrolidin- 
(2Z)-ylidene-acetic acid ethyl ester (138) (157 mg, 1.0 mmol) in dichloromethane 
(2.5 mL) was added and the mixture stirred at 25 °C under a nitrogen atmosphere for 
a further 30 minutes. Dilute sodium hydroxide (50 mL) was added and the resulting 
solution extracted with dichloromethane (3 x 50 mL). The combined
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dichloromethane layers were dried over magnesium sulphate and the solvent 
removed in vacuo. The resulting residue was dissolved in ethyl acetate:hexane (1:4) 
and flushed through a plug of silica gel. The solvent was removed in vacuo to give 
the title compound (210 mg, 70 %) as a pale oil.
Data as previously reported.
Ethyl 3-methyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-4- 
carboxylate (181).
Trimethylsilyl isothiocyanate (1.25 g, 9.5 mmol) was added to a solution of 
acetaldehyde (421 mg, 9.5 mmol) in dichloromethane (10 mL) and the resulting 
solution stirred for 30 minutes at 25 °C under a nitrogen atmosphere. Pyrrolidin- 
(2Z)-ylidene-acetic acid ethyl ester (138) (1.5 g, 9.5 mmol) in dichloromethane (5 
mL) was added and the mixture stirred at 25 °C under a nitrogen atmosphere for a 
further 30 minutes. Dilute sodium hydroxide (50 mL) was added and the resulting 
solution extracted with dichloromethane (3 x 50 mL). The combined 
dichloromethane layers were dried over magnesium sulphate and the solvent 
removed in vacuo. The resulting residue was dissolved in ethyl acetate.hexane (1:4) 
and flushed through a plug of silica gel. The solvent was removed in vacuo to give 
the title compound (1.7 g, 74 %) as a pale yellow oil.
IR (Neat): 3208, 2977, 2922, 1690, 1649, 1512, 1376 cm'1.
*H NMR (500 MHz; CDCI3): 8 = 6.90 (s, 1 H, NH), 4.30 (dq, J  = 3.5 and 6.3, 1 H 
CHN), 4.18 -  4.08 (m, 2 H, CH2N), 4.01 -  3.90 (m, 2 H, CH20), 3.23 (ddd, J  = 18.3,
12.0 and 8.5, 1 H, one of CH2C=C), 2.94 (apparent dt, J -  18.3 and 9.1, 1 H, one of
CH2C=C), 2.04 -  1.95 (m, 1 H, one of CH2Ctf2), 1.90 (ddd, J  = 18.1, 9.1 and 3.8, 1
H, one of CH2C//2), 1.24 -  1.20 (m, 6 H, ester CH3 and CH3CH).
174
13C NMR (125 MHz; CDC13): 8 =179.9 (C=S), 165.4 (C=0), 149.87 (C=CN), 101.8 
(C=CN), 60.3 (CH20), 51.9 (CH2N), 47.8 (CHN), 32.0 (CH2C=C), 23.6 (CH3CH),
21.2 (CH2=CH2), 14.4 (ester CH3).
MS-ES: m/z (%) = 241 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for CnHi7N20 2S: 241.1011; found: 241.1003.
Ethyl 3-pentyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-4- 
carboxylate (182).
Trimethylsilyl isothiocyanate (805 mg, 6.1 mmol) was added to a solution of hexanal 
(610 mg, 6.1 mmol) in dichloromethane (15 mL) and the resulting solution stirred for 
30 minutes at 25 °C under a nitrogen atmosphere. Pyrrolidin-(2Z)-ylidene-acetic acid 
ethyl ester (138) (1.2 g, 6.1 mmol) in dichloromethane (5 mL) was added and the 
mixture stirred at 25 °C under a nitrogen atmosphere for a further 30 minutes. Dilute 
sodium hydroxide (50 mL) was added and the resulting solution extracted with 
dichloromethane (3 x 50 mL). The combined dichloromethane layers were dried over 
magnesium sulphate and the solvent was removed in vacuo. The resulting residue 
was dissolved in ethyl acetate:hexane (1:4) and flushed through a plug of silica gel. 
Solvent was removed in vacuo to give the title compound (1.5 g, 74 %) as a pale oil. 
IR (Neat): 3424, 2930, 1689, 1647, 1377 cm 1.
lU NMR (500 MHz; CDC13): 8 = 7.12 (broad d, J  = 2.42, 1 H, NH), 4.23 (dt, J  = 7.6
(ddd, J  = 18.1, 8.5 and 3.6, 1 H, one of CH2C=C), 2.92 (apparent dt, J  = 18.1 and 9.2, 
1 H, one of CH2C=C), 2.04 -  1.95 (m, 1 H, one of pyrrolidine CH2C//2), 1.92 -  1.83 
(m, 1 H, one of pyrrolidine CH2C//2), 1.54 -  1.48 (m, 1 H, one of NCHC//2) 1.48 -  
1.40 (m, 1 H, one of NCHC//2), 1.26 -  1.25 (m, 9 H, 3 x pentyl CH2 and ester CH3), 
0.81 (t, J  = 6.9, 3 H, pentyl CH3).
138 182
and 3.8, 1 H, CH), 4.17 -  4.08 (m, 2 H, CH2N), 3.97 -  3.92 (m, 2 H, CH20), 3.24
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13C NMR (125 MHz; CDC13): 8 = 176.2 (C=S), 165.5 (C=0), 150.2 (C=CN), 100.7 
(C=CN), 60.2 (CH20), 51.9 (CH2N), 51.8 (CHN), 36.9 (CH2C=C), 31.9 (pyrrolidine 
CH2CH2), 31.4 (pentyl CH2CH), 23.8 (pentyl CH2), 22.5 (pentyl CH2), 21.1 (pentyl 
CH2), 14.3 (ester CH3), 14.0 (pentyl CH3).
MS-ES: m/z (%) = 297 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for Ci5H25N20 2S: 297.1637; found: 297.1628.
(lR,2S,5/0-2-Isopropyl-5-methylcyclohexyl 3-methyl-l-thioxo-l,2,3,5,6,7- 
hexahydropyrrolo[l,2-c]pyriimdine-4-carboxylate (183a) and (183b).
Me
NH+
Me
183a
NH
Acetaldehyde (0.06 mL, 1 mmol) was added to a suspension of silicon 
tetraisothiocyanate (260 mg, 1 mmol) in dry benzene (15 mL). The resulting solution 
was then stirred for 30 minutes at 25 °C under a nitrogen atmosphere. 
Pyrrolidin-(2Z)-ylidene-acetic acid (-)-menthyl ester (139) (338 mg, 1 mmol) in dry 
benzene (5 mL) was added and the mixture stirred at 25 °C under a nitrogen 
atmosphere for a further 3 hours. Dilute sodium hydroxide (50 mL) was added and 
the resulting solution extracted with dichloromethane (3 x 50 mL). The combined 
dichloromethane layers were dried over magnesium sulphate and the solvent 
removed in vacuo to give the title compounds as a 1:1 mixture of diastereoisomers 
(234 mg, 67 %) as a pale yellow oil.
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7/ /  NMR spectrum, (400 MHz; CDCI3) for compounds 183a and 183b
T I | I I I I | I I I I | I I I I | T"l  I T T I I I | I I I V~J I 1 T ~Tt 1 1 r
7 .0 0  6 .5 0  6 .0 0  5 .5 0  5 .0 0  4 .5 0  4 .0 0  3 .5 0  3 .0 0  2 .5 0  2 .0 0  1 .50  1.00  0 .50
ppm (f1)
Selected peaks: 8 = 6.98 (s, 1 H, NH), 6.93 (s, 1 H, NH), 4.76 -  4.66 (m, 2 H, CHO 
major and minor), 4.38 -  4.29 (m, 2 H, C//NH major and minor), 4.02 -  3.87 (m, 4 
H, CH2N major and minor), 3.30 -  3.18 (m, 2 H, one of CH2C=C major and minor),
3.02 -  2.84 (m, 2 H, one of CH2N major and minor).
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13C NMR spectrum (125MHz; CDCh)for compound 183a and 183b
OON
sis
TTTT TT TT TT TTTTTT T TT
ppm (11)
Selected peaks: 8 = 175.9 and 175.8 (C=S), 164.9 and 164.9 (C=0), 149.6 and 149.5 
(NC=C), 102.1 and 101.9 (NC=C), 74.1 and 73.9 (CHO), 60.5 (CH2N), 51.9 
(CHNH).
(7S)-Diethyl 3-methyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-
4,7-dicarboxylate (184a) and (184b).
Reaction o f compound 151 with silicon tetraisothiocyanate and acetaldehyde at 
25 °C in benzene.
OEt
NH
C 0 2Et
MeMe
EtO NHEtO NH
S
151
C 0 2Et 
184a
C 0 2Et 
184b
Acetaldehyde (0.06 mL, 1 mmol) was added to a suspension of silicon 
tetraisothiocyanate (260 mg, 1 mmol) in dry benzene (15 mL). The resulting mixture 
was stirred for 30 minutes at 25 °C under a nitrogen atmosphere. 
(2S)-5- [ 1 -Ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl
178
ester (151) (227 mg, 1 mmol) in dry benzene (5 mL) was added and the mixture 
stirred at 25 °C under a nitrogen atmosphere for a further 3 hours. Solvent was 
removed in vacuo. The residue was redissolved in chloroform and filtered through 
celite. The solvent was removed in vacuo to give the title compound as a mixture of 
diastereoisomers (1.3:1) (243 mg, 78 %) as a pale yellow oil.
JR (Neat): 3329, 2979, 1740, 1692, 1656, 1447, 1377 cm'1.
MS-ES: m/z (%) = 313 (MH+, 100).
HRMS-ES: m/z [M + Na]+ calcd for CuHho^CUSNa: 335.1041; found: 335.1051.
]H NMR spectrum (500 MHz; CDCI3) for compounds 184a and 184b
7.0 6.0 5.0 4.0 3.0 2.0 1.0
ppm (f1)
Selected peaks: 7.18 (broad d, /  = 2.4, NH major), 7.15 (broad d, J  = 1.6, NH minor),
5.21 (dd, J  = 9.2, 4.8, CHN major), 4.98 (d, J  = 9.0, CHN minor).
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13C NMR spectrum (125MHz; CDChjfor compound 184a and 184b
150 100 50
ppm (11)
Selected peaks: 175.9 and 175.7 (C=S), 171.0 and 170.7 (C=0), 165.3 and 165.2 
(C=0), 149.3 and 149.1 (NC=C), 102.4 and 101.9 (NC=C), 63.8 and 63.7 (CHN),
61.7 and 61.6 (CH20), 60.4 and 60.4 (CH20), 48.2 and 48.1 (CHNH).
(75)-Diethyl 3-methyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-
4,7-dicarboxylate (184a) and (184b).
Reaction o f compound 151 with silicon tetraisothiocyanate and acetaldehyde at 
25 °C in dichloromethane.
MeMe
EtO' NHOEt EtO' NH
NH
C 0 2Et
151
C 0 2Et 
184a
C 0 2Et 
184b
Acetaldehyde (0.06 mL, 1 mmol) was added to a suspension of silicon 
tetraisothiocyanate (260 mg, 1 mmol) in dichloromethane (15 mL). The resulting 
mixture was stirred for 30 minutes at 25 °C under a nitrogen atmosphere. 
(25)-5-[ 1 -Ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl
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ester (151) (227 mg, 1 mmol) in dichloromethane (5 mL) was added and the mixture 
stirred at 25 °C under a nitrogen atmosphere for a further 3 hours. The solvent was 
removed in vacuo and the residue was redissolved in chloroform and filtered through 
celite. The solvent was removed in vacuo to give the title compound as a mixture of 
diastereoisomers (1.3:1) (231 mg, 74 %) as a pale yellow oil.
Data as previously reported.
(75)-Diethyl 3-methyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyriinidine-
4,7-dicarboxylate (184a) and (184b).
Reaction o f compound 151 with silicon tetraisothiocyanate and acetaldehyde at 
-78 °C in dichloromethane.
OEt
NH
C 0 2Et
EtO
151
Acetaldehyde (0.06 mL, 1 mmol) was added to a suspension of silicon 
tetraisothiocyanate (260 mg, 1 mmol) in dichloromethane (15 mL). The resulting 
mixture was stirred for 30min at -78 °C under a nitrogen atmosphere. 
(25)-5-[l-Ethoxycarbonyl-meth-(2)-ylidene]-pyrrolidine-2-carboxylic acid ethyl 
ester (151) (227 mg, 1 mmol) in dichloromethane (5 mL) was added and the mixture 
stirred at -78 °C under a nitrogen atmosphere for a further 3 hours. Excess solvent 
was removed in vacuo and the residue was dissolved in chloroform and filtered 
through celite. The solvent was removed in vacuo to give the title compound as a 
mixture of diastereoisomers (1.3:1) (218 mg, 70 %) as a pale yellow oil.
Data as previously reported.
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(7S)-Diethyl 3-methyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-
4,7-dicarboxylate (184a) and (184b).
Reaction o f compound 151 with trimethylsilyl isothiocyanate and acetaldehyde at 
25 °C in dichloromethane.
/ ”CNH
C 02Et
151
Acetaldehyde (0.06 mL, 1 mmol) was added to a solution of trimethylsilyl 
isothiocyanate (260 mg, 1 mmol) in dichloromethane (15 mL). The resulting mixture 
was stirred for 30 minutes at 25 °C under a nitrogen atmosphere. 
(25)-5-[ 1 -Ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl
ester (151) (227 mg, 1 mmol) in dichloromethane (5 mL) was added and the mixture 
stirred at 25 °C under a nitrogen atmosphere for a further 3 hours. Solvent was 
removed in vacuo and the residue was redissolved in chloroform and filtered through 
celite. The solvent was removed in vacuo to give the title compound as a mixture of 
diastereoisomers (1.3:1) (218 mg, 70 %) as a pale yellow oil.
Data as previously reported.
MeMe
NH EtO NHEtO
C 02Et
184a 184b
182
(7S)-Ethyl 4-acetyl-3-heptyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-
c]pyrimidine-7-carboxylate (187a) and (187b).
O Q C7HH
Me Me'
S
+
Me'
S
<302Et C 0 2Et C 0 2Et
1 5 4 187a 187b
Octanal (143 mg, 1.1 mmol) was added to a suspension of silicon tetraisothiocyanate 
(290 mg, 1.1 mmol) in dichloromethane (15 mL). The resulting mixture was stirred 
for 30 minutes at 25 °C under a nitrogen atmosphere. (25)-5-[2-Oxo-prop-(Z)- 
ylidene]-pyrrolidine-2-carboxylic acid ethyl ester (153) (113 mg, 0.5 mmol) in 
dichloromethane (5 mL) was added and the mixture stirred at 25 °C under a nitrogen 
atmosphere for a further 3 hours. Solvent was removed in vacuo and residue was 
dissolved in chloroform and filtered through celite. The solvent was removed in 
vacuo to give the crude title compound as a mixture of diastereoisomers (1.3:1) (274 
mg, 68 %) as a pale yellow oil.
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1H NMR spectrum for the crude reaction products 187
3.50 3.00 2.50 0.50ppm (11)
Selected peaks: 8 = 5.15 (dd, J  = 9.1 and 5.3, 1 H, CHN 187a), 4.95 (d, J  = 8.6, 1 H, 
CHN 187b).
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(7S)-Ethyl 4-benzyl-3-heptyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-
c]pyrimidine-7-carboxylate (188a) and (188b).
Ph Ph
+
C 0 2Et
Ph
1 5 4  1 8 8 a  188b
Octanal (143 mg, 1.1 mmol) was added to a suspension of silicon tetraisothiocyanate 
(290 mg, 1.1 mmol) in dichloromethane (15 mL). The resulting mixture was stirred 
for 30 minutes at 25 °C under a nitrogen atmosphere. (2S)-5-[2-Oxo-2-phenyl-eth- 
(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl ester (154) (113 mg, 0.5 mmol) in 
dichloromethane (5 mL) was added and the mixture stirred at 25 °C under a nitrogen 
atmosphere for a further 3 hours. Solvent was removed in vacuo and residue was 
dissolved in chloroform and filtered through celite. The solvent was removed in 
vacuo to give the crude title compound as a mixture of diastereoisomers (1.3:1) (274 
mg, 68 %) as a pale yellow oil.
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]H NMR spectrum for the crude reaction products 188
TT TT TT TT TT TT TT TT I I 1 ITT TT
8.00 7.50 7.00 6.50 6.00 5.50 5.00 4.50 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50
ppm (11)
Selected peaks: 5 = 5.18 (dd, J  = 8.8 and 4.7, 1 H, CHN 188a), 4.93 (d, J  = 8.5, CHN 
188b).
(7S)-Diethyl 3-heptyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrmiidine-
4,7-dicarboxylate (189a) and (189b).
EtO' NHOEt EtO NH
NH
COoEt
151 1 8 9 a  189b
Hexanal (100 mg, 1 mmol) was added to a solution of trimethylsilyl isothiocyanate 
(131 mg, 1 mmol) in dichloromethane (15 mL). The resulting solution stirred for 30 
minutes at 25 °C under a nitrogen atmosphere. (2S)-5-[l-Ethoxycarbonyl-meth-(Z)~ 
ylidene]-pyrrolidine-2-carboxylic acid ethyl ester (227 mg, 1 mmol) in 
dichloromethane (5 mL) was added and the mixture stirred at 25 °C under a nitrogen
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atmosphere for a further 3 hours. The reaction was quenched with sodium hydroxide 
(0.5 M, 25 mL) and extracted with dichloromethane (3 x 50 mL). The combined 
dichloromethane layers were dried over magnesium sulphate and the solvent was 
removed in vacuo. The resulting residue was dissolved in ethyl acetate:hexane (1:4) 
and flushed though a plug of silica gel. The solvent was removed in vacuo to give the 
title compound as a mixture of diastereoisomers (287 mg, 78 %) as a pale yellow oil.
IR (Neat): 3395, 2931, 2853, 1738, 1709,1655, 1377 cm'1.
MS-ES: m/z (%) = 369 (MH+, 100).
HRMS-ES: m/z [M + Na]+ calcd for Ci8H28N20 4SNa: 391.1667; found: 391.1677.
!H NMR spectrum (500 MHz; CDCl3 )fo r  compounds 189a and 189b.
vv
TT n—r F7 i _ r T
10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0Ppm (11)
Selected peaks: 8 = 7.25 (d, J  = 3.14, 1 H, NH 189b), 7.21 (broad s, NH 189a), 5.18 
(dd, J  = 9.2 and 5.1, 1 H, CHN 189a), 4.96 (d, J = 8.9, 1 H, CHN 189b), 3.34 (dd, J 
= 18.0 and 8.16, 1 H, one of CH2C=C 189a), 3.20 -  3.06 (m, 2 H, CH2C=C 189b),
2.95 (ddd, J  = 18.0, 12.1 and 8.9, 1 H, one ofCH2C=C 189a).
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13C NMR spectrum (125 MHz; CDCI3) for compounds 189a and 189b.
1 > 1 | 1 1 1 1 | m 1 i-p-rrq-rri-rprrrr 
160 150 140 130 120 1
TTTTJTTTTTTTT
0 100 90
TT TT TTT TTTTTT
30
TTTTTT I I I I I I I I
70
ppm(t1)
Selected peaks: 8 = 176.1 and 176.1 (C=S), 170.9 and 170.7 (C=0), 165.4 (C=0)
149.8 and 149.5 (NC=C), 101.2 and 100.8 (NC=Q, 63.8 and 63.7 (CHN), 61.6 and
61.6 (CH20), 60.3 and 60.3 (CH20), 52.3 and 52.2 (CHNH), 37.2 and 36.9 
(CH2C=C), 31.4 and 31.4 (pyrrolidine CH2CH2), 30.6 (pentyl CH2CH), 26.3 and
25.7 (pentyl CH2), 23.8 (pentyl CH2), 22.5 and 22.5 (pentyl CH2), 14.8 and 14.2 
(CH3).
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(7S)-Diethyl 3-phenyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-
4,7-dicarboxyIate (190a) and (190b).
o
OEt EtO
S
C 0 2Et C 0 2Et C 0 2Et
151 190a 190b
Benzaldehyde (0.053 mL, 0.5 mmol) was added to a suspension of silicon 
tetraisothiocyanate (130 mg, 0.5 mmol) in dichloromethane (15 mL). The resulting 
mixture was stirred for 30 minutes at 25 °C under a nitrogen atmosphere. 
(2S)-5-[l -Ethoxycarbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl
ester (151) (113 mg, 0.5 mmol) in dichloromethane (5 mL) was added and the 
mixture stirred at 25 °C under a nitrogen atmosphere for a further 3 hours. Solvent 
was removed in vacuo and the residue was dissolved in chloroform and filtered 
through celite. The solvent was removed in vacuo to give the title compound as a 
mixture of diastereoisomers (139 mg, 74 %) as a pale yellow oil.
IR (Neat): 3300, 2980, 2922, 1739, 1692, 1657, 1455, 1375, 700 cm'1.
MS-ES: rn/z (%) = 375 (MH+, 30), 316 (100).
HRMS-ES: m/z [M + Na]+ calcd for Q ^ N a C ^ S N a : 397.1198; found: 397.1202.
189
}H NMR spectrum (500 MHz; CDChjfor compounds 190a and 190b.
T T-7 I I I I "i r r7 TT T rr
7.00 6.50 6.00 5.50 5.00 4.50 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50
ppm (11)
Selected peaks: 8 = 5.32 (d, J  = 2.7, CHPh 190a) 5.27 (d, J  = 2.9, 1 H, CHPh 190b), 
5.24 (dd, J  = 9.4 and 4.1, 1 H, CHN 190b), 5.07 (d, J  = 8.8, 1 H, CHN 190a).
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13C NMR spectrum (125 MHz; CDCI3) for compounds 190a and 190b
TTT'TV II I | I II I | I TTT TT TTT TT TTT TT TTTT TTT fT T TT
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
ppm (II)
Selected peaks: 5 = 175.1 and 174.9 (C=S), 170.9 and 170.7 (C=0), 165.2 and 165.1 
(C=0), 149.1 and 148.5 (NC=C), 142.8 (aromatic C), 128.8 and 128.7 (aromatic 
CH), 128.3 and 128.3 (aromatic CH), 127.2 and 126.8 (aromatic CH), 101.2 and
100.9 (NC=Q, 64.0 and 64.0 (CHN), 61.8 and 61.7 (CH20), 60.4 (CH20), 56.4 and
56.1 (CHNH), 30.9 and 30.8 (CH2C=C), 26.2 and 25.6 (CH2CH2), 14.2 and 14.2 
(CH3).
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6.5 Experimental Data for Chapter 5
tert-Butyl 2-allyl-5-oxopyrrolidine-l-carboxylate (198).
Boc
198195
di-terf-Butyl dicarbonate (2.7 g, 12.3 mmol) in dichloromethane (10 mL) was added 
to a solution of 5-allylpyrrolidin-2-one (195) (1.6 g, 12.3 mmol), triethylamine (2.0 
mL, 20 mmol) and DMAP (10 mg) in dichloromethane (75 mL) over 15 minutes. 
The resulting solution was stirred at 25 °C for 18 hours. The reaction was quenched 
with saturated ammonium chloride (150 mL) and extracted into dichloromethane (3 x 
100 mL). The combined dichloromethane layers were dried over magnesium 
sulphate and the solvent removed in vacuo. The resulting oil was purified by flash 
chromatography on silica gel (eluent; ethyl acetate:hexane 1:4) to give the title 
compound (2.3 g, 83 %) as a pale oil.
IR (neat): 2978, 1936, 1785, 1750, 1714, 1156, 850, 780 cm 1. 
lK NMR: 8 = 5.61 -  5.51 (m, 1 H, CH=CH2), 4.89 -  4.87 (m, 1 H, one of CH=CH2), 
4.86 -  4.85 (m, 1 H, one of CH=CH2), 3.99 (tdd, J  = 8.6, 5.3 and 3.5, 1 H, CHN), 
2.38 (ddd, J  = 17.8, 11.0 and 9.3, 1 H, one of CH2CO), 2.35 -  2.28 (m, 1 H, 1 H, one 
of CH2CH2), 2.22 (ddd, J  = 17.8, 12.2 and 9.6, 1 H, 1 H, one of CH2CO), 2.15 -  2.08 
(m, 1 H, 1 H, one of CH2Ctf2).
13C NMR: 8 = 174.4 (ester C=0), 149.9 (carbamate C=0), 133.6 (CH=CH2), 118.5 
(CH=CH2), 82.9 (C=0), 53.7 (CHN), 38.1 (CH2CH=CH2), 31.4 (CH2CO), 28.1 
((CH3)C), 21.9 (CH2CH2).
MS-ES: m/z (%) = 84 (100), 184 (MH+, 10)
HRMS-ES: m/z [M + H]+ calcd for C9H14NQ3 184.0974; found: 192.0972.
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4-(l,3-Dioxoisoindolin-2-yl)butyl acetate (199).
Me (
200 199
4-Bromobutyl acetate (200) (1.30 g, 6.6 mmol) was added to a suspension of 
potasium phthalimide (1.23 g, 6.6 mmol) in dimethylformamide (10 mL) and the 
resulting mixture stirred at 100 °C for 6 hours. The resulting mixture was added to 
diethyl ether (150 mL) and washed with water (5 x 200 mL). The combined ether 
layers were dried over magnesium sulphate and the solvent was removed in vacuo. 
The resulting off-white crystalline solid was recrystallised from etherihexane to give 
the title compound (800 mg, 45 %) a white crystalline solid.
Mp: 5 7 -57 .5  °C.
IR (DCM): 2949, 1771, 1712, 1437, 1395, 720 c m 1.
lH NMR: 6 = (500 MHz; CDC13): 6 = 7.75 (apparent dd, J  = 5.4 and 3.1, 2 H, 2 x 
aromatic CH), 7.65 (apparent dd, J  = 5.4 and 3.0, 2 H, 2 x aromatic CH), 4.02 (t, J  = 
6.3, 2 H, OCH2), 3.65 (t, J  = 6.9, 2 H, CH2N), 1.89 (s, 3 H, CH3), 1.74 -  1.57 (m, 4 
H, CH2CH2 ).
13C NMR: 6 = 171.1 (ester C=0), 168.4 (imide C=0), 133.9 (aromatic CH), 132.1 
(aromatic C), 123.3 (aromatic CH), 63.8 (CH20), 37.6 (CH2N), 26.1 (CH2), 25.3 
(CH2), 21.0 (CH3).
MS-ES: m/z (%) = 262 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for Ci4Hi6N 04: 262.1079; found: 262.1078.
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tert-Butyl 8-(ethoxycarbonyl)-7-oxooct-l-en-4-ylcarbamate (203).
NHBoc
1 9 8  20 3
Ethyl acetate (0.64 mL, 6.6 mmol) in THF (4 mL) was added to a solution of lithium 
diisopropylamide (3.3 mL, 2 M solution in heptane, 6.6 mmol) in THF (15 mL) at 
-78 °C over 25 minutes. After stirring for 20 minutes at -78 °C, tert-butyl 2-allyl-5- 
oxopyrrolidine-l-carboxylate (198) (1.5 g, 6.6 mmol) in THF (5 mL) was added over 
30 minutes at -78 °C. The solution was warmed to 25 °C and stirred for 18 hours. 
The reaction was quenched with saturated aqueous ammonium chloride (100 mL) 
and extracted into dichloromethane (3 x 100 mL). The combined dichloromethane 
layers were washed with brine (2 x 150 mL) and dried over magnesium sulphate. The 
solvent was removed in vacuo to give the crude title compound (1.7 g, 81 %) as a 
pale oil.
*H NMR (500 MHz; CDC13): 8 = 5.74 -  5.64 (m, 1 H, CH=CH2), 5.02 (apparent 
broad d, J  = 12.9, 2 H, CH=Ctf2), 4.26 (broad d, J  = 8.2, 1 H, NH), 4.12 (q, J  = 7.1, 2 
H, CH20), 3.59 -  3.49 (m, 1 H, CHN), 3.38 (s, 2 H, COCH2CO), 2.59 -  2.52 (m, 2 
H, COCH2CU2), 2.21 -  2.08 (m, 2 H, Ctf2CH=CH2), 1.82 -  1.74 (m, 1 H, one of 
C//2CHN), 1.58 -  1.42 (m, 1 H, one of CH2CHN), 1.36 (s, 9 H, (CH3)3), 1.21 (t, J =
7.1, 3 H, CH3CH2).
13C NMR (125 MHz; CDC13): 8 = 155.7 (carbamate C=0), 134.0 (CH=CH2), 118.2 
(CH=CH2), 90.1 (OC(CH3)3), 61.4 (OCH2), 49.6 (CHN), 49.5 (COCH2CO), 40.1 
(COCH2), 39.8 (CH2CH=CH2), 28.4 (CH2CH2), 28.4 (C(CH3)3), 14.2 (CH3). Ketone 
and ester carbonyl peaks not observed.
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(Z)-Ethyl 2-(5-allylpyrrolidin-2-ylidene)acetate (204).
EtO
Et02CNHBoc
203 204
tert-Butyl 8-(ethoxycarbonyl)-7-oxooct-l-en-4-ylcarbamate (203) (1.7 g, 5.4 mmol) 
was dissolved in TFA (0.84 mL, 11.0 mmol) and the solution stirred for 3 hours at 25 
°C. Excess TFA was removed in vacuo and the resulting oil dissolved in 
dichloromethane (5 mL). Saturated aqueous sodium carbonate was added until 
neutral to pH paper, and the organic material extracted into dichloromethane (3 x 150 
mL). The combined organic layers were dried over magnesium sulphate and the 
solvent removed in vacuo. The resulting yellow oil was purified by flash column 
chromatography (eluent 4:1 hexane:ethyl acetate) to give the title compound (4.8 g, 
89 %) as a pale yellow oil.
4.00 (m, 2 H, C H 3 C / / 2 ) ,  3.76 (apparent dt, J  = 13.4 and 6.8, 1 H C H N ) ,  2.59 -  2.47 
(m, 2 H, one of C //2CH2CH and one of Ctf2CH=CH2), 2.26 -  2.12 (m, 2 H, one of
one of CH2C//2CH2), 1.53 (apparent dtd, J  = 12.6, 8.7 and 6.8, 1 H, one of 
CH2C//2CH2), 1.18 (t, J  = 7.1, 3 H, CH3).
13C NMR (125 MHz; CDC13): 8 = 134.2 (CH=CH2), 118.0 (CH=CH2), 76.6 (CH=C),
58.9 (CH20), 58.5 (CHN), 40.5 (CH2CH=CH2), 31.9 (CH2C=CH), 27.7 (CH2CH2),
14.8 (CH3). Quaternary peaks not observed.
MS-ES: m/z (%) = 108 (100), 195 (MH+, 20).
HRMS-ES: m/z [M + H]+ calcd for CnHi7N 02: 195.1258; found: 195.1258.
IR (neat): 3364, 2976, 1661, 1598, 1049, 781 cm'1.
*H NMR (500 MHz; CDC13): 8 = 7.91 (s, 1 H, NH), 5.71 (dddd, J = 17.2, 10.2, 7.6 
and 6.4, 1 H, CH=CH2), 4.42 (s, 1 H, CH=C), 5.10 -  5.04 (m, 2 H, CH=CH2), 4.07 -
Ctf2CH2CH and one of C //2CH=CH2), 2.02 (dddd, J = 12.6, 8.4, 6.9 and 5.2, 1 H,
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(3SR,7RS)-Ethyl 7-allyl-3-pentyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2- 
c]pyrimidine-4-carboxylate (205a) and (3/JS,7SR)-ethyl 7-allyl-3-pentyl-l- 
thioxo-l,2,3,5,6,7>hexahydropyrrolo[l,2-c]pyrimidine-4-carboxylate (205b).
Hexanal (205 mg, 2.0 mmol) was added to a solution of trimethylsilyl isothiocyanate 
(262 mg, 2.0 mmol) in dichloromethane (15 mL). The resulting solution was stirred 
for 30 minutes at 25 °C under a nitrogen atmosphere. (Z)-Ethyl 2-(5-allylpyrrolidin- 
2-ylidene)acetate (204) (400 mg, 2.0 mmol) in dichloromethane (5 mL) was added 
and the mixture stirred at 25 °C under a nitrogen atmosphere for a further 30 
minutes. The reaction was quenched with sodium hydroxide (2 M, 50 mL) and 
extracted into dichloromethane (3 x 50 mL). The dichloromethane layers were dried 
over magnesium sulphate and the solvent removed in vacuo. The resulting residue 
was dissolved in ethyl acetate:hexane (1:4) and flushed though a plug of silica gel. 
The solvent was removed in vacuo to give the title compound (522 mg, 74 %) as a 
pale oil.
IR (neat): 3148, 2929, 2858, 1693, 1649, 1380 c m 1.
MS-ES: m/z (%) = 337 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for C18H29N2O4S: 337.1950; found: 337.1937.
204 205a 205b
196
1H NMR spectrum for compounds 205a and 205b
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Selected peaks: 8 = 7.01 (broad s, 2 H, NH, 205a and 205b), 5.84 -  5.72 (m, 2 H, 
C//=CH2, 205a and 205b), 5.19 -  5.08 (m, 4 H, CH=CH2, 205a and 205b), 5.02 -
4.96 (m, 1 H, CH-allyl 205b), 4.63 -  4.57 (m, 1 H, CH-allyl, 205a), 4.34 -  4.29 (m, 2 
H, CH-pentyl, 205a and 205b).
13C NMR(APT) spectrum for compounds 205a and 205b
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Selected peaks: 8 = 207.3 (C=S) 165.6 (C=0), 149.5 (NC=C), 134.1 and 133.6 
(CH=CH2), 118.5 and 118 (CH=CH2), 100.0 (NC=C), 62.3 (CH-allyl), 60.1 and 60.1 
(CH20), 51.9 and 51.6 (CH-pentyl).
7-Allyl-4-(ethoxycarbonyl)-3-pentyl-2,3,6,7-tetrahydropyrrolo[l,2-c]pyrimidin- 
l(5H)-iminium formate (206).
EtO
206
EtO
205
Iodomethane (156 mg 1.1 mmol) was added to a solution of ethyl 7-allyl-l,2,3,5,6,7- 
hexahydro-3-pentyl-l-thioxopyrrolo[l,2-c]pyrimidine-4-carboxylate (205) (400 mg,
1.1 mmol) in methanol (10 mL) and refluxed for 1 hour. The solvent was removed in 
vacuo to give a yellow gum, taken up into methanol (5 mL) and added to a solution 
of ammonium acetate (420 mg, 5.5 mmol) in methanol (6 mL). Ammonia was 
bubbled through the resulting solution for 10 minutes. The resulting mixture was 
heated in a sealed tube for 48 hours at 80 °C. The resulting solution was loaded 
directly onto a silica gel column and eluted with (dichloromethane:methanol:formic 
acid:water, 85:14:0.5:0.5) yielding the title compound (360 mg, 86 %) as a white 
solid.
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]H NMR spectrum for compound 206.
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Selected peaks: 8 = 5.82 -  5.70 (m, 2 H, CH=CH2 major and minor), 5.12 -  5.03 (m, 
4 H, CH=C//2 major and minor), 4.74 -  4.68 (m, 1 H, CHN minor), 4.55 -  4.50 (m, 1 
H, CHN major), 4.38 -  4.33 (m, 2 H, C//NH major and minor), 4.17 -  4.09 (m, 4 H, 
CH2O major and minor), 3.27 (dd, J  = 18.5 and 7.5, 1 H, one of CH2C=C major), 
3.14 (ddd, J  = 19.1, 10.0 and 3.7, 1 H, one of CH2C=C minor), 2.95 (apparent dt, J -
19.1 and 9.1, 1 H, one of CH2C=C minor), 2.87 -  2.75 (m, 1 H, one of CH2C=C 
major).
(45,7/?, ^ a/?)-Ethyl-7-iodomethy 1-4-pentyl-2,4,5,7,8,8a-hexahy dr o-l H-5,6,8b- 
triaza-acenapthylene-3-carboxylate (207).
EtO
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Iodine (700 mg, 2.7 mmol) was added to a solution of 7-allyl-4-(ethoxycarbonyl)-3- 
pentyl-2,3,6,7-tetrahydropyrrolo[l,2-c]pyrimidin-l(5H)-iminium formate (206) (180 
mg, 0.47 mmol) and potassium carbonate (194 mg, 1.4 mmol) in acetonitrile (5 mL)
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and the resulting solution stirred for 18 hours at 25 °C. The resulting solution was 
loaded directly onto a silica column and eluted with ethyl acetateihexane (1:20) to 
give a single diastereoisomer of the title compound (100 mg, 46 %) as a light brown
oil.
IR (DCM): 3428, 2961, 2922, 2858, 1718, 1676, 1457, 1101, 1021 cm 1.
NMR (500 MHz; CD3OD): 5 = 4.33 (dd, J = 8.1 and 4.0, 1 H, H15), 4.16 -  4.08 
(m, 3 H, H5 and H ll) , 3.56 -  3.50 (m, 1 H, H13), 3.44 -  3.32 (m, 3 H, H21 and 90), 
2.88 -  2.79 (m, 1 H, 9a), 2.43 -  2.32 (m, 2 H, 100 and 120), 1.73 -  1.62 
(m, 1 H, 10a), 1.60 -  1.39 (m, 3 H, 12a and 16) 1.39 -  1.1 (m, 6 H, 3 x pentyl CH2) 
1.21 (t, J  = 7.1, 3 H, ester CH3), 0.81 (t, J  = 6.9, 3 H, C4H8Ctf3).
13C NMR (125 MHz; CDC13): 6 = 164.4 (C=0), 148.6 (C=N) 147.9 (NC=C), 103.5 
(C=CN), 60.8 (CH20), 56.4 (CHN), 50.8 (CHN=C), 50.7 (CHNH), 36.9 (CH2C=C),
34.8 (CHCH2CH), 31.2 (pyrrolidine CH2CH2), 29.7 (C4H9CH2), 29.5 (C3H7CH2),
24.0 (C2H5CH2), 22.4 (CH3CH2C3H6), 14.3 (ester CH3), 14.1 (CH3C4H8).
MS-ES: m/z (%) = 446 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for Ci8H29N30 2I: 446.1304; found: 445.1336.
Ethyl l-(methylthio)-3-pentyl-3,5,6,7-tetrahydropyrrolo[l,2-c]pyrimidine-4- 
carboxylate (208).
EtO
SM e
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EtO NH
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Iodomethane (2.0 g, 14.1 mmol) was added to a solution of ethyl 3-methyl-1-thioxo-
l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-4-carboxylate (181) (1.05 g, 3.5 
mmol) in dichloromethane (50 mL) and stirred at reflux for 18 hours. The resulting 
reaction mixture was quenched with dry triethylamine (1.43 mL, 14.1 mmol). 
Solvent was removed in vacuo to give a dark yellow oil. Purification by flash 
chromatography on silica gel (eluent ethyl acetate:hexane 1:6) gave the title 
compound (1.0 g, 91 %) as a clear oil.
IR (neat): 2928, 2356, 1693, 1650, 1596, 1443, 1380 cm 1.
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lU NMR (500 MHz; CDC13): 8 = 4.57 (t, J  = 6.2, 1 H, CH-pentyl), 4.08 (dq, J = 1.5 
and 7.1, 2 H, CH20), 3.64 (dt, J  = 2.5 and 9.3, 1 H, one of CH2CN), 3.44 (dt, J = 7.1 
and 9.3, 1 H, one of CH2CN), 3.15 (ddd, 7=  18.1, 8.4 and 2.6, 1 H, one of CH2C=C),
2.79 (apparent dt, J  = 18.1 and 9.0 1 H, one of CH2C=C), 2.34 (s, 3 H, SCH3), 2.05 -
1.80 (m, 2 H, CH2Ctf2 pyrrolidine), 1.40 -  1.30 (m, 2 H, CH2CH), 1.30 -  1.15 (m, 6 
H, 3 x pentyl CH2), 1.19 (t, J  = 7.1, 3 H, CH3CH20), 0.81 (t, J = 6.8, 3 H, pentyl 
CH3).
13C NMR (125 MHz; CDC13): 8 = 167.0 (C=0), 152.7 (C=CN), 97.4 (C=CN), 59.4 
(CH20), 56.1 (CHN), 48.2 (CH2N), 37.2 (CH2C=C), 31.9 (CH2CH2 pyrrolidine),
30.9 (pentyl CH2CH), 24.5 (pentyl CH2), 22.7 (pentyl CH2), 22.1 (pentyl CH2), 14.5 
(ester CH3), 14.1 (pentyl CH3), 13.8 (SCH3). CSMe peak not observed though all 
other quaternary carbon peaks were of a high intensity.
MS-ES: m/z (%) = 311 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for Ci6H27N20 2S: 311.1788; found: 311.1788.
(3SR,7RS)-Ethyl 7-allyl-l-(methylthio)-3-pentyl-3,5,6,7-tetrahydropyrrolo[l,2- 
c]pyrimidine-4-carboxylate (209).
205
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Iodomethane (2.48 g, 17.6 mmol) was added to a solution of ethyl 7-allyl-l,2,3,5,6,7- 
hexahydro-3-pentyl-l-thioxopyrrolo[l,2-c]pyrimidine-4-carboxylate (205) (2.2:1
mixture of diastereoisomers 1.5 g, 4.4 mmol) in dichloromethane (4 mL) and 
refluxed for 18 hours. The resulting solution was cooled to 25 °C and dry 
triethylamine (1.8 mL, 17.6 mmol), added. The resulting solution was stirred for 30 
minutes at 25 °C. Solvent was removed in vacuo to give a yellow oil purified by 
flash column chromatography (eluent 12:1 hexane:ethyl acetate) to give the title 
compound as a single diastereoisomer (1.0 g, 64 %) as a pale yellow oil.
IR (neat): 3394, 2928, 2856, 1686, 1652, 1443, 1380 cm'1.
201
*H NMR (500 MHz; CDC13): 8 = 5.65 (dddd, J  = 16.9, 10.2, 7.9 and 6.3, 1 H, 
C//=CH2), 5.07 (broad apparent d, J  = 16.9, 1 H, one of CH=C//2), 5.03 (broad 
apparent d, J  = 9.9, 1 H, one of CH=CH2), 4.53 (dd, J  = 7.0 and 3.6, 1 H, pentyl 
CHN), 4.12 -  4.02 (m, 2 H, ester CH2), 3.98 -  3.92 (m, 1 H, CH allyl), 3.14 (ddd, 7 =
18.3, 5.0 and 4.2, 1 H, one of CH2C=C), 2.77 (apparent dt, J  = 18.3 and 9.7, 1 H, one 
of CH2C=C), 2.65 (dd, J  = 13.9 and 5.8, 1 H, one of CH2CH=CH2), 2.33 (s, 3 H, 
SCH3), 2.06 (apparent dt, J  = 13.9 and 9.1, 1 H, one of CH2CH=CH2), 1.87 -  1.81 
(m, 2 H, pyrrolidine CH2C//2), 1.55 -  1.45 (m, 1 H, one of pentyl CH2CH2CH), 1.43 
-1 .3 3  (m, 1 H, one of pentyl CH2C//2CH), 1.29 -  1.16 (m, 6 H, 3 x pentyl CH2), 
1.19 (t, J  = 7.1, 3 H, ester CH3), 0.80 (t, J  = 6.8, pentyl CH3).
13C NMR (125 MHz; CDC13): 8 = 167.3 (C=0), 151.9 (C=CN), 148.8 (C-SCH3),
133.8 (CH=CH2), 118.3 (CH=CH2), 96.5 (C=CN), 59.65 (CH-allyl), 59.3 (ester 
CH2), 56.1 (CH-pentyl), 38.9 (CH2CH=CH2), 36.9 (CH2C=C), 31.8 (pyrrolidine 
CH2CH2), 29.2 (pentyl CH2CH), 26.4 (pentyl CH2), 24.1 (pentyl CH2), 22.7 (pentyl 
CH2), 14.5 (ester CH3), 14.1 (pentyl CH3), 13.8 (SCH3).
MS-ES: m/z (%) = 351 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for C19H31N2O2S: 351.2106; found: 351.2094. 
tert-Butyl 8-((benzyloxy)carbonyl)-7-oxooct-1 -en-4-ylcarbamate (210).
N B oc
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Ethyl acetate (584 mg, 3.9 mmol) in THF (4 mL) was added to a solution of lithium 
diisopropylamide (1.95 mL, 2 M solution in heptane, 3.9 mmol) in THF (15 mL) at -  
78 °C. over 25 minutes. After stirring for 20 minutes at -78 °C, tert-butyl 2-allyl-5- 
oxopyrrolidine-l-carboxylate (195) (1.0 g, 3.9 mmol) in THF (5 mL) was added over 
30 minutes at -78 °C. The solution was warmed to 25 °C and the resulting mixture 
stirred for 18 hours. The reaction was quenched with saturated aqueous ammonium 
chloride (100 mL) and extracted into dichloromethane (3 x 100 mL). The 
dichloromethane layers were washed with brine (2 x 150 mL) and dried over
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magnesium sulphate. The solvent was removed in vacuo, to give the crude title 
compound (1.05 g, 72 %) as a yellow oil.
IR (Neat): 3365, 2976, 2932, 1739, 1713, 1514 cm'1.
lU NMR (500 MHz; CDC13): 5 = 7.33 -  7.23 (m, 5 H, aromatic CH), 5.72 -  5.62 (m, 
1 H, C//=CH2), 5.09 (s, 2 H, CH20), 5.02 -  4.97 (m, 2 H, CH=Ctf2), 4.28 (broad d, J  
= 8.7, 1 H, NH), 3.61 -  3.50 (m, 1 H, CHN), 3.43 (s, 2 H, COCH2CO), 2.55 -  2.49 
(m, 2 H, COCH2), 2.17 -  2.05 (m, 2 H, CH2CH=CH2), 1.80 -  1.65 (m, 1 H, one of 
C //2CHN), 1.52 -  1.38 (m, 1 H, one of CH2CHN), 1.35 (s, 9 H, (CH3)3).
13C NMR (125 MHz; CDC13): 5 = 202.3 (ketone C=0), 167.0 (ester C=0), 155.7 
(carbamate C=0), 135.3 (aromatic C), 134.0 (CH=CH2), 128.6 (2 x aromatic CH), 
128.5 (aromatic CH), 128.4 (2 x aromatic CH), 118.0 (CH=CH2), 79.9 (OC(CH3)3),
67.1 (OCH2), 49.6 (CHN), 49.3 (COCH2CO), 39.9 (COCH2), 39.8 (CH2CH=CH2), 
28.4 ((CH3)3), 28.4 (CH2CH2).
(Z)-Benzyl 2-(5-allylpyrrolidin-2-ylidene)acetate (211).
NHBoc
BnO
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Crude tert-butyl 8-((benzyloxy)carbonyl)-7-oxooct-l-en-4-ylcarbamate (210) (1.1 g,
2.9 mmol) was dissolved in TFA (0.465 mL, 6.0 mmol) and the solution stirred for 3 
hours at 25 °C. Excess TFA was removed in vacuo and the resulting oil dissolved in 
dichloromethane (5 mL). Saturated aqueous sodium carbonate was added until 
neutral to pH paper, and the organic material extracted into dichloromethane (3 x 150 
mL). The combined dichloromethane layers were dried over magnesium sulphate and 
the solvent was removed in vacuo. The resulting yellow oil was purified by flash 
column chromatography (eluent 4:1 hexane:ethyl acetate) to give the title compound 
(600 mg, 79 %) as a pale oil.
IR (Neat): 3414, 2978, 2935, 1719, 1614, 1383, 1317, 1244, 740, 698 cm'1.
JH NMR (500 MHz; CDC13): 8 = 7.80 (broad s, 1 H, NH), 7.19 -  7.06 (m, 5 H, 
aromatic CH), 5.58 (dddd, J  = 17.0, 10.2, 7.4 and 6.5, 1 H, CH=CH2), 4.99 -  4.88 
(m, 4 H, CH=CH2 and CH2Q), 4.38 (s, 1 H, CH=C), 3.64 (apparent quintet, / =  6.7, 1
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H, CHN), 2.47 -  2.34 (m, 2 H, one of CH2C=CH and one of CH2CH=CH2), 2.13 -
2.01 (m, 2 H, one of CH2C=CH and one of Ctf2CH=CH2), 1.95 -  1.84 (m, 1 H, one 
of CH2Ctf2CH), 1.48 -  1.38 (m, 1 H, one of CH2CH2CH).
13C NMR (125 MHz; CDC13): 8 = 170.3 (C=0), 166.1 (C=CH), 137.6 (aromatic C),
134.1 (CH=CH2), 128.4 (2 x aromatic CH), 127.8 (aromatic CH), 127.7 (2 x 
aromatic CH), 118.1 (CH=CH2), 76.4 (CH=C), 64.4 (CH20), 58.9 (CHN), 43.7 
(CH2CH=CH2), 31.9 (CH2C=CH), 27.7 (CH2CH2CH).
(3SR,7RS)-Benzyl 7-allyl-3-pentyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2- 
c]pyrimidine-4-carboxylate (212a) and (3RS,7SR)-Benzyl 7-allyl-3-pentyl-l- 
thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2-c]pyrimidine-4-carboxylate (212b).
Bn02C
211
OBn
C
212a
OBn
+
2 1 2 b
Hexanal (84 mg, 0.84 mmol) was added to a solution of trimethylsilyl isothiocyanate 
(110 mg, 0.84 mmol) in dichloromethane (15 mL). The resulting solution was stirred 
for 30 minutes at 25 °C under a nitrogen atmosphere. (Z)-Butyl 2-(5-allylpyrrolidin-
2-ylidene)acetate (211) (200 mg, 0.84 mmol) in dichloromethane (5 mL) was added 
and the mixture stirred at 25 °C under a nitrogen atmosphere for a further 30 
minutes. The reaction was quenched with sodium hydroxide (0.5 M, 50 mL) and 
extracted into dichloromethane (3 x 50 mL). The combined dichloromethane layers 
were dried over magnesium sulphate and the solvent removed in vacuo. The resulting 
residue was purified by flash chromatography on silica gel (eluent: ethyl 
acetate:hexane 3:10) to give the title compounds as a pale oil.
Major isomer (212a) (143 mg, 44 %).
IR Neat: 3203, 2954, 2857, 1690, 1648, 1388, 748, 697 c m 1. 
ln  NMR (500 MHz; CDC13): 8 = 7.31 -  7.25 (m, 5 H, aromatic CH), 6.84 (broad d, J 
= 1.9, 1 H NH), 5.68 (dddd, J  = 17.1, 10.2, 8.2 and 5.9, 1 H, CH=CH2), 5.14 and
5.07 (AB quartet, J  = 12.3, 2 H PhCH2), 5.08 -  5.01 (m, 2 H, CH=C//2), 4.56 -  4.51 
(m, 1 H, CH-allyl), 4.25 -  4.20 (m, 1 H, C5Hn CHN), 3.32 -  3.26 (m, 1 H, one of
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CH2C=C), 3.07 -  3.01 (m, 1 H, one of CH2C=C), 2.88 -  2.78 (m, 1 H, one of 
CH2CH=CH2), 2.15 -  2.07 (m, 1 H one of CH2CH=CH2), 1.90 -  1.83 (m, 2 H, 
pyrimidine CH2 CH2), 1.58 -  1.47 (m, 2 H, C4H9C//2CH), 1.34 -  1.10 (m, 6 H, 3 x 
pentyl CH2), 0.78 (t, J  = 7.0, 3 H, CH3).
13C NMR (125 MHz; CDC13): 8 = 175.2 (C=S), 165.4 (C=0), 150.1 (C=CN), 136.0 
(aromatic C), 134.1 (CH=CH2), 128.6 (2 x aromatic CH), 128.3 (aromatic CH),
128.2 (2 x aromatic CH), 118.1 (CH=CH2), 99.7 (C=CN), 66.1 (CH20), 62.5 (CH- 
allyl), 52.1 (CH-pentyl), 37.8 (CH2CH=CH2), 35.4 (CH2C=C), 31.4 (pyrrolidine 
CH2CH2), 30.5 (pentyl CH2CH), 25.7 (pentyl CH2), 23.5 (pentyl CH2), 22.5 (pentyl 
CH2), 14.1 (pentyl CH3).
Minor isomer (212b) (60 mg, 23 %).
*H NMR (500 MHz; CDC13): 8 = 7.31 -  7.25 (m, 5 H, aromatic CH), 6.84 (broad d, J 
= 3.2, 1 H NH), 5.70 (dddd, J  = 17.0, 10.1, 7.6 and 6.8, 1 H, CH=CH2), 5.15 and
5.07 (AB quartet, J  = 12.4, 2 H PhCH2), 5.10 -  5.03 (m, 2 H, CH=Ctf2) 4.91 (tdd, J  
= 8.4, 3.8 and 2.3 1 H, CH-allyl), 4.24 (dt, J  = 7.5 and 3.8, 1 H, C5HnCHN), 3.23 
(ddd, J  = 19.1, 9.9 and 2.8, 1 H, one of CH2C=C), 2.93 (apparent dt, J  = 19.1 and 9.4, 
1 H, one of CH2C=C), 2.58 -  2.52 (m, 1 H, one of Ctf2CH=CH2), 2.39 (apparent dt, 
J = 14.7 and 7.8, 1 H one of CH2 CH=CH2), 1.98 (ddd, J = 18.6, 12.9 and 9.9 1 H, 
one of pyrrolidine CH2 CH2), 1.80 (apparent ddt, J  = 12.9, 9.1 and 2.8, 1 H, one of 
pyrrolidine CH2 CH2\  1.50 -  1.43 (m, 1 H, one of C4H9C//2CH), 1.43 -  1.35 (m, 1 H, 
one of C4H9C//2CH), 1 .3 0 -1 .1 1  (m, 6 H, 3 x pentyl CH2), 0.79 (t, J  = 6.9, 3 H, 
CH3).
13C NMR (125 MHz; CDC13): 8 = 175.9 (C=S), 165.3 (C=0), 150.8 (C=CN), 136.0 
(aromatic C), 133.3 (CH=CH2), 128.6 (2 x aromatic CH), 128.3 (aromatic CH),
128.2 (2 x aromatic CH), 118.7 (CH=CH2), 100.3 (C=CN), 66.2 (CH20), 62.4 (CH- 
allyl), 51.2 (CH-pentyl), 37.9 (CH2CH=CH2), 36.8 (CH2C=C), 31.4 (pyrrolidine 
CH2CH2), 30.6 (C4H9CH2), 24.7 (pentyl CH2), 23.8 (pentyl CH2), 22.5 (pentyl CH2), 
14.0 (CH3C4H8).
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(3S/?,7/?S)-Benzyl 7-allyl-l-(methylthio)-3-pentyl-3,5,6,7-tetrahydropyrrolo[l,2-
c]pyrimidine-4-carboxylate (213).
IN 'oH S
c 5h
O
OBn
SMe
212 2 1 3
Iodomethane (2.82 g, 20 mmol) was added to a solution of a diastereomeric mixture 
of isomers of benzyl 7-allyl-3-pentyl-l-thioxo-l,2,3,5,6,7-hexahydropyrrolo[l,2- 
c]pyrimidine-4-carboxylate (212) (2.2:1 mixture of diastereoisomers 2.0 g, 5.2 
mmol) in dichloromethane (4 mL) and refluxed for 18 hours. The resulting solution 
was cooled to 25 °C and dry triethylamine (2.1 mL, 20 mmol), added. The resulting 
solution stirred for 30 minutes at 25 °C. Solvent was removed in vacuo to give a 
yellow oil purified by flash column chromatography (eluent 12:1 hexane:ethyl 
acetate) to give the title compound as a single diastereoisomer (980 mg, 46 %) as a 
pale oil.
IR (Neat): 2927, 2855, 2686, 2650, 2594, 1455, 1384, 734, 697 cm 1.
lU NMR (500 MHz; CDC13): 6 = 7.32 -  7.20 (m, 5 H, aromatic CH), 5.65 (dddd, J  =
17.2, 10.1, 7.8 and 6.2, 1 H, Ctf=CH2), 5.08 (apparent bs, 2 H, CH20 ) 5.06 (dd, J  =
17.2 and 1.2, 2 H, one of CH=CH2), 5.04 (dd, J  = 10.1 and 1.2, 1 H one of CH=CH2) 
4.58 (dd, J  = 1 2  and 3.6, 1 H, pentyl CHN), 3.98 -  3.91 (m, 1 H, CH allyl), 3.13 
(ddd, J -  18.2, 5.5 and 3.8, 1 H, one of C/f2C=C), 2.76 (apparent dt, J  = 18.2 and
10.3, 1 H, one of C //2C=C), 2.65 (apparent broad dd, J  = 13.7 and 5.6, 1 H, one of 
CH2CH=CH2), 2.32 (s, 3 H, SCH3), 2.10 -  2.02 (m, 1 H, one of C//2CH=CH2), 1.85 
-  1.78 (m, 2 H, pyrrolidine CH2Ctf2), 1.57 -  1.47 (m, 1 H, one of C4H9C//2CH), 1.46 
-1 .3 1  (m, 1 H, one of pentyl CH2C//2CH), 1.30 -  1.11 (m, 6 H, 3 x pentyl CH2),
0.78 (t, J  = 6.9, pentyl CH3). Assignments confirmed by ^ ^ H  COSY NMR 
spectroscopy.
I3C NMR (125 MHz; CDC13): 5 = 166.9 (C=0), 152.6 (C=CN), 148.8 (C-SCH3),
136.9 (aromatic C), 133.7 (CH=CH2), 128.5 (3 x aromatic CH), 127.8 (2 x aromatic 
CH), 118.3 (CH=CH2), 96.1 (C=CN), 65.3 (CH20), 59.6 (CH-allyl), 56.2 
(C5H„CH), 39.1 (CH2CH=CH2), 36.9 (CH2C=C), 31.9 (pyrrole CH2CH2), 29.3
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(C4H9CH2CH), 26.4 (pentyl CH2), 24.1 (pentyl CH2), 22.7 (pentyl CH2), 14.1 
(CH3C4H8), 13.8 (SCH3).
MS-ES: m/z (%) = 413 (MH+, 100).
HRMS-ES: m/z [M + H]+ calcd for C24H33N20 2S: 413.2263; found: 413.2263. 
(S)-tert-Butyl 2-(iodomethyl)-5-oxopyrrolidine-l-carboxylate (216).106
N B oc N B oc
2 1 5  2 1 6
Sodium iodide (13.6 g, 90 mmol) was added to a solution of (S)-tert-butyl 2-oxo-5- 
(tosyloxymethyl)pyrrolidine-l-carboxylate (215) (1.76 g, 6.6 mmol) in acetonitrile 
and refluxed for 4 hours. The resulting suspension was filtered and the solvent 
removed in vacuo. The resulting solid was recrystalised from ethanol to give the title 
compound (1.33 g, 62 %) as a white crystalline solid.
*H NMR (500 MHz; CDC13): 5 = 3.78 (dt, J  = 11.5 and 5.8, 1 H, CHN), 3.17 (d, J  = 
5.8, 2 H, CH2I), 2.43 -  2.35 (m, 1 H, one of CH2CO), 2.30 -  2.20 (m, 1 H, one of 
CH2CO and one of CH2C //2), 1.80 -  1.72 (m, 1 H, one of CH2CH2).
13C NMR (125 MHz; CDC13): 8 = 178.5 (C=0), 55.2 (CHN), 30.4 (CH2CO), 27.4 
(CH2CH), 11.8 (CH2I).
tert-Butyl 2-(formylmethyl)-5-oxopyrrolidine-l-carboxylate (217).
N B ocN B oc
1 9 8  217
tert-Butyl 2-allyl-5-oxopyrrolidine-l-carboxylate (198) (100 mg, 0.4 mmol) was 
added to a solution of potassium osmate (5 mg) 2,6-lutidine (43 mg 0.4 mmol) and 
sodium metaperiodate (340 mg, 1.6 mmol) in dioxane:water (3:1) and the resulting
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solution stirred for 18 hours at 25 °C. The resulting solution was diluted with water 
(100 mL) and extracted with dichloromethane (3 x 75 mL). The dichloromethane 
layers were dried over magnesium sulphate and the solvent was removed in vacuo to 
give a dark brown oil. The residual brown oil was purified by flash column 
chromatography (eluent 4:1 hexane:ethyl acetate) to give the title compound (86 mg, 
93 %) as a clear gum.
IR (neat): 2978,2925, 1784, 1752, 1715,1458, 1311,1152 cm 1.
‘H NMR (500 MHz; CDCI3): 8 = 9.73 (t, J  = 1.2, 1 H, CHO), 4.58 (tdd, J = 8.8, 3.8 
and 2.3, 1 H, CHN), 2.95 (broad apparent dd, J  = 17.4 and 3.8, 1 H, one of 
CH2CHO), 2.65 (ddd, J  = 17.4, 8.8 and 1.2, one of Ctf2CHO), 2.52 (ddd, J = 17.8,
10.8 and 9.1, 1 H, one of CH2CO), 2.41 (ddd, J  = 17.8, 9.5 and 3.1, 1 H, one of 
CH2CO), 2.23 (m, 1 H, one of CH2CH2), 1.68 (apparent ddt, J  = 13.2, 9.1 and 2.6, 1 
H, one ofCH 2C //2).
13C NMR (125 MHz; CDC13): 8 = 199.1 (aldehyde C=0), 173.6 (amide C=0), 149.9 
(carbamate C=0), 83.7 (OC), 52.9 (CHN), 48.1 (CH2CHO), 31.2 (CH2CO), 28.1 
((CH3)3), 23.6 (CH2CH2).
(2/?)-5-[l -Ethoxy carbonyl-meth-(Z)-ylidene]-pyrrolidine-2-carboxylic acid ethyl 
ester (151).
1
f  N B oc
C 0 2Et
C 0 2Et
2 1 9
A solution of lithium diisopropylamide (4.0 mL, 2 M solution in heptane, 8.0 mmol) 
in THF (15 mL) was cooled to -78 °C. Ethyl acetate (0.78 mL, 8.0 mmol) in THF (4 
mL) was added over 25 minutes. After stirring for 20 minutes at -78 °C, ethyl (R)-l- 
terf-butoxycarbonyl-5-oxopyrrolidine-2-carboxylate (2.1 g, 7.8 mmol) in THF (5 
mL) was added over 30 minutes at -78 °C. The solution was then allowed to warm to 
25 °C and left to stir for 18 hours. Saturated aqueous ammonium chloride (100 mL) 
was added and the solution extracted with dichloromethane (3 x 100 mL). The
N B oc
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combined organic layers were washed with brine (2 x 150 mL), dried over 
magnesium sulphate and the solvent removed in vacuo to give a yellow oil (2.48 g,
7.2 mmol) which was dissolved in TFA (1.1 mL, 14.5 mmol). The resulting solution 
was stirred for 3 hours at 25 °C. Excess TFA was removed in vacuo and the 
resulting, oil dissolved in dichloromethane (5 mL). Saturated aqueous sodium 
carbonate was added until neutral to pH paper, and the organic material extracted 
into dichloromethane (3 x 100 mL). The combined organic layers were dried over 
magnesium sulphate and the solvent removed in vacuo. The resulting yellow oil was 
purified by flash column chromatography (eluent 4:1 hexane:ethyl acetate) to give 
the title compound (1.3 g, 71 %) as a pale yellow oil.
Data identical to compound 151.
(3S,7/?)-diethyl 3-((S)-2,2-dimethyl-l,3-dioxolan-4-yl)-l-thioxo-l,2,3,5,6,7-
hexahydropyrrolo[l,2-c]pyrimidine-4,7-dicarboxylate (220) and (3/?,7/?)-diethyl 
3-((S)-2,2-dimethyl-l,3-dioxolan-4-yl)-l-thioxo-l,2,3,5,6,7-hexahydro- 
pyrrolof 1,2-c ] pyri midine-4,7-dicarboxylate (221).
C 0 2 Et
NH
C 0 2Et
+ NH
C 0 2Et
2 1 9 220 221
(/?)-2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde (260 mg, 2 mmol) in 
dichloromethane (5 mL) was added to a solution of trimethlysilyl isothiocyanate (260 
mg, 2 mmol) in dichloromethane (10 mL). The resulting solution was stirred for 30 
minutes at 25 °C under a nitrogen atmosphere. (2/?)-5-[l-Ethoxycarbonyl-meth-(Z)- 
ylidene]-pyrrolidine-2-carboxylic acid ethyl ester (219) (455 mg, 2 mmol) in 
dichloromethane (5 mL) was added and the mixture stirred at 25 °C under a nitrogen 
atmosphere for a further 30 minutes. The reaction was quenched with sodium 
hydroxide (0.5 M, 50 mL) and the mixture extracted with dichloromethane (3 x 50
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mL). The combined dichloromethane layers were dried over magnesium sulphate and 
the solvent removed in vacuo to give the crude title compound as a yellow oil.
NMR spectrum (500 MHz; CDCI3) for crude compounds (220) and (221).
1—r 1 1 1 I 1 1 1 r 
3.00  :
1—1—1—1—|—1—r 
I 2.00
1 1 I 1 1 r
1.50
1 1 1 1 I 1
I 0.005.50 5.00 4.00 3.50 2.504.50 1.00 0.50
ppm (II)
Selected peaks: 8 = 5.20 (dd, J  = 9.5 and 3.7, 1 H, CHN 220), 5.03 (d, J  = 8.7, 1 H, 
CHN 221), 4.62 -  4.57 (m, 2 H, CtfNH both 220 and 221).
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(35,75)-diethyl 3-((S)-2,2-dimethyl-l,3-dioxolan-4-yl)-l-thioxo-l,2,3,5,6,7-
hexahydropyrrolo[l,2-c]pyrimidine-4,7-dicarboxylate (222) and (3/?,7S)-diethyl 
3-((S)-2,2-dimethyl-l,3-dioxolan-4-yl)-l-thioxo-l,2,3,5,6,7-hexahydro- 
py rrolo [ 1,2-c] pyrimidine-4,7-dicarboxy late (223).
NH
151 222 223
(/?)-2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde (260 mg, 2 mmol) in
dichloromethane (5 mL) was added to a solution of trimethlysilyl isothiocyanate (260 
mg, 2 mmol) in dichloromethane (10 mL). The resulting solution was stirred for 30 
minutes at 25 °C under a nitrogen atmosphere. (2S)-5-[l-Ethoxycarbonyl-meth-(Z)- 
ylidene]-pyrrolidine-2-carboxylic acid ethyl ester (151) (455 mg, 2 mmol) in 
dichloromethane (5 mL) was added and the mixture stirred at 25 °C under a nitrogen 
atmosphere for a further 30 minutes. The reaction was quenched with sodium 
hydroxide (0.5 M, 50 mL) and extracted into dichloromethane (3 x 50 mL). The 
combined dichloromethane layers were dried over magnesium sulphate and the 
solvent removed in vacuo to give the crude title compound as a yellow oil.
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]H NMR spectrum (500 MHz; CDCI3) for crude compounds (222) and (223).
’ 1 1 n  1 1 1 1 1 1 'r 1 1 1 M 1 1 ! 1 1 1 1 1 11 1 1 t  1 1 1 1 1 11 1 1 1 11 11 1 11 1 1 1 1 1 1
5.50 5.00 4.50 4.00 3.50 3.00 2.50 2.00 1.50 1.00
ppm (11)
Selected peaks: 8 = 5.20 (dd, J  = 9.5 and 3.7, 1 H, CHN 222), 5.02 (d, J  = 8.9, 1 H, 
CHN 223), 4.62 -  4.57 (m, 2 H, CHNH both 222 and 223).
(3/?,7S)-ethyl 7-((tert-butyldimethylsilyloxy)methyl)-3-heptyl-l-thioxo-
1.2.3.5.6.7-hexahydropyrrolo[l,2-c]pyrimidine-4-carboxylate (224a) and
(3S,7S)-ethyl 7-((tert-butyldimethylsilyloxy)methyl)-3-heptyl-l-thioxo-
1.2.3.5.6.7-hexahydropyrrolo[l,2-c]pyrimidine-4-carboxylate (224b).
/
TBSO
T B SO  TBSO
58  2 2 4 a  224b
C7H7 n 15
NH
Silicon tetraisothiocyanate (91 mg, 0.35 mmol) was added to a solution of octanal 
(45 mg, 0.35 mmol) in dichloromethane (15 mL) and the resulting solution stirred for 
30min at 25 °C under a nitrogen atmosphere. Ethyl 2-[(5/?)-5-({[fc?rt-
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butyl(dimethyl)silyl]oxy}methyl)pyrrolidinylidene] ethyl ester (58) (100 mg, 0.35 mmol) in 
dichloromethane (5 mL) was added and the mixture stirred at 25 °C under a nitrogen 
atmosphere for a further 3 hours. Excess solvent was removed in vacuo. The residue 
was redissolved in chloroform and filtered through celite and the solvent removed in 
vacuo to give the crude title compound as a mixture of diastereoisomers (140 mg, 85 
%) as a pale yellow oil.
1H NMR spectrum (500 MHz; CDCI3 ) for crude compounds (224a) and (224b).
jLA.
M M | M , I | I I M | I IT ' [ M I I | I I I I | I I I
7.50 7.00 6.50 6.00 5.50 5.00
11111111111 r  11111111111111' 1111111111111111111111
4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.504.50 0.00
ppm (f1)
Selected peaks: 8 = 5.02 -  4.95 (m, 1 H, CHN 224a), 4.69 -  4.63 (m, 1 H, CHN 
224b), 4.29 -  4.24 (m, 2 H, CHNH both 224a and 224b).
213
3-Pentyl-1 -thioxo-1,2,3,5,6,7-hexahy dropy rrolo[l ,2-c]pyrimidine-4-carboxylic 
acid (225)
EtO
SM e
HO
SM e
208 225
Ethyl 1 -(methylthio)-3-pentyl-3,5,6,7-tetrahydropyrrolo[l ,2-c]pyrimidine-4-
carboxylate (208) (500 mg, 1.6 mmol) in methanol (3 mL) was added to a solution of 
sodium hydroxide in methanol (10 %, 15 mL) and heated in a sealed tube at 100 °C 
for 18 hours. The reaction was quenched with saturated ammonium chloride and 
extracted into dichloromethane (2 x 50 mL). The combined dichloromethane layers 
were dried over magnesium sulphate and the solvent removed in vacuo to give the 
crude title compound (380 mg, 84 %) as a pale yellow oil.
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}H NMR (500 mHz, CDCI3) spectrum for compound 225.
I I ! I 1 1 1 1 I 1 
6.00
1 1 1 I 1 1 1 1 I 1 1 1 1 I 1 1 1 1 I 1 1
5.50 5.00 4.50 4.00
i , i | i i , i p - n - r p - r  , , , 
3.00 2.50 2.00
1 1 1 1 I 1 1 1 1 I r_T
) 1.00 0.506.50 1.50
ppm (11)
Selected peaks: 8 = 4.24 -  4.20 (m, 1 H, CHN), 3.97 -  3.93 (m, 2 H, CH2N), 3.66 (s, 
3 H, CH3), 3.24 (ddd, J  = 18.4, 8.5 and 3.6, 1 H, one of CH2C=C), 2.93 (dt, J  = 18.4 
and 9.3, 1 H, one of CH2C=C), 2.50 -  1.85 (m, 2 H, CH2CH2  pyrrolidine), 1.55 -
1.36 (m, 2 H, pentyl-C//2CH), 1.30 -  1.15 (m, 6 H, 3 x pentyl CH2), 0.8 (t, J  = 6.6, 3 
H, CH3).
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Appendix A 
Compound List
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